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DIETARY MODULATION OF CANINE METABOLISM FOR OBESITY MANAGEMENT 
AND CANCER RISK REDUCTION 
 
 Metabolic aberrancies associated with environmental exposures and excess 
adiposity can increase risk for multiple chronic diseases. Obesity is the primary nutritional disorder 
of companion dogs and incidence and prevalence rates continue to increase, yet littl  is known 
about underlying metabolic disruption in obese dogs or the role of environmental contaminas to 
which companion dogs are exposed. Cooked common beans (Pha eolus vulgaris, L.) are a rich 
source of macro-, micro-, and phytonutrients that have potential to support healthy weig t 
management in dogs, modulate metabolism, and decrease risk for chronic disease, but have yet to 
be evaluated for safety and digestibility in dogs. Given the prevalence of obesity in companion 
dogs and the potential of bean consumption to improve health, the overarching hypothesis for thi  
dissertation is that cooked beans are well tolerated and palatable in dog food and beneficially 
modulate underlying metabolic pathways associated with canine obesity and environmental 
exposures. The major objectives in this dissertation were to 1) determine environmental exposures 
and obesity associated metabolic aberrancies in companion dogs; 2) investigate the feasibility, 
safety and digestibility of incorporating cooked bean powders into nutritionally complete dog food 
formulations; and 3) determine the effects of weight loss and bean intake on metabolic p rameters. 
To accomplish these objectives, 66 clinically healthy, adult companion dogs of various breed  and 
genders were recruited to participate in randomized, controlled bean-based dietary int rvention 
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studies performed at Colorado State University Veterinary Teaching Hospital and Wellington 
Animal Hospital. The specific hypotheses tested were: 
 Companion dogs are exposed to detectable levels of environmental pollutants and 
exhibit altered metabolomes associated with obesity.  
 Dry dog foods formulated with 25 % weight/weight cooked bean powders are safe, 
digestible, and well tolerated compared to a nutrient matched control diet.  
  Dogs consuming bean-based diets will have altered lipid and carbohydrate 
metabolism, reduced inflammation, increased expression of satiety gut hormones, 
and decreased insulin resistance.  
We first determined the background exposures to pesticides as detected in urine from 21
normal weight dogs. Urine samples collected from the dogs were screened for a panel of 301 
pesticides using an established ultra-performance liquid chromatography-mass spectrometry 
(UPLC-MS/MS) platform. Fifteen distinct pesticides were detected: the most frequently detected 
compounds in canine urine were atrazine, fuberidazole, imidacloprid, terbumeton, and clopyralid. 
We next evaluated 66 clinically healthy dogs that were normal weight, overweight, or obese for 
differences in serum biochemistry, microbiome, and metabolome. The proportion of overweight 
and obese dogs with hemolysis, creatinine kinase, and aspartate aminotransferase (AST) levels 
outside reference ranges was higher than normal weight dogs. Levels of AST, chloride, and 
gamma-glutamyl transpeptidase were lower in overweight or obese dogs. The fecal microbio es 
were evaluated in a subset of 50 dogs using 16S Illumina based sequencing. The fecal microbiome 
comprised, in order of abundance, the phyla Firmicutes, Bateroidetes, Proteobacteria, nd 
Actinobacteria. Significant variation existed between all dogs with no differenc s found at the level 
of phyla, class, order, family, or genus level. The fecal, plasma, and urine metabolome of 66 dogs 
were evaluated by liquid chromatography (LC) and gas chromatography coupled to mass 
spectrometry (MS), and 266 compounds were differentially expressed by weight phenotype. 
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Difference in plasma metabolites accounted for 44 % of the variation between normal weight,
overweight, and obese dogs.  
To determine the safety and digestibility of incorporating cooked bean powders into 
nutritionally complete dog foods, three clinical trials were carried out. Dogs consuming bean-based 
diets maintained indices of adequate nutritional intake as mandated by the Association of 
American Feed Control Officials (AAFCO) feeding trials. Bean-based diets were as digestible as 
the matched, standard ingredient, control (CON) dog foods. In overweight dogs undergoing weight 
loss, the black bean (BB) diet had higher total dry matter and crude protein digestibility and both 
the navy bean (NB) and black bean diets had higher carbohydrate digestibility than the CON diet. 
No increased flatulence or major change in fecal consistency was reported by any of the owners for 
any dogs.  Normal weight dogs consuming beans had lower serum cholesterol levels than the CON
dogs, and dogs undergoing weight loss on bean-based diets had decreases in serum HDL, LDL, 
and triglycerides. Metabolites associated with lipid, carbohydrate, and protein metabolism were 
altered in bean consuming dogs; however in dogs undergoing weight loss, the greatest shift in the 
metabolome was observed in response to weight loss, independent of diet.  
This work highlights the utility of metabolomic platforms for evaluating the metabolism 
of dogs and determining intervention responsive metabolic pathways. These data provide a 
foundation for continued investigation into the role of beans for healthy weight management and 
obesity and cancer prevention in dogs.   
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CHAPTER 1: INTRODUCTION 
OBESITY PREVALENCE, HEALTH RISKS, AND MANGAEMENT IN COMPANION 
DOGS 
The human obesity epidemic remains at an all-time high in the United States with recent 
estimates showing that 39 % of all adults and 17 % of children are obese.1 While the prevalence 
of human obesity seems to have stabilized over the last 10 years1, the incidence of companion 
dog obesity is still increasing2: up to 40 % of dogs are overweight or obese in the U.S.3, and 
canine obesity prevalence is also high in the UK4, Australia5, and in China.6  
Health Risks and Metabolic Dysfunction Associated with Obesity  
Excess adipose tissue is associated with an increased incidence of disease in both humans 
and dogs. The economic impact of obesity related health problems underscores the significance 
of the increased risk. For example, on a per capita basis in the U.S., the average medical 
spending for obese humans is 42 % higher than for lean humans.7 Similarly, overweight dogs 
tend to require medical intervention for chronic diseases 2-3 years earlier than lean dogs.8 Obese 
humans and dogs are at higher risk for developing orthopedic disease, such as osteoarthritis, 
cardiorespiratory complications, diabetes mellitus, dyslipidemia, urinary tract disorders, 
hormonal and reproductive anomalies, and some types of cancer.9; 10 Some of the most 
challenging consequences of obesity to address are the sub-clinical aberrancies that often precede 
the development of overt disease.10 Figure 1 summarizes the relationship between metabolic 
dysfunction associated with obesity and the increased risk for the development of disease.  
Obesity is associated with dysregulated metabolic pathways that are often summed 






mellitus and cardiovascular disease. Metabolic syndrome is clinically diagnosed with a 
combination of abdominal adiposity, hyperlipidemia, inflammation, and insulin resistance and is 
associated with increased risk of heart disease and insulin independent diabetes.11 In a tudy of 
35 obese dogs, 20 % met the criteria for metabolic syndrome.12 Some authors argue the merit of 
diagnosing metabolic syndrome in dogs on the basis that cardiovascular disease is less common 
in dogs than people and that the type of diabetes seen in dogs is closer to the human type I 
diabetes.13 However, the characteristics of metabolic syndrome in dogs still demonstrate 
underlying adipose dysfunction that merit further investigation to determine the relationship 
between obesity, metabolic dysfunction, and the increased risk for chronic disease.   
The Complexities of Weight Management 
In its simplest form, the cause of obesity is an energy imbalance: more energy is 
consumed than is expended, leading to an expansion of adipose tissue.10 However, the 
environment, feeding and begging behavior, and individual physiology may all play roles in 
determining energy requirements, expenditure, and consumption in dogs.14; 15  
Emerging evidence supports the role of environmental exposures in obesity and increased 
risk for chronic disease (Figure 1). Organophosphorus pesticides can increase insulin resi ta ce, 
alter glucose and lipid metabolism, and increase inflammation.16 High exposures to some organic 
contaminants are associated with increased levels of circulating glucose, insulin cholesterol, and 
triglycerides, as well as higher body mass index (BMI).17 Adult mice orally exposed to an 
organophosphate experienced significant increases in body weight, ad libitum food consumption, 
serum cholesterol, and insulin resistance.18 In obese rats exposed to an empirically derived, 
environmentally relevant mixture of contaminants, Mailloux et al. demonstrated alterations in 






Further demonstrating the relationships between obesity, altered metabolism, and pesticide 
exposures, Arrebola et al. demonstrated that certain pesticide exposures increased risk for 
hypertension, but only in individuals with a BMI over 26.3 kg/m2.20 The role of environmental 
contaminate exposures in canine obesity merits investigation, however little is known about 
baseline exposures in dogs, much less the physiological effects.  
Multiple strategies exist to address weight management, including pharmacological, 
behavioral, exercise, and diet interventions. The primary target for the majority of weight 
management strategies starts with a diet or nutritional intervention that helps improve satiety, 
maintain lean muscle mass, and a healthy nutritional status.21-24 Given the continued rise in 
canine obesity, novel dietary strategies are warranted to prevent and manage obesity in 
companion dogs. Common beans merit investigation as an ingredient in dog food as they have 
the potential to improve weight management in companion dogs, as well as reduce the risk for 
multiple chronic diseases and obesity associated comorbidities. The following section will 







Figure 1: Metabolic dysfunction associated with obesity and environmental exposures. This figure 
summarizes data from human, dog, and murine studies demonstrating the effects of obesity and exposures to 








BEANS ARE AN IMPORTANT FOOD FOR WEIGHT MANAGEMENT  
Common beans (Phaseolus vulgaris, L.), such as black, pinto, and navy beans are edible, 
dry, non-oil seeds, or pulses, in the legume family.25 They comprise over half of the consumed 
legumes worldwide25, with over 18 million metric tons produced globally each year.26 Of the 
bean classes grown in the U.S., the most common are pinto, followed by navy, and black.27 
Legumes represent an important crop for increasing environmentally sustainable agriculture 
practices because of their unique ability to fix nitrogen into soil25 and potential to reduce reliance 
on resource intensive animal protein production28, legumes can support the nutritional 
sustainability29 of dog food formulations. In addition to providing potential environmental 
benefits, bean consumption is associated with improved health and weight management. For 
example, in epidemiological studies, bean intake is inversely associated with all-cause 
mortality30 and strongly associated with longevity31, higher intakes of fiber and minerals, better 
weight management, and lower blood pressure.32 Beans contain unique macro and micronutrients 
when compared to other grains33 and consumption has been shown to reverse dyslipidemia34-36, 
reduce inflammation37-39, improve gut hormone expression and insulin sensitivity40-42, modulate 
apoptotic markers43, and support a healthy microbial community.44 Figure 2 summarizes the 
potential of common bean intake to correct metabolic aberrancies directly and through healthy 











Cooked common beans are excellent sources of macro-, micro-, and phyto-nutrients that 
work together to support healthy weight management.45 On average, cooked, dehydrated 
common beans contain about 70 % total carbohydrates, up to 30 % total dietary fiber, 15-30 % 
protein, less than 2 % crude fat, and supply about 386 Kcal/100 g dry matter.46-48  
Table 1 shows the specific profiles of black and navy beans, the two cultivars evaluated 
in this dissertation for use in dog food formulations.   
Figure 2: The role of bean intake to reduce risk for chronic disease directly and through healthy 
weight management. This figure represents the potential benefits of bean intake and weight management to 
ameliorate metabolic aberrancies associated with environmental exposures and obesity (Figure 1) to reduce 












Bean carbohydrates can be categorized by the methods used to detect them and by their 
dietary interactions with a mammalian host. Cooked common beans contain 50 %- 70 % total 
carbohydrate, the majority of which is starch (up to 30 % of dry matter) and fiber (up to 30 % of 
dry matter).49 The remaining carbohydrates are primarily made up of polysaccharides and 
oligosaccharides, but also contain some disaccharides and monosaccharides.49; 50  Sucrose and 
fructose make up the majority of the monosaccharides, while stachyose, raffinose and verbascose 
make up the oligosaccharides.51 About 85 % of the starch fraction can be digested by mammalian 
enzymes, the remaining 15 % is classified as resistant starch.52 The digestible starch of cooked 
whole beans provides approximately 26 % rapidly digestible starch, 17 % slowly digestible 
starch, and 12 % very slowly digestible starch. Cooked whole beans have a starch digestibility 
index of 4853, compared to wheat bread with an index of 10054, resulting in a low glycemic 
response.55  
Fiber 
Fiber is defined as the non-digestible carbohydrates and lignin content.56 A 
preponderance of evidence in human studies support that fiber intake is inversely associated with 
excess body weight and may improve weight loss by altering gut hormone expression, 
decreasing energy density of food, improving satiety, and altering nutrient metabolism and 
Table 1: Nutrient and energy composition of cooked black 
and navy beans by proximate analysis. 
Per 100 g Dry Matter Black Bean Navy Bean 
Carbohydrate, g 69.21 71.98 
Total Dietary Fiber, g 25.39 29.01 
Protein, g 25.86 22.74 
Total lipid, g 1.58 1.71 
Ash, g 3.36 3.59 
Energy, kcal 385 387 






absorption in the intestine.57 In normal weight dogs, high fiber diets, especially those with 
fermentable fiber58, have been shown to reduce caloric intake. When high fiber diets are 
combined with 30 % protein, satiety also improved.59 In overweight colony beagles fed a weight 
management diet, a fiber supplement lowered caloric intake and increased weight loss.60; 61 
Companion dogs that consumed a high fiber and high protein diet lost, on average, 12 % more 
body weight with a 20 % greater loss of body fat mass than dogs consuming a high protein, 
moderate fiber diet.62  
Fiber composes about half of the total carbohydrate fraction of cooked common beans 
and total dietary fiber ranges from 14 -30 % of the total dry matter.49; 50 The fiber content of 
cooked beans is attributed with decreasing serum cholesterol levels, increasing satiety, 
improving weight management, and inhibiting the growth of cancer cells.45; 50; 63-67 
 Increasing bean intake in dogs, humans, and lab animals has had a minimal impact on 
the composition of a healthy, stable gut microbiota44; 68; 69, but  instead seems to alter the 
metabolic function of the bacteria in the gut by increasing short chain fatty acid (SCFA) 
production.70 Propionate production increases both in ex vivo colonic fermentations44 and in 
plasma samples of individuals consuming beans.70 Butyric acid has been shown to increase with 
in vitro bean fermentations, and in rats fed a bean-based diet, is also associated with increasing 
lipid oxidation by altering carbohydrate metabolism in the liver.71 Increased SCFA production 
may represent an important mechanism for the observed decreased lipemia, increased satiety, 
and improved weight loss associated with bean intake.72; 73  
Protein and Amino Acids 
Total dry matter of cooked, common beans comprises up to 30 % protein, about twice 






globulins74, the primary globulin is phaseolin, a storage protein with low levels of sulfur-
containing amino acids. Thus the amino acid profiles of beans tend to be low in methionine, but 
high in lysine.25 The albumin fraction contains lectins and enzyme inhibitors which are present in 
high amounts of raw beans and include alpha-amylase inhibitors and Bowman-Birk trypsin and 
chymotrypsin inhibitors – the presence of which are almost negligible after cooking.75 
Independently, lectins, alpha-amylase inhibitors and Bowman-Birk inhibitors demonstrate 
modulation of gut hormone secretion, interference with tumor cell growth and metabolism, 
influence on the gut microbiome, decreases in inflammation, and modulation of lipid 
metabolism.75 Given the observation of these effects in clinical trials and epidemiological 
studies, cooked bean proteins may retain enough inhibitory activity to confer a health benefit, 
while minimizing any potential nutritional deficit.75 Beans are also relatively high in arginine and 
glutamine, thermogenic amino acids that further modulate both carbohydrate and fat metabolism 
for improved glycemic control and weight loss.71 
Micronutrients 
Beans are exceptionally high in B vitamins, magnesium, and potassium. Beans are also 
rich in phosphorus, calcium, iron, and zinc, but low in sodium.25 Linder, et al. evaluated the 
micronutrient concentration in a range of dog food diets when fed at caloric restriction levels 
suitable for weight loss. Magnesium, riboflavin, and niacin were among the micronutrients fou d 
to be deficient in commercial diets when at restricted levels.24 Thus, beans have the potential to 
support micronutrient sufficiency during weight loss in dogs. Furthermore, the high potassium 
and low sodium content in beans have the potential to beneficially modulate blood pressure, 








A wide range of small, bioactive molecules in beans provide additional health and weight
management benefits. Cooked beans have alpha-amylase inhibition activity that may be 
associated with slowing carbohydrate digestibility in the small intestine and reducing dietary 
energy extraction.75 While bean derived alpha-amylase inhibitors have been used to improve 
human weight loss, the compounds isolated from raw bean extracts have had variable results in
clinical trials.77 Phytates also lower carbohydrate digestibility, and in high concentrations, can 
chelate calcium, iron, zinc, and magnesium.25 Phytate is the primary storage molecule of 
phosphorus in plants78 and while it is reduced with both soaking and cooking79, bean seeds 
selected for low phytate concentration have been shown to improve iron absorption in women.78 
While this study did not report the protein content of the low phytate bean cultivars, other plants 
have shown a direct correlation between phytate content and protein content.25 Furthermore, 
phytates demonstrate strong chemopreventive properties80 and serum lipid lowering activity45 
indicating that in low concentrations, they may confer more of a health benefit than a nutritional 
liability in the context of a balanced diet formulation. Cooked common beans contain a wide 
range of polyphenols that include phenolic acids, flavonoids, and triterpenic acids. Total 
phenolics acids reported in cooked bean cultivars average around 1,600 ug/100 g dry matter 
gallic acid equivilents and some abundant acids include ferulic acid, o-coumaric and p coumaric 
acid, sinapic acid, and caffeic acid.81 Beans with colored seed coats tend to have the highest 
concentration of flavonoids including catechin, genistein, epicatechin, kaempferol, and some of 
the polyphenol resveratrol.81 In general, polyphenols have been shown to reduce inflammation, 
cardiometabolic disease, oxidative stress, and inhibit the cell cycle of neoplastic cell .64; 65; 81-85 






improved weight loss and dyslipidemia by altering fat metabolism and improving glucose 
homeostatsis.86-90 Cooked beans also contain the phytosterols -sitosterol, stigmasterol, and 
camesterol - plant-derived lipids with structural similarity to cholesterol63. Phytosterols have 
been shown to reduce hyperlipidemia by competitively inhibiting cholesterol incorporation into 
micelles at the intestinal lumen, upregulating reverse transporters in enterocytes that increase the 
rate at which lipids are excreted back into the lumen after initial absorption, and finally by again 
competitively inhibiting the incorporation of cholesterol into chylomicrons.91 
 
DISSERTATION AIMS AND HYPOTHESES 
Given the prevalence of obesity in companion dogs and the potential of bean 
consumption to improve health, our goal was to investigate the feasibility, safety, and 
digestibility of incorporating cooked bean powders into nutritionally complete dog food 
formulations. The overarching hypothesis for this dissertation research project is that cooked 
beans are well tolerated and palatable in dog food and beneficially modulate underlying 
metabolic pathways associated with canine obesity and environmental exposures.  Our overall 
objectives were to 1) determine environmental exposures and obesity associated metabolic 
aberrancies in companion dogs; 2) investigate the feasibility, safety, and digestibil ty of 
incorporating cooked bean powders into nutritionally complete dog food formulations; and 3) 
determine the effects of weight loss and bean intake on metabolic parameters. Our goal was to 
formulate bean-based nutritionally complete dog diets with isocaloric and nutrient matched bean-
free control diets and to investigate the effects of these diets on nutritional, clinical, met bolic, 
inflammatory, and endocrine function in normal weight and overweight companion dogs. Navy 
and black beans were chosen based on their availability in the U.S. and their differences in seed 






cultivars are presented in Table 1. Sixty-six clinically healthy, adult, male and female dogs of 
diverse breeds participated in one of three clinical trials. The characteristics of individual dogs 
are presented in Appendix 1. The specific aims, experiments, and hypotheses are detailed below 
and summarized in Figure 3. 
Specific Aim 1: Determine canine environmental and obesity related exposures.  
Experiment 1A: Measure pesticide exposures in normal weight dogs. Exposure to 
environmental contaminants has been associated with increased risk for obesity, metabolic 
dysfunction, and chronic disease in humans and lab animals, and has been minimally 
investigated in companion dogs. Because natural exposures have not previously been reported in 
companion dogs, our objective was to determine baseline exposures to agrochemicals, believed 
to be important sources of potential metabolic and endocrine disruptors, which may increase risk 
for obesity and chronic disease. This experiment is presented in Chapter 2: Multiresidue analysis 
of pesticides in urine of healthy adult companion dogs.92  
 Hypothesis: Companion dogs are exposed to low dose mixtures of pesticides that 
can be detected in urine using an agrochemical mass spectrometry based 
screening panel.  
Experiment 1B: Determine differences in serum biochemistry, metabolome, and 
microbiome between normal weight, overweight, and obese dogs. Multiple studies have reported 
minor differences in clinical blood analytes and the microbiome of normal and overweight dogs; 
however differences in the metabolome have not yet been investigated. The objective of this 
experiment was to determine potential differences in this cohort of Northern Colorado dogs by 
comparing clinical blood analytes and metrics, the microbiome, and the metabolome that reflect 






This experiment is presented in Chapter 3: Serum biochemistry microbiomes, and metabolomes 
of clinically healthy normal weight, overweight, and obese dogs.  
 Hypothesis: Overweight and obese dogs have higher levels of organ stress, altered 
gut microflora, and metabolic aberrancies than normal weight dogs.   
Specific Aim 2: Determine safety and digestibility of bean-based dog foods 
Experiment 2A: Evaluate the safety and digestibility of a navy bean-based diet in dogs 
for weight maintenance. Given the potential health benefits of bean consumption in companion 
dogs, the objective of this experiment was to determine the safety and digestibility of a 25 % 
weight/weight navy bean diet compared to a matched, placebo control diet for adult dog weight 
maintenance. This experiment is presented in Chapter 4: Effects of cooked navy bean powder on 
apparent total tract digestibility and safety in healthy adult dogs.93  
 Hypothesis: A nutritionally complete, navy bean-based diet is equally digestible, 
palatable, tolerable, and supports weight maintenance and nutritional 
requirements of adult companion dogs, compared to a matched control diet. 
Experiment 2B: Determine the safety and digestibility of navy and black bean-based 
diets in overweight dogs undergoing weight loss. Our objective was to determine if a bean-based 
diet is digestible and meets the nutritional requirements of adult dogs undergoing short- and 
long-term calorically restricted weight loss compared to an isocaloric, nutrient matched control 
diet. This experiment is presented in Chapter 5: Navy and black bean-based dog foods are 
digestible during weight loss in overweight and obese adult companion dogs.  
 Hypothesis: Nutritionally complete black and navy bean-based diets support 
healthy weight loss, are digestible, and nutritionally adequate for short- and long-
term calorically restricted companion dog weight loss compared to a control diet.  
Specific Aim 3: Determine the effects of consuming a bean-based diet on the ca ine metabolome, 
serum biochemistry, gut hormones, and inflammation.  
Experiment 3A: Determine the effects of consuming beans on the normal weight canine 






molecule profiles of a nutritionally complete dog diet and the effects of consumption on serum 
lipids and metabolism in healthy, normal weight adult dogs. This experiment is presented in 
Chapter 6: Consumption of cooked navy bean powders modulates the canine fecal and urine 
metabolome.94  
 Hypothesis: We hypothesized that the addition of navy bean powder results in 
distinct phytochemicals compared to the control diet and that consumption of the 
navy bean diet modulates the chemical composition of the canine fecal and urine 
metabolome.  
Experiment 3B: Determine the effects of consuming beans during weight loss on canine 
biochemistry. The objective of this study was to measure changes in clinical, serum biochemistry 
of adult dogs undergoing weight loss on a bean-based or control diet. This experiment is 
presented in Chapter 7: Nutritional weight loss therapy with cooked bean powders regulates 
serum lipids and biochemical analytes in overweight and obese dogs.95 
 Hypothesis: Overweight and obese dogs undergoing calorically restricted weight 
loss will have improved serum biochemical profiles and dogs consuming a bean-
based diet will have improved serum lipid profiles compared to dogs consuming a 
matched, no-bean diet.  
Experiment 3C: Determine the effects of consuming beans during weight loss on the 
canine metabolome, inflammasome, and gut hormones. The objective of this study was to 
evaluate the metabolic changes that occur in dogs during short term weight loss and the influence 
of bean consumption on metabolism. This experiment is presented in Chapter 8: Eff cts of bean 
consumption on canine metabolism and inflammation during calorically restricted weight loss.   
 Hypothesis: Dogs consuming a bean-based diet during weight loss will have 
alterations in lipid and carbohydrate metabolism, reductions in inflammatory 
cytokines, less reduction in satiety hormones and increases in insulin sensitizing 






Figure 3: Overview of study design for investigating the role of bean-based diets for improving canine health. Dogs completed a double-blinded, 
randomized, controlled dietary intervention clinical trial to evaluate the safety, digestibility, and feasibility of incorpo rating 25 % weight/weight 






CHAPTER 2: MULTIRESIDUE ANALYSIS OF PESTICIDES IN URINE OF HEALTHY 
ADULT COMPANION DOGS1 
INTRODUCTION 
Chronic diseases are the leading cause of death in both dogs and humans and prevalence 
is expected to increase.96; 97 While there are multiple risk factors, the association between 
pesticide exposure and chronic disease risk has been of increasing public health concern. 
Environmental pesticide exposures in humans have been associated with heart disease, obesity, 
arthritis, cancer, respiratory disease, diabetes, and neurodegenerative disorders.98 Em rging 
evidence supports that when exposures occur in combination, the aggregate, unintended 
consequences of pesticide toxicity increase99-101, the effects cannot be simply accounted for by 
summing the effects from compounds in isolation102, and therefore highlights the need to study 
relevant chemical mixtures. Studies investigating the effects of complex toxicant mixtures are 
difficult in that the exposure doses of the known pesticides can vary substantially103, nd the 
cumulative exposures during critical phases of growth and development are largely unknown. 
Thus it has been challenging to interpret results from studies that demonstrate a single target 
mechanism of action for a specific pesticide exposure and for determining a relationship to 
disease pathogenesis. Advancements are being made in overcoming the challenges associated 
with the study of complex mixtures.104 For example, improved instrumentation methods have 
helped to establish lower limits of detection for many chemicals, permitting more accurate body-
burden assessments with health and/or disease outcomes.  
                                                 
1 This chapter was published in Environmental Science and Technology December 2014:48(24):14677-85. 
Doi: 10.1021/es503764s. Authors are Genevieve M. Forster, Dustin G. Brown, Greg P. Dooley, Rod L. 






Companion dogs are relevant to study because they develop similar complex human 
diseases such as cancer.105; 106 Shared lifestyles of dogs and humans support their use as 
biosentinels for monitoring environmental exposure107, and was demonstrated with development 
of mesothelioma in dogs whose owners were regularly exposed to asbestos.108 Elevated levels of 
flame-retardants and associated toxins found in dog serum109, pesticides in urine after exposure 
to treated lawns110; 111, and concentrations of organohalogenated compounds in dog serum were 
reported in 2011 to be consistent with reported levels in humans. 112 Studies that have 
demonstrated associations between exposure to environmental contaminants and canine disease 
risk in dogs include: 1) exposure to 2,4-dichlorophenoxyacetic acid  and increased risk of 
transitional cell carcinoma113; 2) a diagnosis of lymphoma and herbicide exposure114; 3) topical 
insecticide use and increased risk for bladder cancer115; and 4) the presence of pyrethroids in 
adipose tissue adjacent to canine mammary tumor tissues and the aggressiveness of the tum r
phenotype.116 Monitoring environmental exposures in dogs has the potential to increase our 
knowledge of human exposures, alongside our understanding of mechanisms for disease 
progression. 
Until recently, a background exposure profile in healthy individuals has been difficult to 
establish for a defined population given lifestyle differences, namely variation in diet, living 
environment, travel, illness, and geographical location.103; 117; 118 Advances in mass spectrometry 
applications, including metabolomics, provides a unique opportunity for toxicologists to advance 
our knowledge of low dose chemical mixtures in humans and animals.119 This study was 
designed to determine a chemical exposure mixture relevant to healthy companion dogs on 
controlled ingredient diets during a one-month period.120 A panel that was validated for detecting 






samples from a cohort of healthy dogs to assess total exposure.  The findings presented 
demonstrate the complexity of chemical mixtures of environmental organic compounds across 
diverse, companion dog breeds. 
 
MATERIAL AND METHODS 
Diets 
Two diets were formulated and fed to pet dogs as previously described: “Control” and 
“Navy Bean”.120 Both diets were matched in nutrient and energy content and contained rice, 
corn, wheat, beet pulp, flaxseed, meat and bone meal, and poultry fat. Corn and wheat 
ingredients were adjusted in the navy bean diet to account for the inclusion of 25% 
weight/weight cooked navy bean powder.120  Diets were formulated to meet the Association of 
American Feed Control Officials and Nutritional Research Council guidelines for adult dog 
maintenance.121; 122 Both kibble diets were extracted and analyzed for presence of pesticides.  
Canine Participants and Urine Collection 
Twenty-one clinically healthy, adult, male and female companion dogs, of various breeds 
and normal weights were enrolled at the Flint Animal Cancer Center and Veterinary Teaching 
Hospital at Colorado State University as part of a dietary intervention trial  to investigat  the 
digestibility of dry beans as a major ingredient in dog food.120 The study veterinarian determined 
the enrolled dogs were clinically healthy upon determination of a normal physical exam and 
blood chemistry results. Owners completed a health history questionnaire for each dog and were 
asked to provide information on any medication use including anthelmintics or supplements.  






tick prevention. Dogs were recruited from the Fort Collins, CO area, which consisted of both 
rural and urban environments; water sources were primarily municipal, and specific data on 
drinking water sources was not collected. As previously described, dogs were randomized to one 
of two dietary groups: “Control” or “Navy Bean”, n=11 and 10, respectively.120 Owners were 
instructed to exclusively feed the study diets, and were provided with diet logs to record any 
additional food consumed by the dogs. Table 2 shows the month of each urine sample collection, 
the major animal and plant ingredient of each diet consumed before starting the study, and any 
common treats or table scraps fed as reported by owners.  
 
 
Table 2: Urine collection dates and baseline dietary intake for 21 clinically healthy dogs evaluated for 
pesticide exposure. 
Dog ID 
Collection Date (2010) Baseline Diet Major 
Ingredients Treats and Snacks1 Baseline 4 Week 
NB1 August August Chicken and Wheat Biscuits, CET chews, human food 
NB2 August August Lamb and Rice Milk bones 
NB3 August September Chicken and Corn Che ie’s a d Puri a Dog Bis uits 
NB4 August September Meat/Bone Meal and Corn Biscuits and table scraps 
NB5 August September Meat/Bone Meal and Corn Human food, bones, and rawhides  
NB6 August September Meat/Bone Meal and Corn Human food, bones, and rawhides 
NB7 September October Chicken and Corn Dog biscuits 
NB8 September October Meat/Bone Meal and Corn Dog biscuits 
NB9 September October Chicken and Rice Peanut butter 
NB10 September October Chicken and Corn  
C1 August August Chicken and Corn  
C2 August August Chicken and Pea Hills dental and chicken jerky treats 
C3 August September Chicken and Rice Rawhide chews 
C4 No Sample September Chicken and Rice Rawhide chews 
C5 August September Chicken and Rice  
C6 September October Chicken and Corn Milk Bones 
C7 September October Chicken and Corn Bread 
C8 September October Chicken and Corn Science diet biscuits 
C9 No Sample October Chicken and Corn Science diet biscuits 
C10 October November Chicken and Rice  
C11 October November Chicken and Rice  






Two urine samples were collected either by “free-catch” as urine was voided or by 
ultrasound-guided cystocentesis, before (“baseline”) and after consuming a study diet for 4 
weeks. Urine samples were stored at -80°C until the time of analysis. Two of the “Control” dogs 
had insufficient amounts of urine for pesticide detection at baseline and were excluded from 
statistical analysis, however all 4 week urine samples were screened and presented.  Uri ary 
pesticide detection data from both baseline and 4 week timepoints were obtained for a total of 19 
dogs. All study protocols were approved by the Colorado State University Institutional Animal 
Care and Use Committee and dog owners provided informed consent for study participation.  
 Pesticide Extraction 
Approximately 1 mL of each urine sample was adjusted to pH 5.2 with a 2M sodium 
acetate buffer and incubated with 10 μL of -glucuronidase (Sigma, St Louis, MO) for 2 hr at 
55°C. Urine samples were diluted 1:10 into 9 mL of Milli-Q water and spiked with 20 μL of 10 
μg/mL D5-atrazine (Sigma Aldrich) as an internal standard. A total of 5 g of each dog food diet 
was manually homogenized in 5 mL of Milli-Q water and also spiked with 20 μL of 10 μg/mL 
D5-atrazine. Diet and urine samples were extracted using Agilent SampliQ QuEChERS kits 
designed to follow AOAC Method 2007.01. Briefly, 15 mL of 1 % acetic acid in acetonitrile was 
added to each sample in a pre-cleaned 50 mL conical falcon tube. One pre-weighed packet 
containing 6 g of magnesium sulfate (MgSO4) and 1.5 g sodium acetate (NaOAc) was then 
added and the sample shaken vigorously for 1 min.  Solid material was separated by 
centrifugation at 2000 RCF.  An 8 mL aliquot of supernatant was taken and added to a 15 mL 
vial containing 400 mg of primary and secondary amino sorbent and 1200 mg MgSO4. 
Dispersive solid phase extraction was achieved by vortexing samples for 2 min and then 






nitrogen gas to 500 μL, and diluted to 1 mL with 5mM ammonium formate/0.01 % formic acid 
for Ultra Performance Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (UPLC-
MS/MS) analysis.  
UPLC-MS/MS Qualitative Pesticide Analysis 
This 301 pesticides screening method utilized UPLC-MS/MS with electrospray 
ionization in the positive mode. The instrument used in the analysis was an Agilent 1290 UPLC 
coupled to an Agilent 6460 triple quadrupole mass spectrometry, which was equipped with an 
ESI source using Agilent Jet Stream Technology (Agilent, Santa Clara, CA). Pesticides were 
separated on a Zorbax Eclipse Plus C18 column (2.1X 150mm, 1.8 μm particle size) (Agilent) at 
60 °C.  A volume of 15 μL from each diet and urine sample was injected and a binary mixture of 
5mM ammonium formate/0.01 % formic acid (A) and methanol with 5mM ammonium 
formate/0.01 % formic acid (B) at a flow rate of 0.5 mL/min. The gradient used was 4 % B 
increasing to 98 % B at 15 min, and held for 5 min. The ionization source conditions used were 
as follows: nebulizer gas flow of 5 L/min at 325 °C and 30 psi; sheath gas flow of 11 L/min at 
375 °C; and the capillary voltage 3500 V. The optimized fragmentor, collision energy, and two 
MS-MS transitions for each analyte were imported to the method from the Agilent Pesticide 
Screening Dynamic Multiple Reaction Monitoring (MRM) Database (Agilent # G1733AA). The 
dwell times for the transitions were maximized based on the number of concurrent MRMs. A test 
mix containing 136 pesticides was run prior to each sample set to calibrate retention time 
windows at 100 ng/mL for each analyte. The data collection and processing were performed by 
using Agilent MassHunter software (v. B.04.01). Samples were analyzed using Agilent Mass 
Hunter Quantitation software (v. B.04.01). For each sample, individual pesticides were inspected 






the pesticides were confirmed by retention time and the product ion ratio correlation between the 
sample peaks and corresponding standards (+/- 20 %). Table 3 lists the detected compounds, 
retention times, and precursor and product ions detected. 







ions (m/z) Classification EPA Registered Use 




corn, sorghum, sugarcane, and 
residential lawns 123 








Citrus, pineapple, and non-
agricultural weed control 124 




Clopyralid 2.00 192.0 
174.0 
110.0 
Herbicide Sugarbeets, mint, and wheat 125 
Ethoxyquin 11.38 218.2 
174.1 
148.0 
Insecticide Pears 126 















Corn, lettuce, broccoli, apples, 
potatoes 127 














Ornamental, non-crop grasses, 
shrubs, and vines 129 




Legumes, flax, lettuce, safflower, 
lettuce, and fallow land 
Propoxur 8.22 210.1 
168.1 
111.0 
Insecticide Indoor applications 130 
Pymetrozine  3.57 218.1 
105.0 
79.0 
Insecticide Fruit and vegetables 131 
Spinosad A 13.20 732.5 
142.1 
98.0 
Insecticide Fruit, vegetables and grains 132 




Thiabendazole  6.57 202.0 
175.0 
131.1 
Fungicide Fruit, vegetables and grains 133 




Wheat, barley, pastures, and 
rangeland 134 







LC-MS/MS Quantitative Atrazine Analysis 
Urine samples were prepared for analysis by spiking β00 μL of urine with β5 μL of 1μg/ 
D5 atrazine, as an internal standard, followed by briefly vortexing. Two hundred μL of ice cold 
acetonitrile was added, samples vortexed again, and then centrifuged at 10,000 RCF for 5 
minutes. Supernatants were transferred to autosampler vials for LC-MS/MS analysis. The 
instrument used in the analysis was an Agilent 1290 UPLC coupled to an Agilent 6460 triple 
quadrupole mass spectrometry, which was equipped with an ESI source using Agilent Jet Stream 
Technology (Agilent, Santa Clara, CA). 
Atrazine was separated on a Zorbax Eclipse Plus C18 column (β.1X 100mm, γ.5μm 
particle size) (Agilent) at 40 °C. A sample volume of 10μL was injected and a binary mixture of 
0.1 % formic acid (A) and acetonitrile/0.01 % formic acid (B) at a flow rate of 0.5 mL/min. The 
gradient used was 40 % B increasing to 100 % B at 5 min. The positive ionization source 
conditions used were as follows: nebulizer gas flow of 8 L/min at 325 °C and 45 psi; sheath gas 
flow of 11 L/min at 390 °C; and the capillary voltage 3500 V. The ion transitions monitored for 
atrazine were 216.1->132 /174.1 m/z and 221.1 ->179.1 for D5-atrazine. Atrazine identifications 
were confirmed by retention time (1.47 mins) and the product ion ratio (13.2) correlation 
between the sample peaks and corresponding standards (+/- 20 %).  Samples were quantitated 
with linear regression using Agilent Mass Hunter Quantitation software (v. B.04.01). The lower 
limit of quantification for atrazine in dog urine for this study was 20 pg/mL or 20 parts per 
trillion.  
Determination of Pesticide Bioactivity Potential 
Pesticides with positive detections in canine urine were screened in the Pubchem 






selected, confirmed, and recorded with the BioAssay Identification (AID) number. All results are 
reported in Table 4. 
 
 
Table 4: Reported bioactivities of detected pesticides from PubChem BioAssay database. 
Pesticide1 Bioactivity 
Atrazine 
Activates cAMP Responsive Element signaling (AID: 662)  
Activates insulin secretion (AID: 743287) 
Carcinogenic (AID: 1189, 1208, 1205) 
Inhibits the activation of platelets (AID: 1663) 
Fuberidazole 
Activates the  AhR signaling pathway (AID:743085, 743122) 
Agonist of the ER-α signaling pathway (AID: 743079) 
Genotoxic (AID: 720516) 
Imidacloprid 
Inhibits cell surface uPA activity preventing formation of plasmin (AID: 540303) 
Inhibits tyrosyl-DNA phosphodiesterase I (AID: 686978) 
Thiabendazole 
 
Activates the  AhR signaling pathway (AID: 743085) 
Increases SMN2 gene splice variant expression (AID: 1458) 
A ti ates ’UTR Ste -Loop Driven Prion Protein mRNA translation (AID: 1999) 
Activates BRCA1 Expression (AID: 624202) 
Agonist of the  ER-α sig ali g path a  (AID: 743079) 
Inhibits insulin promoter activity (AID: 1273) 
Inhibits tubulin formation (AID: 742594) 
Genotoxic (AID: 720516) 
Clopyralid Activates the AhR signaling pathway (AID: 743085) 
Nicotine 
Agonist of the nAchR (AID: 742462) 
Agonist of the AR signaling pathway (AID: 743036) 
Bupirimate 
 
Disruptor of mitochondrial membrane potential (AID: 720635)  
Antagonist of the GR signaling pathway (AID: 720725) 
Antagonist of the AR signaling pathway (AID: 743122, 743063, 743054) 
Antagonist of the PPAR-  sig ali g path a  (AID: 743199) 
Agonist of the antioxidant response element signaling pathway (AID: 743219) 
Propham Agonist of the ER-α sig ali g path a  (AID: 743079) 
Metobromuron Activates the AhR signaling pathway (AID: 743122, 743085) 
Ethoxyquin 
 
Antagonist for Hypoxia Response Element Signaling Pathway (AID: 915)  
Inhibits Cytochrome p450 isoforms (AID:  894, 899, 883, 884, 1851)  
Activates Caspase-3/7 (AID: 588813)  
Inhibits hydroxyacyl-coenzyme-A dehydrogenase, Type II (AID: 886) 
Inhibits 15-human lipoxygenase  1 and 2 (AID: 881, 887) 
Inhibits hydroxysteroid (17-beta) dehydrogenase 4 (AID: 893) 
Inhibits Histone Lysine Methyltransferase G9a (AID: 504332) 
Inhibits vitamin D receptor (AID: 504847) 
Inhibits bromodomain adjacent to zinc finger domain, 2B (AID: 504333) 
Inhibits human tyrosyl-DNA phosphodiesterase 1 & 2 (AID: 686979, 720702) 
Activates heat shock response signaling pathway (AID: 743228) 
Agonist of the PPAR-  sig ali g path a  (AID: 743094, 743140) 
Activates the AhR signaling pathway (AID: 743122) 
Antagonist of the thyroid receptor signaling pathway (AID: 743065) 
Agonist of the antioxidant response element signaling pathway (AID: 743202) 
1https://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi. AhR: aryl hydrocarbon receptor; AR: androgen receptor ER-α: 
estrogen receptor-alpha; GR:  glucocorticoid receptor, nAchR: neuronal acetylcholine receptor; PPAR- / : pero iso e 






RESULTS AND DISCUSSION 
Pesticide screening reveals mixed chemical exposures in dogs.  
The purpose of this study was to assess pesticide exposure in a cohort of twenty-one, 
clinically healthy adult dogs by analyzing diets and urine using a targeted UPLC-MS/MS 
pesticide screening panel. Fifteen pesticides that have not been previously reported in dog urine 
were detected at either baseline or 4 week time points (Figure 4, A and B) in 19 of the 21 dogs 
with both baseline and 4 week urine samples. Eight pesticides were detected at both time points.  
In order of detection frequency, indicated by the percent of positive dogs at baseline and 4 
weeks, respectively, were atrazine (100 % and 100 %), fuberidazole (74 % and 53 %), 
imidacloprid (42 % and 26 %), terbumeton (21 % and 11 %), hydroxyatrazine (11 % and 5 %),  
triasulfuron (5 % and 21 %), clopyralid (5 % and 5 %), and nicotine (5 % and 16 %). At baseline 
thiabendazole (11 %), propham (5 %), and metobromuron (5 %), were detected; however these 
three pesticides were below detection limits in all dogs at four weeks. Bupirimate (5 %), 
spinosad A (5 %), and propamocarb (5 %) were detected at 4 weeks only. Individual exposure 
profiles are shown for each of the 21 dogs at baseline and 4 weeks (Figure 4C). In the first of the 
two dogs with unavailable baseline data, atrazine, fuberidazole, and triasulfuron were detected in 
the 4 week sample and in the second dog, atrazine and ethoxyquin were detected. The use of 
heartworm prevention was reported in dogs C10 and C11, however the owner did not report the 







 To demonstrate the accuracy of the pesticide detection in urine, Figure 5 shows the 
positive detection of atrazine in a canine urine sample compared to control. The retention time of 
a 50 ng/mL atrazine standard was 1.47 min, which was identical to the peak detected in the urine 
sample. The ion ratio of the product ions 174 m/z and 132 m/z was 14.2 for the 50 ng/mL 
atrazine standard. The product ion ratio for the peak detected in the urine sample was 14.6, 
Figure 4. Detected pesticides in dog urine at baseline and 4 weeks. Detection frequency is shown in 
figures A and B. Each bar represents the total number of dogs screened for urinary excretion of pesticides by 
UPLC-MS/MS. The dark shaded portion of each bar represents the number of canine urine samples in which 
the pesticide was detected and the light shaded portion of the bar indicates the number of urine samples that 
the pesticide was not detected at (A) baseline and (B) after 4 weeks of controlled dietary intake. Profile 
exposures for each dog are shown at baseline and 4 weeks, where detected pesticides are illustrated by a dot 







which was within 10 % of the atrazine standard. This positive detection methodology was 
applied to all pesticides detected in this study. -glucuronidase was added to remove glucose 
moieties in urine, however detoxification of pesticides could include metabolites that undergo 
conjugation, hydrolysis, oxidation, methylation, and acetylation. Future detection panels for 
biomonitoring should account for biotransformation of parent pesticides and recent 
advancements in pesticide and metabolite identification as well as non-targeted metabolomics 
have improved biomonitoring capabilities.119 The UPLC-MS/MS screening method utilized in 
this study was selected for the advantage of high-throughput sensitivity and specificity as this 
profile of pesticide residues have not been reported in dogs from natural exposures. The 
comparative quantification of these residues between urine samples using this method is 
imprecise due to potential differences in extraction efficiencies, ion suppression potential, and 
Figure 5. Validation of atrazine identification. )on ratio correlation for atrazine’s 
qualifier (216.1 > 132.0) and quantifier (216.1 > 174.1) ions in (A) 50ng/mL standard and 
(B) an individual dog urine sample at 4 weeks. Positive identifications were confirmed by 






urine concentration between biological replicates. Importantly, a relatively large number of 
parent pesticides were detected in canine urine, which supports the inclusion of parent 
compounds for biomonitoring and the utility of UPLC-MS/MS as a screening tool.  
Atrazine levels in canine urine were below limits of quantificaton.  
Given that atrazine was detected all in canine urine samples, we next quantified atrazine 
using LC-MS/MS quantification methods. Atrazine was only found in 3 samples above the limi  
of quantification equal to 20 pg/mL (20 parts per trillion). One dog with both baseline and 4 
week timepoints had atrazine present in levels above the limit of quantification: 108.6 pg/mL at 
baseline and 86.9 pg/mL at 4 weeks. The third sample with quantifiable atrazine exposure levels 
was one of the dogs excluded from previous analysis due to the lack of a baseline urine sample. 
This dog’s urine had 117.1 pg/mL at the 4 week time point. Blank samples spiked with D5-
atrazine did not contain atrazine product ions indicating the atrazine peaks in urine were 
authentic and not the result of an impurity of the internal standard at low levels. Hydroxyatrazine 
was detected in 2 dogs and may have been the result of either atrazine metabolism or exposure to 
the hydroxylated metabolite of atrazine. The screening panel did include metabolites of atrazine 
but none were detected in urine samples.  
Diet effects on urinary pesticide contents.  
To determine the contribution of dietary intakes to canine pesticide exposure, we 
controlled the diets of all dogs for 4 weeks. The control diet was formulated using common pet 
food ingredients of corn, wheat, rice, poultry, and meat and bone meal. Wheat and corn were 
decreased and 25 % weight/weight replaced with a novel cooked navy bean powder ingredient. 
120 Pesticide detection in the study diets consisted of the insecticides pymetrozine, azinophos-






5). No commonly used crop pesticides included in 
our screening panel were detected in the study 
provided diets, yet some of the classes of 
chemicals were detected in urine, such as 
triazines, benzimidazoles, carbamates, and 
pyrimidines. The detected pesticides with elimination or absorption data available, the report d 
half-life is less than 48 hours: atrazine135, triazines in general136, clopyralid 137,  imidacloprid138, 
nicotine139, terbumeton140, and triasulfuron.141  
These findings suggest that the acute dietary intake was not the primary route of pesticide 
exposure in this companion dog cohort study, however, given the wide variety of dog foods 
available and the potentially diverse sources of ingredients globally, future investigations should 
still consider dietary pesticide exposures, the relevant time frame for exposures to accumulate in 
the host, and other, non-dietary, sources of exposure, such as water, air, and exposures to 
medications. 
Pesticide Bioactivities.   
Atrazine, fuberidazole, imidacloprid, thiabendazole, clopyralid, nicotine, bupirimate, 
propham, metobromuron, and ethoxyquin have records of bioactivity as indexed in the PubChem 
BioAssay database (Table 4). These data suggest that this mixture of pesticides has potential to 
impact xenobiotic transformation by activating the aryl hydrocarbon receptor (AhR) and 
modulating cytochrome p450 expression (fuberdiazole, thiabendazole, clopyralid, 
metobromuron, and ethoxyquin).142-147 Energy metabolism may also be affected by atrazine, 
thiabendazole, bupirimate, and ethoxyquin by modulating insulin secretion and activity, 
disrupting oxidative phosphorylation by disrupting membrane potential, and via preventing 
Table 5: Detected pesticides in canine diets. 
Pesticide 
Detection in Diet 
Control Navy Bean 
Pymetrozine     
Fuberidazole     
Bromacil     
Propoxur     
Azinophos-Ethyl ND   






reduction of nicotinamide adenine dinucleotide during -oxidation.148-151 Cell cycle regulation, 
proliferation, and DNA integrity may also be influenced by imidacloprid, thiabendazole, 
bupirimate, and ethoxyquin by DNA phosphodiesterase inhibition, inducing BRCA1 expression, 
promoting oxidative stress, and activating caspases.152-156 Modulation of endocrine function by 
atrazine, thiabendazole, nicotine, bupirimate, propham, and ethoxyquin may occur via activating  
multiple pathways including the cAMP responsive element signaling upstream of 
phosphodiesterase IV; as well the estrogen receptor alpha (ER-α), androgen receptor (AR), and 
glucocorticoid receptor.90; 157-162 Fluctuations in lipid metabolism and inflammation may occur 
from bupirimate and ethoxyquin as antagonists to the peroxisome proliferator-activated receptor 
(PPAR) signaling pathway and inhibitors of lipoxygenases.163-166 Protein expression 
modifications both directly and epigenetically were shown by thiabendazole and ethoxyquin via 
induction of gene splice variations,  activation of translation, and inhibition of histone 
methlytransferases.167-169  Increased prevalence of chronic diseases in dogs and humans in 
conjunction with emerging evidence supporting that pesticide exposure increases risk for chronic 
diseases provide the rational for more rigorous pesticide mixture biomonitoring.98 Moreover, 
exposure effects of pesticides as single compounds may be exacerbated by exposures to complex 
mixtures of chemicals.170 This study confirmed the presence of a complex mixture of pesticides 
in a cohort of healthy dogs and demonstrates low-dose, environmentally relevant contents. 
Further research is warranted to determine the exposure duration, possible synergies, and dose 
dependent effects of combined pesticide exposures on chronic disease risk. Results from broad-
spectrum screening methods, as applied in this study, demonstrating a wide range of low-leve  






complex exposure combinations and a mechanistic understanding of how environmental 
toxicants may impact health merit continued analysis throughout the lifespan.171  
Companion dogs as sentinels for human environmental exposures and models for disease.  
Dogs and humans share the same living environments and thus harbor a similar variety of 
exposures from materials, air, water, and food. Dogs experience a shorter lifespan than humans, 
allowing for cost effective and timely prospective studies. By utilizing companion dogs as 
sentinels for environmental exposures in humans and increasing our capability to screen for 
multiple chemicals, we can determine relevant mixtures for future studies that will help to better 
understand how pesticide mixtures target multiple cell pathways important for health and 
affecting disease risk.107 The findings  reported herein suggest that more advanced biomonitoring 
studies will be needed to investigate synergistic and dose dependent effects of relevant pesticide
exposures as chemical mixtures as was recently accomplished for parabens.103 This study 
highlights a significant knowledge gap with respect to environmental toxicant burden in healthy, 
adult, companion dogs and demonstrates the feasibility for continued investigations of the canine 
exposome during the lifespan, and the relationships to health and disease.2 
 
  
                                                 
2 We would like to thank Amy Keller and Cadie Tillotson for their technical assistance. EPR and DGB are 
members of the Halifax Project (www.gettingtoknowcancer.org) which was established to collate 
information on relevant, low-dose mixtures of chemical exposures and has provided a conceptual 






CHAPTER 3: SERUM BIOCHEMISTRY, MICROBIOMES, AND METABOLOMES OF 
CLINICALLY HEALTHY NORMAL WEIGHT, OVERWEIGHT, AND OBESE DOGS 
INTRODUCTION 
Obesity is a serious multi-factorial nutritional disorder impacting over half of all dogs in 
developed countries. Overweight and obese dogs are at greater risk for multiple diseas s ncluding 
osteoarthritis, dyslipidemia, and cardiovascular disease, and some types of cancer, and suffer from 
decreased quality of life and shorter life expectancy.10; 172 Advancements are being made in the 
nutritional management of obesity and emerging evidence supports the role of the owner’s
awareness of obesity related issues, socioeconomic status, activity level, and veterinary 
supervision.21 Recent studies have demonstrated alterations in serum biochemistry 173, intestinal 
microflora composition 174, inflammatory biomarkers 175, and gut hormones 176 between obese and 
normal weight dogs, however the impact of these parameters on disease outcome are largely 
speculative.  
Metabolomics is the study of global metabolite profiles present in a sample at a snapshot in 
time and may provide a deeper layer of metabolic analysis to determine subclinical metabolic 
alterations that are associated with disease outcomes.177 Metabolomic platforms have been used in 
multiple species to demonstrate previously unknown alterations in amino acid, lipid, and 
carbohydrate metabolism with underlying links to inflammation, oxidative stress and perturbations 
in the gut microflora177-190, however, this approach has been minimally applied to understanding 
obesity in dogs.  
The objective of this study was to determine difference metabolic differences in normal 






biochemistry and metabolic panels, evaluated the fecal gut microflora, and assessed the fecal, 
plasma and urine metabolome of 66, clinically healthy, adult, companion dogs of various ages, 
breeds, genders, and levels of excess adiposity. We hypothesized that OW and OB dogs will have 
higher levels of serum lipids, altered microflora composition, and shifts in the metabolome 
associated with altered lipid, amino acid, and carbohydrate metabolism when compared to NW 
dogs.       
METHODS AND MATERIALS 
Canine Participants and Sample Collection 
Informed, written consent was obtained from all owners before dogs began participation in 
the study. Dogs were enrolled at the Colorado State University Veterinary Teaching Hospital (Fort 
Collins, CO) and the Wellington Veterinary Hospital (Wellington, CO).  
Clinically healthy adult dogs with no known medical problems or dietary allergies were 
recruited to participate in one of three previously reported clinical trials (Chapters 4 & 5, Table 
6).95; 120 A physical exam was performed by a study veterinarian and a complete serum 
biochemistry panel and whole blood cell differential performed to confirm that each dog was 
healthy prior to enrollment. A Body Condition Score (BCS) was assigned to each dog on a 9-point 
scale 191 where a score of 5 is considered “i eal” and every unit increase in BCS over 5 
corresponds to a 10-15 % increase in bodyweight, such that a BCS of 8/9 corresponds to 
approximately an 30 % excess bodyweight. Dogs with a BCS of 4-5/9 were considered “normal 
weight” (n=17), dogs with a BCS of 6-7/9 were considered “overweight” (n=27), and dogs with a 
BCS 8-9/9 were considered “obese” (n=22)192. Signalment data were also collected from owners 
and medical records and included breed, age, and sex. A wide range of breeds were repres nted in 






n=5; Terriers (American Pit Bull and Boston), n=5; Border Collie and mixes, n=1 and n=4, 
respectively; Golden Retriever, N=4; Australian Shepherd and mixes, n=3 and 1, respectiv ly; 
Hounds (Daschund and Basset), n=3; Dalmatian, n=2; Saint Bernard, n=2; Spaniels, n=2; Boxer, 
n=1; Corgie, n=1; Karelian Bear Dog mix, n=1, Keeshond, n=1, Rottweiler, n=1; Shiz Shu, n=1; 
Standard Poodle, n=1; Wire-hair Pointer, n=1; and otherwise unknown mixed breeds, n=12.   
Serum samples for biochemical analysis were collected via venipuncture into a tube 
without anticoagulant, allowed to coagulate for 15 minutes and centrifuged for 15 minutes at 1,500 
x g.  Plasma samples for metabolomic analysis and complete blood cell counts were collect d into 
tubes containing EDTA, immediately placed on ice, and centrifuged within 20 minutes of 
collection at 4 °C for 15 minutes at 1,500 x g. The plasma was removed and stored at -80 °C until 
analysis. Urine was collected by free catch or ultrasound guided cystocentesis at the discretion of 
the veterinarian, immediately placed on ice or stored at 4 °C, then transferred to -80 °C in 1ml 
aliquots. Owners were instructed to collect fecal samples within 5 hours of being voided by the 
Table 6: Characteristics of 66 normal weight, overweight, or obese clinically healthy 
dogs analyzed to determine metabolic aberrancies between weight classes. 
 
Normal Weight Overweight Obese p-value2 














Sex4    0.905 
Female 9 16 12  
Male 8 11 10  
1Weight class was determined by Body Condition Score (BCS) using a 9 point scale 
(Laflamme, 1997): Normal Weight, BCS 4-5/9, n=17; Overweight, BCS 6-7/9, n=27; 
Obese, BCS 8-9/9, n=22. 2Continuous variables (age and weight) were evaluated for 
differences across groups using a Kruskal-Wallis test and categorical variables (sex) were 
evaluated using a Chi-square test. P < 0.05 was considered significant. Groups with 
significant differences are indicated with different letter superscripts.  3Age as reported by 
owner. 4All dogs were neutered with the exception of one male in the normal weight group, 






dog. Fecal samples were immediately frozen after collection and stored at -20 °C, lyophilized until 
dry, and stored at -80 °C until extracted for microbial and metabolomic analysis.  
Serum Biochemistry and Hemograms 
All clinical analyses were performed at the Clinical Pathology Laboratory t Colorado 
State University as previously described.193 Briefly, serum biochemical analysis was performed 
under standard conditions on a clinical chemistry analyzer (Hitachi 917, Roche Diagnostics; 
Indianapolis, IN) and the complete blood count was performed on an automated analyzer (Advia 
120, Bayer; Tarrytown, NY).  
Microbiome Analysis 
In brief, DNA was extracted from 150 mg of lyophilized stool using the MO BIO 
PowerFecal DNA isolation kit (MO BIO Laboratories, Carlsbad, CA, USA) per the manufacturer’s 
instructions. The targeted 16S small-subunit ribosomal genes were amplified using universal 515F 
(5’-GTGCCAGCMGCCGCGGTAA-γ’) and 806R GGACTACVSGGGTATCTAAT primers 
(Caporaso et al. 2011) via polymerase chain reaction (PCR) using a 12bp unique Golay barcoded 
primer for each sample (Lauber et al. 2008).  The sample amplicons were subsequently cleaned 
using MO BIO UltraClean-htp 96 Well PCR Clean-Up Kits (MO BIO Laboratories, Carlsbad, CA, 
USA), quantified using the Quant-iT PicoGreen dsDNA Reagent and Kits (Life Technologies 
Corporation, Grand Island, NY, USA) and pooled for sequencing.  DNA extraction, amplification 
and cleaning were performed at the Natural Resource Ecology Laboratory at CSU.  
Sequencing was performed on a MiSeq platform (Illumina, San Diego, CA, USA) at the 
RTSF genomic core facility at Michigan State University. Sequences reads were normalized to 
total number of reads. Sequencing data were processed using the Quantitative Insights Into 






taxonomic unit, taxonomy assignment, and UniFrac analyses followed with Principle Coordinates 
Analysis (Lozupone and Knight 2005, Lauber et al. 2009).  
Metabolomic Analysis  
Fecal, plasma, urine, and diet samples were extracted and derivatized as prviously 
described.94 Samples were analyzed by GC and liquid chromatography (LC) coupled to mass 
spectrometry (MS) under previously described conditions.94; 194 Individual features, described by 
mass, charge and retention time were generated in XCMS. The average abundance of uplicate 
injections were normalized to total ion current and clustered together into individual metabolites.195 
The relative abundance of each cluster was calculated based on the weighted sum of all features 
within the cluster and scaled to a median of one. Spectra were screened against in-hou e and 
external libraries including NIST v12 (www.nist.gov), Massbank, Metlin, and Golm 
(http://gmd.mpimp-golm.mpg.de) metabolite databases for annotation. 
Statistical Analysis 
Baseline characteristics of the dogs were evaluated using a Kruskal-Wallis test for the 
continuous variables of age, and weight followed by Dunn’s Multiple Comparison test to 
determine the groups with significant differences. A Chi-square test was used to evaluate groups 
for differences in the categorical variable of sex and presence of abnormal clinicblood values for 
parameters where all expected values were greater than 1 and at least 20 % of the expected values 
were greater than 5. Differences in proportional data were considered significant when p < 0.05, 
and trends were considered when p < 0.10. Clinical blood parameters were analyzed with an 
ANCOVA where both weight class and age were evaluated. Pair-wise comparisons were Tukey-
Kramer adjusted and parameters without normal distributions were log transformed for statistical 






microbiome and metabolome data were evaluated with a one-way ANOVA in R.196 An FDR 
correction was applied to all data with multiple comparisons.197 Significance was considered at a 
corrected p value < 0.1 and trends were considered when p <0.2. For non-corrected p values,
differences were considered significant when p < 0.05, and trends were considered when p < 0.10. 
RESULTS 
Baseline Characteristics of Canine Participants 
Sixty-six adult NW, OW, and OB dogs were enrolled to evaluate differences in serum
analytes, microbiome, and metabolome across weight phenotypes. The baseline charact ristics of 
dogs in each group are presented as medians and interquartile ranges in Table 6. The median age in 
years, as reported by owners in the NW dogs was 3.0 (2.5-4.5), 5.0 (3.0-6.0) in OW, and 5.5 (3.0-
7.0) in the OB group. There was a significant difference in age across the three groups (p = 0.04) 
with the median age of the NW dogs significantly younger than the OB dogs (p < 0.05). The 
median weight of the NW dogs was 22.5 kg (19.4-30.8 kg), 30.6 kg (22.4-37.3 kg) for the OW 
dogs, and 37.7 (24.6 – 39.8 kg) for the OB dogs. As expected, dogs in the OB group were 
significantly heavier than dogs in the NW group (p < 0.05). Ideal weights were calculated for he 
OW and OB dogs based on the assumption of a 10 % increase in total body weight for every unit 
increase in BCS over 5192 and no differences were seen in calculated ideal weights across groups 
(data not shown, p = 0.79). Within the NW group, there were 9 neutered female dogs, 7 neutered 
male dogs, and one intact male dog. In the OW group, there were 15 neutered female dogs, 1 intact 
female dog, and 11 neutered male dogs. In the OB group, there were 11 neutered female dogs, 1 
intact female dog, and 10 neutered male dogs. For the microbiome and urine metabolome analysis, 
fecal samples from a subset of 51 dogs were processed and analyzed. All dogs in the NW remained 






There were no differences in weight, age, or sex distribution of the 66 dogs compared to the subse  
of 51 dogs (p < 0.05, data not shown).  
Serum Biochemistry and Hemograms of Normal Weight, Overweight and Obese Dogs  
Thirty-nine clinical serum and whole blood parameters were measured or calculated for 
all 66 dogs. Parameters evaluated included differential cell counts, cell morphology, and serum 
biochemical analytes (Figure 6). All dogs were considered healthy by the evaluating study 
veterinarian, however 63 of the 66 dogs had at least one value outside of normal ranges in 31/39 
parameters. The most commonly observed parameter outside of normal ranges was the 
albumin:globulin (A/G) ratio which was elevated in 38/66 dogs. The distribution of dogs with 
elevated A/G ratios was not different by weight class (p = 0.962). Fifty-five percent of dogs with 
elevated A/G ratios (21/38) also had increased levels of albumin or decreased levels of globulin 
(data not shown), the distribution of which, was also not different by weight class. Hemolysis of 
blood samples was over 60.0 mg/dL in 25/66 dogs: the distribution across weight class was 
different across weight classes (p = 0.014) with OW dogs having the highest proportion of 
hemolytic samples (15/27), followed by OB dogs (8/22), and then NW dogs (2/17). Creatinine 
kinase (CK) was elevated in 9/66 dogs, all of which were OW or OB: this distribution was 
different across weight classes (p = 0.038), OW dogs had the highest proportion (7/27), followed 
by OB dogs (2/22). Aspartate aminotransferase (AST) was elevated in 5/66 dogs and slightly 
below 16 IU/L in 1 NW and OW dog. All 5 dogs with elevated AST levels were OW (5/27), thus 
the proportion of abnormal values by weight class was different by weight class (p = 0.020). 
Cholesterol was elevated in 5/66 dogs and decreased in one OB dog, the proportion of dogs with 
abnormal values tended to be different by weight class (p = 0.080): NW (2/17), OW (0/27), and 






which were decreased in 14/66 dogs, 13 of which had clumped platelets (data not shown). The 
proportion of dogs with low platelets was equally distributed across weight classes: 5/17 NW, 
5/27 OW, and 4/22 OB (p = 0.631). The proportion of dogs with low levels of potassium, 
globulin, or lymphocytes; high levels of packed cell volume (PCV) hemoglobin, alkaline 
phosphatase (ALP), lipemia, eosinophils, red blood cell counts (RBC),  or calculated osmolality; 
or mixed levels of monocytes was not different by weight class (p > 0.05). A chi square statistic 
could not be calculated for red blood cells (RBC), mean corpuscular volume (MCV), red blood 
cell distribution width (RDW), mean platelet volume (MPV), glucose, sodium, bicarbonate, 
anion gap, segmented neutrophils, magnesium, alanine amino transferase (ALT), nucleated cell 
counts, mean corpuscular hemoglobin concentration (MCHC), or blood urea nitrogen (BUN) as 
these analytes were outside of normal ranges in less than 4 dogs and the distributions did not 
meet the assumptions for calculating a Chi-square statistic (Figure 6). There were no values 
outside of reference ranges for plasma protein, creatinine, phosphorus, calcium, total protein, 





Figure 6: Number of serum, plasma, and whole blood parameters with values outside of reference 
ranges in normal weight, overweight, and obese dogs. Bars indicate the total number of values outside of 
reference ranges for each parameter by weight class: NW = white portion, OW = gray portion, OB= black 
portion. Distribution across was weight classes for each parameter was evaluated for differences using a Chi-
square.  Asterisks (*) indicate parameters with distribution differences by weight class (p < 0.05), pound signs #  indicate a trend p < . , and dots •  indicate parameters from Chi-square analysis. 
Abbreviations: RBC, red blood cell; HGB, hemoglobin; PCV, packed cell volume; MCV, mean corpuscular 
volume; MCHC, mean corpuscular hemoglobin concentration; RDW, red blood cell distribution width; MPV, 
mean platelet volume; BUN, blood urea nitrogen; A/G,  albumin:globulin; CK, creatinine kinase; ALP, alkaline 














































































































































Normal Weigt n = 17
Overweight n = 27






























All measured serum, plasma, and whole blood parameters and reported as medians and 
range (min-max, Table 7). Initially, a non-parametric one-way ANOVA was used to determine 
differences across groups and found that compared to NW dogs, OW or OB dogs had higher levels 
of segmented neutrophils, plasma protein, higher anion gap, CK, and tended to have higher levels 
of albumin; OW and OB dogs also had lower magnesium, lower levels of GGT, sodium, calculated 
osmolality, and AST (data not shown). However, age was found to co-vary with lymphocytes, 
monocytes, phosphorus, globulin, A/G ratios, cholesterol, CK, ALP, ALT and AST. An ANCOVA 
statistical approach was used to control for the effects of age and AST, GGT, and chloride were 
significantly different when age was accounted for. AST was decreased by an average of 4 IU/L in 
OB dogs compared to NW; chloride was decreased on average by 2 mEQ/L; and GGT was 
decreased in both OW and OB dogs by 3 IU/L and 2.5 IU/L, respectively.  No differences were 
seen across groups in nucleated cells, lymphocytes, monocytes, eosinophils, plasma protein, RBC, 
HGB, PCV, MCV, MCHC, RDW, platelets, MPV, glucose, BUN, phosphorus, calcium, 
magnesium, total protein, albumin, globulin, A:G ratio, cholesterol, total bilirubin, ALP, AT








Table 7: Serum biochemistry and whole blood counts of normal weight, overweight, and obese dogs.  







Nucleated Cells 4.5-15.0 x109/L 7.9 (5.8-12.1) 9.3 (5.6-14.7) 10.05 (5.8-15.4) 0.260 
Seg. Neutrophils 2.6-11.0 x109/L 4.9 (2.5-9.3) 6.3 (3.2-10.2) 7.25 (4.3-11.4) 0.109 
Lymphocytes 1.0-4.8 x109/L 2.3 (0.9-4.4) 1.8 (1-3.8) 1.6 (0.6-3.0) 0.641 
Monocytes 0.2-1.0 x109/L 0.5 (0.1-1.0) 0.5 (0.1-0.9) 0.6 (0.1-1.3) 0.978 
Eosinophils3 0.1-1.2 x109/L 0.35 (0.2-2.1) 0.4 (0.1-1.8) 0.4 (0.1-1.1) 0.677 
Plasma Protein - g/dL 6.5 (6.1-7) 6.8 (6.3-7.5) 7 (6.4-7.8) 0.206 
RBC 5.5-8.5 x1012/L 7.3 (6.7-8.5) 7.3 (6.5-9.2) 7.6 (6.7-9.03) 0.510 
HGB 13.0-20.0 g/L 17.2 (15.7-19.6) 18 (16-21) 18.25 (15.8-21) 0.309 
PCV 40-55 % 50 (46-56) 51 (46-60) 53 (44-60) 0.542 
MCV 62.0-73.0x10-15L 68 (64-73) 70 (65-78) 68.5 (37-73) 0.331 
MCHC 33.0-36.0 x109/L 34 (34-36) 35 (34-37) 35 (33-36) 0.221 
RDW 12.0-15.0 % 12.5 (12.1-13.3) 12.9 (11.9-14.5) 13.2 (11.4-13.9) 0.206 
Platelets 200.0-500.0x109/L 239 (142-324) 264 (106-453) 290 (123-444) 0.283 
MPV 7.5-14.6 x10-15L 11.1 (9.6-14.2) 10.4 (8.5-15.3) 11.2 (8.2-16.7) 0.589 
Glucose 75-130 mg/dL 97 (71-120) 94 (80-123) 98.5 (81-139) 0.641 
BUN 7-32 mg/dL 18 (12-31) 15 (11-32) 16 (9-39) 0.700 
Creatinine 0.4-1.5 mg/dL 1.1 (0.8-1.4) 1.1 (0.8-1.5) 0.9 (0.7-1.3) 0.206 
Phosphorus 2.1-6.0 mg/dL 3.8 (2.6-5) 3.5 (2.4-4.8) 3.3 (2.4-5.2) 0.827 
Calcium 9.2-11.7 mg/dL 10.7 (10-11.5) 10.7 (10-11.7) 10.7 (10-11.5) 0.987 
Magnesium 1.9-2.7 mg/dL 2.1 (1.8-2.4) 2.05 (1.9-2.7) 1.9 (1.7-2.2) 0.136 
Total Protein 5.3-7.2 mg/dL 6.1 (5.6-6.8) 6.3 (5.4-7) 6.4 (5.8-7) 0.860 
Albumin 2.5-4.0 mg/dL 3.8 (3.5-4.2) 3.9 (3.4-4.7) 4 (3.6-4.5) 0.125 
Globulin 2.0-3.8 mg/dL 2.4 (2-3.2) 2.4 (1.6-3.3) 2.35 (1.7-2.8) 0.641 
A/G Ratio 0.8-1.6 1.7 (1.1-2) 1.7 (1-2.4) 1.7 (1.3-2.4) 0.331 
Cholesterol 130-300 mg/dL 229 (175-339) 232 (168-293) 241 (124-341) 0.542 
Total Bilirubin 0.0-0.3 mg/dl 0.1 (0-0.2) 0.1 (0.1-0.3) 0.1 (0-0.2) 0.221 
CK3 50.0-275.0 IU/L 90 (52-212) 146 (62-2179) 150.5 (73-350) 0.109 
ALP3 20.0-142.0 IU/L 40 (10-138) 45 (16-830) 47 (21-477) 0.987 
ALT3 10.0-110.0 IU/L 31 (27-164) 41 (19-118) 35 (21-109) 0.743 
AST3 16.0-50.0 IU/L 29 (15-47)a 29 (14-93)a 25 (16-39)b 0.043 
GGT 0.0-9.0 IU/L 3.0 (0.0-5.0)a 0.0 (0.0-5.0)b 0.5 (0.0-3.0)b 0.040 
Sodium 142.0-152.0mEQ/L 147 (144-151) 146 (140-157) 147 (142-150) 0.199 
Potassium 4.0-5.0 mEQ/L 4.4 (3.9-4.7) 4.3 (3.7-4.9) 4.3 (3.5-4.7) 0.677 
Chloride 108.0-120.0mEQ/L 113 (110-118)a 112 (109-119)a 111 (108-115)b 0.040 
Bicarbonate 16.0-25.0mEQ/L 21.5 (18.8-28.4) 20.2 (17.6-23.9) 20.15 (16.8-25.3) 0.330 




293 (287-303) 290 (282-314) 291 (284-306) 
0.237 
Lipemia3 0.0-40.0 mg/dL 16 (0-39) 9 (0-770) 8.5 (4-122) 0.987 
Hemolysis3 0.0-60.0 mg/dL 35 (7-82) 72 (13-403) 46 (3-220) 0.283 
1Abbreviations: RBC, red blood cell; HGB, hemoglobin; PCV, packed cell volume; MCV, mean corpuscular volume; 
MCHC, mean corpuscular hemoglobin concentration; RDW, red blood cell distribution width; MPV, mean platelet 
volume; BUN, blood urea nitrogen; A/G, albumin:globulin; CK, creatinine kinase; ALP, alkaline phosphatase; ALT, 
alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transpeptidase. 2Data are 
shown as median and range (min-max) and were evaluated for differences across groups using an ANCOVCA with 
the variables of age and body weight classification and FDR corrected. Differences between groups were 
determined with pairwise comparisons and a Tukey-Kramer correction. P < 0.1 was considered significant. Groups 
with significantly different medians are indicated with different letters. 3Parmeteres not normally distributed were 






Fecal Microbiome of Normal Weight, Overweight, and Obese Dogs 
The fecal microbiome was assessed in 17 NW dogs, 21 OW dogs, and 12 obese dogs. 
Significant variation existed within dogs that was not consistent by weight class (Figure 7). 
Firmicutes was the most abundant phylum and comprised 56 % - 73 % of the canine fecal 
microbiome. Bateroidetes comprised 24 %-37 %, Proteobacteria 2 % - 3 %, and Actinobacteria 
0.02 %. The most abundant genus was Blautia, followed by Bacteroides, unclassified members of 
the Lachnospiraceae family, and [Rumminococcus]. No differences between weight classes were 
seen at the level of phyla, class, order, family or genus (data not shown)
Figure 7: Phyla level variation in the fecal microflora of normal weight, overweight, and obese 
companion dogs. Each bar represents the total relative abundance and is colored by phyla. Dogs are 






Fecal, Plasma, and Urine Metabolome of Normal Weight, Overweight, and Obese Dogs 
To determine potential metabolic 
differences between NW, OW, and OB dogs, fecal, 
plasma and urine samples were analyzed via GC- 
and LC-MS (Table 8). None of the fecal 
metabolites detected by GC were significantly 
different between the weight groups, 37 fecal 
metabolites detected by LC were different: 36 were 
higher in the NW dogs relative to the OW and OB 
dogs while 1 was lower. Plasma contained the 
greatest number of metabolites that were different 
between dog weight classes: 30 were detected by GC, half of which were higher in the NW dogs; 
155 were detected by LC, 57 were higher in NW dogs while 98 were higher in OW and OB dogs. 
In urine, only one compound was different in the GC data, however it was a very small peak with a 
low number of features and was therefore not counted in this dataset. By LC, 44 compounds were 
different by weight class, 23 were elevated in NW dogs and 21 were elevated in OW ad OB dogs. 
To determine differences in the global metabolite variation between the NW, OW, and OB 
dogs, we evaluated each matrix and platform with PCAs and found significant variation in fecal, 
plasma, and urine samples (Figure 8). The greatest variation between weight phenotype was 
captured in the plasma metabolome: compounds detected by LC (Figure 8A) and GC (Figure 8B) 
explained 45 % and 14 % of the variation, respectively. Urine metabolome explained 5 % of the 
variation (Figure 8C) and variation in the fecal metabolome was 3.9 % (Figure 8D).  
Table 8: Canine metabolites detected in fecal, 
plasma, and urine samples that differentiate 
normal, overweight, and obese dogs.  
 GC LC 
Fecal  1,112 795 
Significant by weight class 0 37 
Elevated in NW dogs 0 36 
Elevated in OW and OB dogs 0 1 
Plasma 554 348 
Significant by weight class 30 155 
Elevated in NW dogs 15 57 
Elevated in OW and OB dogs 15 98 
Urine 1,139 1,318 
Significant by weight class 0 44 
Elevated in NW dogs 0 23 
Elevated in OW and OB dogs 0 21 
Total Significant  30 236 
Total number of detected metabolites in each matrix by 
platform are bolded. Significance was determined by a 
one-way ANOVA and FDR corrected p values < 0.10 were 
accepted as significant. NW= normal weight, 



















Figure 8: Variation in the normal weight, overweight, and obese canine metabolome. Significant 
variation in A) plasma metabolites detected by LC-MS; B) plasma metabolites detected by GC-MS; C) urine 
metabolites detected by LC-MS; and D) fecal metabolites detected by LC-MS. Dogs classified as normal weight 
are indicated by circles, overweight dogs by squares, and obese dogs by triangles.   
DISCUSSION  
The objective of this study was to determine the subtle, obesity-related changes in the 
physiology of OW and OB dogs compared to NW dogs to provide insight into metabolic 
aberrations that could lead to the onset of overt, clinical disease. Clinical blood and serum, and 
fecal and plasma metabolomic analyses were performed on 66 clinically healthy adult, companion 
dogs with a wide range of BCSs, breed, age, and living environments. Fecal microbiome and urine 
metabolomics were performed on a subset of these dogs as well.  
Overweight and Obese Dogs had More Clinical Blood Parameters Outside of Reference Ranges 
than Normal Weight Dogs. 
The proportion of OW and OB dogs with clinical blood values outside of reference 
ranges was higher than NW dog for hemolysis, CK, and AST, and tended to be higher for 
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cholesterol (Figure 6). However, of these parameters, only AST levels were significantly 
different between groups and were lower in the OB dogs compared to NW. In addition to AST, 
GGT and chloride were also reduced in OW and OB dogs (Table 7). In this cohort of dogs, age 
was significantly correlated to analytes related to liver and kidney function, white blood cell 
populations, and phosphorus. Previous studies have reported that compared to lean dogs, 
overweight dogs have higher levels of cholesterol176; 198-200, triglycerides176; 198; 199; 201, and 
lipoproteins199, while other studies have found no differences in one or more lipid parameters.198; 
199; 201 Age associations have been reported for lipids, CK, and creatinine201; 202, however a 
relationship between hemolysis and obesity has not, to the best of our knowledge, previously 
been reported in dogs. In this cohort of dogs, the level of hemolysis was not associated with 
obesity, but overweight and obese dogs were more likely to have a hemolytic blood draw than 
NW dogs. While this could be a finding specific to this study, it could also represent a true 
phenomenon where dogs with excess adiposity may have more traumatic blood draws, and thus a 
higher probability of high RBC lysis. In these dogs, the level of hemolysis was associated with 
segmented neutrophil counts, plasma protein, CK, and AST. While not controlled for in this 
analysis, future studies involving venipuncture for blood collection may need to account for 
obesity associated hemolysis during collection.  
Overall, very few differences were seen across clinical blood parameters in NW vs. O  
and OB dogs and conflicting results have been published in different cohorts of dogs. These 
findings support the need for sub-clinical metabolic assessments in OW dogs as the clinical 
biochemical analyses inconsistently detected differences in otherwise healthy dogs and may not be 






The Canine Fecal Metabolome Comprised Significant Individual Variation and Did Not 
Correspond to Weight Classification.  
The fecal microbiome of 50 dogs was analyzed to determine differences in the microbiota 
composition that could contribute to metabolic alterations in NW and OW or OB dogs. Consistent 
with previous reports, the phyla Firmicutes was the most abundantly represented.69; 174 Contrary to 
previous reports, no changes were seen between any of the weight classes (NW, OW, OB) while 
increases in Actinobacteria174 and Proteobacteria200 have been reported in lean and obese 
companion dogs and colony dogs, respectively. While sample size is comparable between this 
study and reported results, the individual variations was much higher and could reflect the die , 
age, and environment of the dogs, however there could also be differences in sample collection. 
Other studies have reported immediate collection and subsequent freezing of samples after 
spontaneous defecation, however in this study, owners were instructed to collect each fecal 
samples within 5 hours of defecation and then samples were frozen. Additional bias may l o have 
been introduced via the normalization approach: total sum scaling was used to normalize each read 
to the total number of reads, however this has been found to skew results in samples with z ro or 
low reads of a particular sequence. To overcome this potential bias, a weighted, cumulative sum 
scaling has been proposed and seems to overcome some of this bias.203 While confirmatory studies 
with larger samples sizes are needed to establish the relationship between obesity and the fecal 
microbiota of dogs, future studies should also incorporate an approach to assess the function of the 
microbiome, not just the composition.  
Overweight and Obese Dogs Have Significant Variations in the Metabolome Compared to Normal 
Weight Dogs 
Two hundred, sixty-six compounds were found to differ significantly across weight classes. 






45 % of the variation between NW, OW, and OB dogs (Figure 8A). Previous metabolomic studies 
in humans have found significant variation in plasma amino acids, glycerides, and 
phosphatidylcholines between obese and lean individuals187; 188 which may also be revealed in this 
canine data set. To the best of our knowledge, this is the first metabolomic report in obese d gs and 
may reveal important associations between metabolic aberrancies and risk for the development of 
overt chronic disease.  
CONCLUSION 
In this cohort of 66 NW, OW, and OB companion dogs, obesity was associated with minor 
changes in clinical serum analytes, however OW and OB dogs were more likely to have altered 
serum analytes in relation to the reference range. We also found that OB dogs were more likely to 
have hemolytic blood draws which could further limit the sensitivity of clinical metabolic l od 
panels for detecting subtle alterations in metabolism. The fecal microbiome of these dogs exhibited 
significant variation between individual dogs and differences across weight class could not be 
determined. In spite of the significant variation between dogs, the metabolome provided robust 
differences between NW, OW, and OB dogs. Identification of these metabolites could reveal 
important indicators of aberrant metabolism that could be used to identify dogs at risk for
developing obesity associated co-morbidities. This study has demonstrated that OW and OB dogs 
have significant metabolic differences from NW dogs and has highlighted the potential of 
metabolomics to further our understanding of obesity in companion dog.3 
                                                 
3 We would like to thank Guy Beresford for processing the fecal samples for microbiome analysis, Ann 
Hess for her assistance with the statistical analysis, Husen Zhang for the microbiome analysis, Kelly 
Santangelo for her assistance with interpreting the clinical blood panel, and Cadie Tillotson for her 
assistance with the collection of samples. We would also like to acknowledge the Clinical Trials Core at the 






CHAPTER 4: EFFECTS OF COOKED NAVY BEAN POWDER ON APPARENT TOTAL 
TRACT DIGESTIBILITY AND SAFETY IN HEALTHY ADULT DOGS4 
INTRODUCTION 
Staple foods are important determinants of health in humans and companion animals.204; 
205 Developing nutritional guidelines to improve health and prevent disease in dogs has 
contributed to the production of numerous commercial dog foods  with novel carbohydrate206, 
fiber26; 207, and protein sources.208; 209  Despite the success of plant-based nutrients in dog food, 
dry bean (Phaseolus vulgaris L., Fabaceae) is one staple food crop of global agricultural and 
nutritional importance that has been overlooked in commercial pet food formulations.  Evidence 
supports that in addition to providing excellent sources of protein, fiber, minerals, essential 
vitamins, and bioactive compounds in higher concentrations than cereal grains, such as wheat 
and corn33, beans have chronic disease fighting properties, which slow or prevent disease 
progression.210   
Navy beans were selected for this study because of their reported health benefits211; 212 
and availability in a cooked powder form. Navy bean consumption has not previously been 
examined in colony or companion canines.  Digestibilities of the starch and fiber fractions of 
uncooked legumes were evaluated for canines i  vitro and showed lower digestibility compared 
to other carbohydrate sources.207  However, cooked beans have been successfully incorporated 
                                                 
4 This chapter was published in Journal of Animal Science August 2012:90(8):2631-38. DOI: 
10.2527/jas.2011-4324. Authors are Genevieve M. Forster, Dale Hill, Gordon Gregory, Kristen M. 
Weishaar, Sue Lana, John E. Bauer, and Elizabeth P. Ryan(120). Forster, G. M., D. Hill, G. Gregory, K. M. 
Weishaar, S. Lana, J. E. Bauer, and E. P. Ryan. 2012. Effects of cooked navy bean powder on apparent 







into homemade canine diets (R. L. Remillard, Veterinary Nutritional Consultations, Inc., 
Hollister, NC, personal communications) and soybeans, another legume, are digestible by 
dogs.213 
The major objective of this study was to examine safety and digestibility of cooked navy 
bean powder in healthy dogs compared to a placebo control, commercial canine diet formulation. 
We hypothesized that cooked navy bean powder as a major ingredient in an adult canine diet 
formulation, is palatable, safe, and digestible.  
 
MATERIALS AND METHODS 
The Colorado State University Institutional Animal Care and Use Committee approved 
all clinical trial operations, animal care procedures, and collection of biological samp es for 
safety and digestibility of experimental research diets before beginning the study. 
Study Design  
Twenty-one healthy, adult, free-living dogs of different breeds were recruited to 
participate in a randomized, double-blinded, and placebo controlled canine dietary intervention 
study at the Veterinary Teaching Hospital’s Animal Cancer Center at Colorado State University.  
Dogs were randomized in a 1:1 manner for equal allocation to study groups and the study 
clinician determined a BCS during the baseline physical exam.  Each dog received a study code 
number and both the owner and clinician were blinded to the assigned study arm. Dogs were 
transitioned on to the study diets over a 4 d period.  Blood, urine, and feces were collected at 
baseline, d 14, and d 28 of the study.  A 96 h pooled fecal sample was collected on d 15-19 of the 







Inclusion/Exclusion Criteria for Canine Participation 
Male and female dogs between the ages of 2 and 7 yr, had BCS between 4 and 7 on a 9 
point scale 214, and weighed at least 10 kg were eligible to participate.  Of the 21 dogs recruited, 
10 different known breeds and several mixed breeds were represented in the study and randomly 
distributed across treatment groups (Table 9). Dogs were excluded if they had any reported 
dietary allergies, intestinal sensitivities/discomforts, or prior history of cancer.  Dogs must not 
have taken antibiotics or analgesics for at least 1 mo before starting the study.  Heartworm 
prevention was allowed.  Dog owners provided informed consent before their pet’s enrollment at  
the Colorado State University Animal Cancer Center.  Participants were required to be present 
for baseline, d 14, and d 28 study visits, provide a 96 h fecal sample collection after the dog(s) 
had consumed the study diets for 10 d, and record daily food intake and daily fecal scores for 28 
d.  Compliance to study protocol was determined by clinical trials coordinator with weekly 
phone calls to dog owners and during each study visit.  Palatability and tolerance of the diet were 
determined using a pet health history survey that was completed by the owners on d 14 and d 28.  
Owners were asked about any incidence of vomiting, nausea, diarrhea, flatulence, and changes in 
physical activity, appetite and water intake as well as to report any apparent changes in behav or. 
 
 
Table 9: Breeds of twenty-one canine dietary 
intervention study participants by diet group. 
  Number of Dogs 
Breed1 Control Navy Bean 
Australian Cattle Dog 2 2 
Dalmatian - 1 
Hound Mix 1 - 
Mixed (unknown) 2 2 
Pitbull Mix 2 - 
Pointer - 1 
Retriever (Golden/Lab) 3 1 
St. Bernard 1 - 
Standard Poodle - 1 
Terrier/Terrier Mix - 2 
Total 11 10 






Canine Diet Formulations  
Two canine diet formulations were 
used in this study that meet nutritional 
recommendations according to published 
feeding guidelines.215  A formula similar to an 
AAFCO approved, commercially available 
adult canine diet formulation containing 27 % 
protein and 12 % crude fat was used for the 0 
% bean, placebo control.  The control diet was 
mixed and manufactured under the same 
conditions and locations as the experimental 
bean diet (ADM Alliance Nutrition Feed 
Research Pilot Plant, Quincy, IL & Applied 
Food Biotechnology Plant in St. Charles, MO). 
The bean diet was formulated to match the 
control diet in macronutrient and caloric 
content, except for the inclusion of 25 % 
cooked navy bean powder (ADM Edible Bean 
Specialties, Decatur, IL).  Adjustment of major 
food ingredients, such as wheat and corn, were 
made to account for differences in the 
contribution of cooked navy bean powders to 
macro and micronutrients and total caloric 
Table 10: Ingredient and chemical composition of 
cooked navy bean powder and control diets fed to 
twenty-one healthy, adult dogs. 
 Control Navy bean 
Ingredient, % (as-fed) 
Navy bean powder - 25.00 
Meat and bone meal 14.83 13.86 
Bre er’s ri e  12.50 12.50 
Corn 11.25 11.25 
Corn gluten meal 14.24 9.35 
Wheat middlings 14.50 8.27 
Poultry fat 7.77 7.75 
Poultry by product 
meal 
6.50 6.50 
Wheat grain 14.50 1.67 
Beet pulp 1.00 1.00 
Ground flaxseed 0.75 0.75 
Salt 0.50 0.50 
Bre er’s east 0.50 0.50 
Vitamin Premix1   0.50 0.50 
 MCaP 0.08 0.39 
KCl 0.30 0.10 
L-L s•HCl  0.22 - 
Met - 0.07 
ChCl 0.05 0.05 
Analyzed composition (as-fed) 
DM, % 95.01 94.28 
n-6 Fatty acids, % 2.26 2.02 
n-6/n-3 fatty acid 
ratio 
10.91 10.06 
LA/ALA ratio 10.54 9.79 
(LA + ARA)/(ALA + EPA 
+ DHA) 
10.7 9.93 
AAFCO ME, kcal/kg 3,380 3,416 
Analyzed composition (%, dry matter) 
Organic matter 91.37 91.83 
Ash 8.63 8.17 
Crude protein 31.15 29.91 
Acid hydrolyzed fat 14.00 13.58 
Crude fiber 2.95 3.18 
Gross energy, kcal/kg 4,968 4,958 
1ADM Alliance Nutrition, Quincy, IL. Provided per kilogram of navy 
bean diet: vitamin A, 7,500 IU; vitamin D, 750 IU; vitamin E, 93.75 
IU; thiamine, 3.75 mg; riboflavin, 30 mg; pantothenic acid, 12 mg; 
niacin, 15 mg; pyridoxine, 1.875 mg; folic acid, 0.26 mg; vitamin 
B12, 37.5 µg; choline, 1,700 mg; iron from ferrous sulfate, 282 mg; 
copper from copper sulfate, 15 mg; manganese from manganous 
oxide, 31 mg; zinc from zinc oxide, 187 mg; iodine from calcium 
iodate, 2 mg; selenium from sodium selenite, 0.7 mg. Provided per 
kilogram of control diet: vitamin A, 7,500 IU; vitamin D, 750 IU; 
vitamin E, 93.75 IU; thiamine, 3.75 mg; riboflavin, 30 mg; 
pantothenic acid, 12 mg; niacin, 15 mg; pyridoxine, 1.875 mg; folic 
acid, 0.26 mg; vitamin B12, 37.5 µg; choline, 1,711 mg; iron from 
ferrous sulfate, 303 mg; copper from copper sulfate, 16 mg; 
manganese from manganous oxide, 39 mg; zinc from zinc oxide, 
196 mg; iodine from calcium iodate, 2 mg; and selenium from 
sodium selenite, 0.7 mg. LA = linoleic acid, ALA = alpha linoleic 






contents.  The fatty acid content of both diets was matched as well.  Marine type long chain n-3 
fatty acids were not present in either diet.  The percentage of ingredients and chemical 
components are listed for each study diet in Table 10.   
Canine Diet Intervention 
Dog owners were instructed to feed only the research diet provided by study clinical 
coordinator for the entire study duration and to measure out a prescribed amount of food for 
canine consumption each day.  The prescribed daily caloric consumption was determined by 
body weight and according to the dog’s normal feeding habits (1 or β feedings daily).  Water was 
provided ad libitum.  The total required daily caloric intake for maintenance of each dog was 
calculated at the baseline study visit using the following formula: daily ME requirement (kcal) = 
110 x BW 0.75, where BW is measured in kg.216  This formula was used to maintain a stable 
weight in dogs for the study duration.  An inappropriate weight change was defined by a change 
in BW of 2 % per wk or 4 % change from each visit (AAFCO, 2010).  Owners measured and 
recorded the volume of food offered and refused.  The total amount consumed was calculated by 
subtracting the weight of the refused food from offered food.  The owner completed a daily 
intake record for 28 d and a space was provided to record any intake aside from research diet that 
may impact study results.   
Blood and Urine Sample Collection 
Non-fasted blood samples were collected via jugular puncture at baseline, d 14, and d 28 
of the study.  At each visit approximately 18 mL of blood was collected; 1 mL of whole blood 
was collected into an evacuated red top tube without anticoagulant for biochemistry panel 
analysis.  Another 1 mL of blood was collected into an evacuated lavender top tube containing 






The additional blood was used to isolate peripheral blood mononuclear cells and serum for future 
analyses. Urine samples were usually collected by the owner at home using provided specimen 
containers.  In some cases when the owner was unable to obtain a urine sample, ultrasound 
guided cystocentesis was used.  
Blood and Urine Analysis 
The Clinical Pathology Laboratory at Colorado State University performed all blood and 
urine analyses.  The biochemistry panel was analyzed using a clinical chemistry analyzer 
(Hitachi 917; Roche Diagnostics, Indianapolis, IN) and CBC was detected using an analyzer 
(Advia 120; Bayer, Tarrytown, NY). Urinalysis was measured using standardized clinical 
laboratory procedures. Color and clarity were assessed visually, specific gravity was determined 
using a refractometer with water as a reference.  A chemstrip (Cobas Chemstrip 10 MD; Roche 
Diagnostics, Indianapolis, IN) was used to determine pH, protein, glucose, ketones, bilirubin, 
and blood concentrations.  Any samples positive for protein were further analyzed with the 
sulfosalicylic acid turbidometric test (Exton’s Method).  Microscopic analysis of the urine 
sediment was used to determine and quantify cellular components, crystals, casts, and bacteria. 
All methods used have been previously described.217    
Fecal Scores and Sample Collection 
Owners reported daily fecal scores using a 3-point scale with 1 = well formed, 2 = soft, 
and 3 = runny.  A comment space was provided on the score sheet to obtain any observational 
changes per owner’s discretion.  A 4 d (96 h ) total fecal collection was performed for the 
measurement of apparent total tract macronutrient digestibility after 10 d of consuming 100 % of 






stored at -20 °C.  At the end of the collection period, the samples were weighed, pooled, and 
stored at -20 °C and then freeze-dried prior to proximate analysis. 
Proximate Analyses for Assessing Apparent Total Tract Nutrient Digestibility 
Proximate analysis of both the research diets and the 96 h pooled fecal samples were 
performed accordingly: Method 935.29 for DM, 920.39, for fat, 942.05 for ash, and 990.03 for 
CP.218 Organic matter was calculated by subtracting ash from DM or 100 %.  Gross energy was 
measured using an oxygen bomb calorimeter (Model 1261; Parr Instruments, Moline, IL).  Crude 
fiber content was determined (Crude Fiber Method; ANKOM Technology, Macedon, NY) and 
study samples were coded and blinded for proximate analyses ADM Alliance Nutrition 
Laboratory, Quincy, IL).  The lipid profile of the navy bean and control diets was determined 
according to previously reported protocols.219  Digestibility of protein, fat, OM, and DM were 
calculated by the following formula where nutrients were measured in grams on a DM basis: 
Nutrient digestibility (%) = [(nutrient intake – nutrient in feces)/ nutrient intake] × 100.  
Metabolizable energy was calculated by the following formula: ME (kcal/kg of food) = {GE of 
food consumed – GE of feces collected – [(g of protein consumed – g protein in feces) × 
correction factor for energy lost in urine]}/grams of food consumed × 1,000. 215 Feed and fecal 
values on a DM basis were used in all calculations and the correction factor for energy lost in 
urine was 1.25 kcal/g.215 
Statistical Analysis 
Data are presented as means and SEM.  Non-paired t-test probabilities were used to 
determine differences in digestibility, nutrient intake, ME, fecal output, age, and weight means 
between the 2 diet groups.  Blood results were analyzed in both diet groups and across time 






Grubbs test.  Fisher’s Exact Test was applied for assessing differences in BCS and sex between 
diet groups.  A probability of P < 0.05 was accepted as statistically significant.  Statistical 
analyses were performed using a software package (GraphPad Prism version 5.03 for Windows; 
GraphPad Software, San Diego, CA).  
 
RESULTS 
Canine Participant Characteristics 
A diverse set of breed participants 
were recruited for this study to provide 
broad representation of the canine 
population.  Table 11 shows the mean and 
SEM of age in years, weight in kilograms, 
median BCS, and sex by study arm of the 
21 dogs who participated in the study.  No 
differences were determined at baseline 
across treatments.   
Peripheral Blood Outcome Measures  
We evaluated the safety of 25 % (wt/wt) navy bean powder dietary intake compared to a 
0 % bean, placebo control canine diet. No changes in blood diagnostic test results including 
HGB, packed cell volume (PCV), serum albumin concentrations, and serum alkaline phosphate 
activities (ALP) were detected across treatment groups. Table 12 shows the average serum levels 
of these characteristics for both groups at baseline, d 14, and d 28 with the laboratory reported 
normal ranges.  Average values for the navy bean and control diet groups on d 28, respectively, 
Table 11: Comparison of age, weight, body condition 
scores, and sex of twenty-one canine dietary 
intervention participants by diet. 
Characteristic Navy bean1 Control2 P-value 
Age, yr 4.1 ± 0.53 3.2 ± 0.35 0.17 
Weight, kg 23.4 ± 1.47 28.2 ± 3.30 0.21 
BCS3, number of dogs 1.0 
   4 and 5 8 9  
   6 and 7 2 2  
Sex4, number of dogs 0.67 
   Female 6 5  
   Male 4 6  
Data are reported as mean ± SEM. 1n = 10; 2 n = 11. 
3Purina 9-point scale where BCS 4 and 5 are ideal and 6 
and 7 are slightly overweight (Laflamme, 1997). 4All 
female participants were spayed and all but 1 male in the 
control group was castrated. For age and weight, P-
values were determined using a non-paired t-test. For 
count data, P- alues ere deter i ed usi g a     Fisher’s 
Exact test. Differences were considered significant when 






were 17.3 and 18.3 for HGB; 49 and 53 for PCV; 3.8 and 4.0 for serum albumin; and 37 and 44 
for ALP.  In addition to these blood characteristic measurements required for assessing the 
nutritional adequacy of diets 122, complete blood cell count and biochemistry profiles were 
conducted to determine safety.  Measured characteristics included: glucose, blood urea nitrog n, 
creatinine, phosphorus, calcium, magnesium, total protein, globulin, albumin to globulin ratio, 
cholesterol, total bilirubin, creatinine 
kinase, alanine aminotransferase, 
aspartate transaminase, gamma-
glutamyl transpeptidase, Na, K, Cl, 
lipemia, and hemolysis. 
No adverse changes were 
detected in any of the laboratory 
values examined between the 
treatment groups.  The characteristics 
of the CBC and biochemistry panel 
were determined to be within normal 
ranges (data not shown).  
Furthermore, no laboratory values were changed or outside of the normal range in any of the 
dogs from baseline.  In one control group participant, ALP levels were chronically elevated 
above the normal range; however, there was no significant change over baseline and the absence 
of any other abnormalities or clinical signs supported continued study participation.  Inclusion of 
this subject elevated the mean ALP value of the control group; this result was determined to be 
an outlier and was, therefore, excluded from the analysis.  
Table 12: Assessment of blood characteristics of twenty-one 
clinically healthy adult dogs consuming a control or navy-
bean based diet for 28 days. 
Analyte  
(Reference Range) Control Navy Bean p- value 
Hemoglobin (13 – 20 g/dL) 0.15 
Baseline 17.8 ± 0.34 17.4 ± 0.42  
Day 14 18.0 ± 0.35 17.3 ± 0.67  
Day 28 18.3 ± 0.42 17.3 ± 0.32  
Packed cell volume (40 – 55 %) 0.13 
Baseline 51 ± 0.81 51 ± 1.12  
Day 14 52 ± 1.02 50 ± 1.00  
Day 28 53 ± 1.28 49 ± 0.82  
Albumin (2.5 – 4.0 mg/dL) 0.16 
Baseline 3.9 ± 0.08 3.8 ± 0.08  
Day 14 4.0 ± 0.08 3.8 ± 0.07  
Day 28 4.0 ± 0.07 3.8 ± 0.06  
Serum alkaline phosphatase (20 – 142 IU/L) 0.39 
Baseline 55 ± 11.7 43 ± 6.30  
Day 14 46 ± 8.63 37 ± 5.00  
Day 28 44 ± 8.63 37 ± 5.27  
Data are reported as mean ± SEM. Control, n = 10; Navy Bean, n 
= 11. Reference ranges used at the Diagnostic Medicine Center, 






Urinalysis Results  
A urinalysis, as an additional safety measure, was applied herein given the potential for 
beans at 25 % (wt/wt) of diet to modulate overall metabolic status as well as liver and kidney 
metabolism.  Urinalysis was conducted at baseline, d 14, and d 28 post intervention in all 
participants.  All laboratory values assessed, including specific gravity, protein, bilirubin, 
ketones, blood, and crystal formation were determined to be within normal ranges and no 
differences were observed between groups (data not shown).  An intriguing trend was observed 
for urine pH such that the bean diet group had an average pH at baseline of 6.5 that decreased 
after d 14 to 5.5, and then normalized to an average baseline value of 6.5 at d 28.  The control 
group demonstrated an opposite trend whereby the average urine pH was 6 at baseline, increased 
to a pH of 7 at d 14, and then returned to urine pH of 6 at d 28.  There was no observed clinical 
or statistical significance for this transient response in urine pH between the bean diet and 
control diet groups because both groups normalize at d 28 and there were no clinical changes in 
urate lithogenesis.  These findings were reported herein as the experimental relevance of the 
acidic, yet transient urinary response to bean consumption may be important for future clinical 
dietary bean investigations.   
Nutrient Intake, Body Weights, Digestibility, Metabolizable Energy, and Fecal Characteristics  
No differences in macronutrient intakes, apparent total tract digestibility, fecal 
characteristics, or ME were observed between the bean and control diet groups, as shown in 
Table 13.  Protein, fat, and OM intakes are reported on a DM basis.  Average DMI: 325.70 g/d 
and 336 g/d; CP intake: 97.42 g/d and 104.7 g/d; fat intake: 44.23 g/d and 45.83 g/d; and OM 
intake: 299.10 g/d and 307.2 g/d, for the navy bean and control diets, respectively.  Average bean 






68.89 % DM, 78.22 
% & 79.49 % CP, 77.57 % 
& 74.91 %  OM, 94.49 % 
& 93.85 % acid hydrolyzed 
fat, and 3,313 kcal/kg & 
3,195 kcal/kg ME, for the 
navy bean diet and control 
diet groups, respectively. 
No differences were 
observed between the 
groups. The total amount 
of fecal matter and fecal 
quality scores did not change between the 2 groups.  Fecal output average was 96.07 g/d and 
103.7 g/d for the bean diet and control diets, respectively.  Owners most frequently reported 
well-formed stools.  Two dogs, 1 from each group increased weight by 4 %  
on d 14 and the prescribed amount of food was reduced by 37.5 g/d for the dog consuming the 
bean diet and 32.6 g/d for the dog consuming control diet.  All other dogs maintained weight 
throughout the study duration.  Owners reported a minimal incidence of food intake outside of 
the provided diet; however these occurrences were equally distributed across groups. Isolated 
incidences of vomiting and diarrhea were reported in both groups as unrelated to diet by owner.  
None of the owners reported increased incidence of flatulence and both diets were reported as 
equally palatable to all study participants based on no differences detected in reported dietary 
intake or eating preferences as determined and reported by dog owners. 
Table 13: Nutrient intakes, apparent total tract digestibility, 
metabolizable energy, and fecal characteristics of 21 dogs fed either a 25 
% navy bean or isocaloric, nutrient matched control diet.  
Nutrient/Characteristic Control
 Navy Bean P-value 
Daily Nutrient Intake (dry matter basis)      
 Dry matter, g 336.3  ± 30.60 325.7 ± 19.10 0.78 
 Crude protein, g 104.7 ± 9.53 97.42 ± 5.71 0.53 
 Acid hydrolyzed fat, g 45.83 ± 4.21 44.23 ± 2.59 0.76 
 Organic matter, g 307.2 ± 27.96 299.1 ± 17.54 0.81 
Apparent Total Tract Digestibility, % 
 Dry matter 68.89 ± 5.08 68.58 ± 5.60 0.96 
 Crude protein 79.49 ± 3.52 78.22  ± 3.90 0.81 
  Acid hydrolyzed fat 93.85 ± 1.17 94.49  ± 1.05 0.69 
 Organic matter 74.91 ± 3.30 77.57  ± 3.81 0.60 
Metabolizable energy, kcal/kg 3,195 ± 150 3,313 ± 164 0.60 
Fecal characteristics 
 Fecal output, g/d 103.7 ± 15.75 96.07 ± 14.38 0.72 
  Fecal score 1 1  
Data are shown as mean ± SEM. Control, n=11, Navy Bean, n=10. Fecal 
samples were scored according to the following system: 1 = well formed, 2 = 







The results reported herein demonstrate that cooked navy bean powder incorporated at 25 
% (wt/wt) in an extruded dog diet is safe, palatable, and a digestible source of carbohydrates, 
protein, and fat for healthy, adult canines.  Digestibility of selected commercial dry canine diets 
have been reported between 73.2 % and 84.5 % for DM, 77.2 % and 87.8 % for CP, 88.1 % and 
97.1 % for fat, and 72.5 % for OM in both dogs and other model systems. 220; 221  Navy bean diet 
apparent total tract digestibility met these values. Compelling findings of no changes in any of 
the blood and urine characteristics tested further substantiates safety in systemic markers of 
canine wellness after consumption.  Of particular note in the urinalysis results was the lack of 
clinically relevant changes in crystal formation in any of the individual dogs consuming the navy 
bean diet, in spite of the transient change in urine pH, as legume consumption is contraindicated 
for dogs at risk for urolithiasis (Hand, 2000).  These results in healthy canines provide a strong 
basis for future nutritional investigations of cooked bean powder intake in companion animals 
with chronic diseases, as beans are gaining widespread popularity for dietary disease prevention 
strategies in humans.32; 67; 210; 222; 223 
In addition to the novelty of including beans as a staple food ingredient for dogs, it is 
possible that beans may serve as a higher quality source of protein and fiber, provide a low 
glycemic index food, and deliver unique bioactive compounds for enhanced canine nutrition.  
Navy beans contain essential amino acids and may have improved bioavailability when 
compared to other plant protein sources.  They may also provide less fat when compared to 
animal protein sources.223  Bean fiber was shown to be readily metabolized by human intestinal 
flora into short chain fatty acids in an ex vivo incubation model with fecal samples.224  Canine 






profiles. 225; 226  Diets high in fiber and protein have been shown to improve satiety 213; 227 and 
low glycemic index starch has been shown to alter lipid profiles 228 in dogs during weight loss. 
Rodent and human studies have shown that increased dietary bean intake inhibits tumor 
formation 229, controls and manages diabetic outcomes 230; 231, improves blood lipids for reduced 
risk of cardiovascular disease 232, and enhances intestinal health.233  Epidemiological studies 
suggest that legume consumption may be an important dietary predictor of longevity in humans 
and model organisms.234-236  These chronic disease-fighting properties for increasing bean 
consumption reported from studies in humans and rodents merit investigation in companion 
canines. 
Dry beans may not have been incorporated into commercial canine diet formulations 
because of perceptions that increased cooked bean intake would result in increased flatulence, 
intestinal distress, or be unpalatable to dogs.  The lack of change in fecal characteristics or 
flatulence between the study groups was a compelling finding from this trial given the relatively 
high concentration of navy beans at 25 % (wt/wt).  The lack of change in flatulence from canine 
bean consumption supports the experimental strengths and advantages of conducting double 
blinded, placebo controlled nutrition intervention studies in free-living animals.   
The antinutrient bean components may be another reason why beans have not been 
utilized in commercial canine diet formulations.  Bean antinutrients are primarily found in raw, 
uncooked beans.237  Cooking significantly reduces antinutrient levels (e.g. amylase inhibitors, 
trypsin inhibitors, and the lectin protein phytohemagglutinin), and utilization of cooked bean 
powders further reduces potential for deleterious effects.238; 239  Utilizing a commercial source of 
cooked navy bean powder and incorporation into a dry expanded product reduces the potential 






In support of the safety and digestibility of beans reported herein, the effects of beans for 
canine chronic disease control and prevention merits further exploration.  We judge that the 
incorporation of 25 % (wt/wt) bean powder is a practical starting dose for achieving results from 
functional food attributes and that further digestibility testing may be required to safely increase 
the quantity of beans in canine diets.  It should be noted that for dogs with a high risk for 
urolithiasis, inclusion of legumes may be inappropriate as legumes are relatively high in purines, 
protein, calcium, and magnesium and may therefore aggravate symptoms.205  In conclusion, 
canine diets containing cooked navy bean powder are safe, digestible, palatable, and demonstrate 
promise to become a novel food ingredient for dogs.  This study sets the foundation for future 







CHAPTER 5: NAVY AND BLACK BEAN-BASED DOG FOODS ARE DIGESTIBLE 
DURING WEIGHT LOSS IN OVERWEIGHT AND OBESE ADULT COMPANION DOGS5 
INTRODUCTION 
Obesity is the primary nutritional disorder in companion dogs.240 Recent surveys estimate 
that 34-59 % of pet dogs in the United States, Europe and China are overweight or obese.5; 6; 241 
Overweight dogs may have shorter, reduced-quality of life8; 240; 241 and increased risk for 
developing chronic diseases such as diabetes, cardiovascular and respiratory disease, urinary 
tract infections, pancreatitis, osteoarthritis, and some types of cancer.3; 242  
For clinically healthy dogs, the primary treatment for obesity is nutritional therapy.243 
Because excess adiposity is directly related to a positive energy balance, the most practical
dietary approach for weight loss is caloric restriction. An adequate weight loss diet has a nutrient 
composition that supports lean mass retention, induces fat mass reduction, and increases 
satiety.241 Diets high in protein and fibre have been shown in both humans and dogs to promote 
weight loss and maintain lean muscle mass62; 244, as well as reduce voluntary food intake in 
dogs.245 Emerging research supports that in addition to macronutrients, there are specific foods 
and dietary patterns that may promote weight loss as a function of bioactive components and 
phytochemicals.246-248 For example, in people, consumption of non-soy legumes such as common 
beans (Phaseolus vulgaris, L.), split peas, lentils, and chickpeas, is associated with decreased 
risk for obesity32, reduced adiposity without caloric restriction249, voluntary reduction of caloric 
                                                 
5 This chapter has been accepted for publication to Journal of Applied Animal Nutrition. The authors are 
Genevieve M. Forster, Nora Jean Nealon, Dale Hill, Tracey D. Jensen, Teva L. Stone, John E. Bauer, and 
Elizabeth P. Ryan. G.M.F and N.J.N. contributed equally to this manuscript. British spelling is used per 






intake250, increased satiety, and in some cases, resulted in higher levels of weight loss with 30 % 
caloric restriction compared to an isocaloric, low legume or legume-free diet intervention.251  
Common beans, such as navy, black and pinto, are excellent candidates for a weight loss-
promoting food because they contain high quality proteins, have a carbohydrate profile with a 
low glycemic index, are abundant in dietary fibre, and are rich sources of iron, zinc, folate and 
magnesium.252 The high protein content and amino acid profiles of beans have been associated 
with increased energy expenditure during weight loss and the arginine and glutamine content in 
particular was associated with improved carbohydrate and fat oxidation.76 The fibre fraction 
from beans is abundant in resistant starch, which can augment weight loss via slower 
carbohydrate digestion and increased microbial fermentation.251; 253 Common beans also contain 
a wide range of bioactive phytochemicals such as alpha-amylase inhibitors, phenolic compounds, 
and phytosterols which may modulate excess nutrient absorption, reduce dietary energy 
availability, promote satiety, and improve lipid metabolism.251; 254-256 Due to the fact that dry 
bean consumption promoted weight loss in humans and rodents, the potential of beans to 
promote weight loss in dogs merits investigation because dogs have similar digestive physiology, 
obesity related co-morbidities, and environmental exposures to people.  
Common beans are safe and digestible in normal, healthy weight dogs.257 Bean-based diet 
formulations support short-term apparent weight loss, and were reported effective at reducing 
low density lipoprotein (LDL), high density lipoprotein (HDL), and triglycerides (TG) when 
compared to a control, no bean diet.258 Therefore, the objectives of this current study were to: 1) 
evaluate the apparent total tract digestibility (ATTD) of nutritionally complete, navy (NB) and 
black (BB) bean diets in overweight or obese dogs undergoing calorically restricted weight loss 






bean, nutrient-matched control (CON) diet using the outcome measurements defined by the 
Association of American Feed Control Officials (AAFCO)122 compared to an isocaloric, nutrient 
matched, standard ingredient, control diet. We hypothesise that cooked bean powders added at 
25 % weight/weight (w/w) into a nutritionally complete extruded dog food formulation will be 
digestible, support weight loss, and maintain indices of nutritional adequacy as compared to no-
bean control diet. 
 
MATERIALS AND METHODS 
Study Design 
The four-week short-term and twenty-six-week long-term studies were prospective, 
randomised, double-blinded, controlled, three-arm, dietary intervention clinical trials for 
calorically-restricted weight loss.  The three study groups were CON, NB, or BB. The short-term 
weight loss study was conducted at the Colorado State University Veterinary Teaching Hospital 
(Fort Collins, CO) and the long-term study was conducted at the Wellington Veterinary Hospital 
(Wellington, CO). Owners signed an informed consent form and provided a medical history 
before dogs were enrolled in the study. All dogs were transitioned to the study-provided diet 
(CON, NB, BB) over a 4-day period by increasing the proportion of the study-provided food 
mixed into the dog’s regular food as previously described.257 At the end of the study period, all 
dogs were transitioned back to their regular food. Owners were instructed to exclusively feed the 
study kibble in the amounts prescribed. For the short-term study, owners were given pre-
measured daily packets of food, and in the long-term study owners were given measuring cups 






instructed to feed only the prescribed dog food for the duration of the study. Water was provided 
ad libitum and no treats were allowed.  
Body weights were assessed bi-weekly and caloric intake was adjusted as needed to 
achieve a target weight loss of 0.5 % - 2 % body weight per week. For the short-term study 
(n=30), a 96-hour faecal collection was performed at 2 weeks, after the dogs had been 
exclusively consuming the study food for 10 days. For the long-term study (n=15) a 96-hour 
faecal collection was performed at 12 weeks. Owners were instructed to collect the canine faecal 
samples within 5 hours of being voided. Samples were frozen and stored at -20° C until analysis. 
Compliance to the study protocol was determined by owner surveys, diet logs (short-term study 
only), number of faecal samples collected, and apparent weight loss.  
Eligibility Criteria for Companion Dog Participants 
The Colorado State University Institutional Animal Care and Use Committee approved 
all clinical trial operations, animal care procedures, and collection of biological samp es for 
analysis before beginning the study (IACUC 13-4316A).  
Adult, male and female dogs between the ages of 2-7 years, with a body condition score 
(BCS) of at least 6 on a 9-point scale 191 and body weight of at least 10 kg, with no known health 
concerns were recruited for study participation. All dog owners provided written informed 
consent for participation. After enrollment, all dogs were evaluated by the study veterinarian, 
assessed for hematologic and biochemical anomalies, assigned a BCS, and screened for 
hypothyroidism with a total thyroxine (T4) test as previously described.258  Dogs were excluded 
from participation for hypothyroidism, abnormal blood results (unless determined by the 
veterinarian to be within normal limits for a specific dog), or a history or diagnosis of cancer, 






administered antibiotics or analgesics within 1 month of starting the study. The preventive use of 
anthelmintics was allowed. Dogs could be removed from the study at the discretion of the study 
veterinarian or request of owner. All dogs were monitored throughout the study for adverse 
changes in clinical blood, serum, or plasma analytes. At the end of each study period, 
hemoglobin, packed cell volume (PCV), albumin, and alkaline phosphatase (ALP) were 
compared to the AAFCO reference ranges for nutritionally adequacy.122 One dog (short-term 
study, CON) had chronically-elevated ALP (830 g/dl at baseline that decreased to 320 g/dl at 4
weeks) and participated at the discretion of the attending veterinarian. Hemoglobin and PCV 
values were not obtained from one dog at the end of study (long-term study, BB) due to a clotted 
blood sample post-collection.  
Fifty-six dogs were screened for participation in the short term or long term weight loss 
study and 49 were enrolled. Seven dogs failed the pre-screen exam for either renal or hepatic 
abnormalities (n=2), detection of previously undiagnosed cancer (n=2), hypothyroidism (n=1), 
urinary tract infection (n=1), or aggression and difficult handling (n=1). Thirty-three dogs were 
enrolled in the short-term study and randomised based on BCS to CON, BB, or NB study groups.  
Three dogs were withdrawn due to physical injury (n=1), owner unable to keep study-related 
appointments (n=1), and not consuming the study provided dog food (n=1).258  Sixteen dogs 
were enrolled in the long-term study and randomised based on BCS to the CON, BB, or NB 
study groups. One dog was withdrawn from the long-term study after diagnosis with tapeworm 
and the owner’s non-compliance to study protocol by feeding dog treats. Individual 
characteristics of each dog are presented in Appendix 1and summaries of the baseline 
characteristics are shown in Table 14. Breeds included dogs from retriever, terrier, herding, and 






between study diet groups for age, weight, sex, and BCS. There was one dog in each of the short-
term and long-term studies that was not neutered. One 8-year-old dog was included in the short-




CON, BB, and NB dietary study groups were provided a dry, extruded, pelleted dog food 
that was formulated to meet nutritional recommendations for adult dog maintenance 122; 243 and 
adjusted to consist of 27 % protein and 8 % fat. The CON, BB, and NB diets were mixed and 
manufactured under the same conditions and location (ADM Alliance Nutrition Feed Research 
Pilot Plant, Quincy, IL; Applied Food Biotechnology Plant, St. Charles, MO) and formulated to 
be isocaloric and nutrient matched. The CON diet ingredients consisted of poultry meal, wheat, 
corn, brewer’s rice, pork and bone meal, flaxseed, fishmeal, brewer’s yeast, and added vitamins 
Table 14: Baseline characteristics of dogs completing cooked bean powder-based calorically restricted 
weight loss study interventions. 
Characteristic 
Control Group Black Bean Group Navy Bean Group  
Median (IQR) Median (IQR) Median (IQR) p-value4 
Age1, yr 0.16 
 Short-term  6.0 (4.7-7.0) 5.0 (2.8-5.3) 4.5 (3.5-6.0)  
 Long-term 3.0 (2.0-8.5) 3.0 (3.0-4.5) 6.0 (4.5-7.0)  
Body weight, kg 0.25 
 Short-term      34.5 (20.7-39.6) 28.8 (16.5-34.1) 29.25 (20.4-38.1)  
 Long-term      36.5 (29.2-40.4) 37.7 (26.7-45.7)    39.5 (27.3-56.1)  
 
 Number of Dogs  
Sex2 Female Male Female Male Female Male 0.61 
 Short-term  7 3 6 4 4 6  
 Long-term  3 2 4 1 2 3  
BCS3 BCS 6-7 BCS 8-9 BCS 6-7 BCS 8-9 BCS 6-7 BCS 8-9 0.33 
 Short-term  7 3 4 6 7 3  
  Long-term  2 3 2 3 1 4  
Thirty dogs completed the short-term, 4 week study: Control Diet, N=10; Black Bean Diet, N=10; Navy Bean Diet, N=10. 
Fifteen dogs completed the long-term, 6 month study: Control Diet, N=5; Black Bean Diet, N=5; Navy Bean Diet, N=5.1Age as 
reported by owner.2All dogs were neutered with the exception of one female in the short-term study control group and 1 
female in the long-term study black bean group. 3Body Condition Score (BCS) was determined using a 9 point scale 
(Laflamme, 1997).4Continuous variables (age and weight) were evaluated for differences across groups using a Kruskal-Wallis 






and minerals (Table 15). The BB and NB diets contained identical ingredients as the CON diet 
with the inclusion of cooked BB or NB bean powder (ADM Bean Specialties, Decatur, IL) added 
at 25 % w/w to the BB and NB diets. To account for the inclusion of the cooked bean powders, 
the wheat and corn ingredients were reduced to achieve iso-nutrient formulations to the CON 
diet. The metabolisable energy (ME) of the diets was calculated using modified Atwater Factors 
and estimated at 3,314 kcal/kg.243  
Table 15: Diet ingredients and chemical composition of control, black, and navy bean-based dog foods 
fed to overweight and obese dogs during calorically restricted weight loss. 
Ingredient, % (as-fed) Control Diet   Black Bean Diet   Navy Bean Diet 
 black bean (cooked powder) -  25.00  - 
 cooked navy bean powder -  -  25.00 
 poultry meal 19.53  19.00  19.61 
 wheat grain 19.00  2.66  3.62 
 wheat middlings 19.00  11.61  9.42 
 corn grain 16.11  17.67  19.00 
 re er’s ri e 10.00  10.00  10.17 
 pork and bone meal 7.32  3.95  2.56 
 poultry fat 3.00  3.00  3.00 
 flaxseed 1.00  1.00  1.00 
 fish meal 1.00  1.00  1.00 
 brewer's yeast 1.00  1.00  1.00 
 digest 1.00  1.00  1.00 
 calcium carbonate 0.80  1.28  1.47 
 salt 0.50  0.50  0.50 
 vitamin-trace mineral premix a, b, c, d 0.50  0.50  0.50 
 potassium chloride 0.14  0.05  0.05 
 choline chloride 0.10  0.10  0.10 
 monocalcium phosphate -  0.68  1.00 
Analysed Composition, % (as-fed) 
 dry matter 95.02  95.59  94.96 
 moisture 4.98  4.41  5.04 
 crude protein 26.60  26.90  26.30 
 nitrogen free extract 47.82  47.99  48.96 
 acid hydrolyzed fat 8.40  8.10  8.00 
 crude fibre 3.90  4.30  3.70 
 total dietary fibre 16.98  17.96  18.65 
 soluble fibre 4.05  3.36  5.25 
 insoluble fibre 12.93  14.60  13.40 
 ash 8.30  8.30  8.00 
Gross energy, kcal/kg 4,505   4,371   4,375 
Est. metabolisable energy, kcal/kg 3,314  3,314  3,314 
a. Provided per kilogram of control, black bean, and navy bean diets: vitamin A, 7,500 IU; vitamin D, 750 IU; vitamin E, 93.75 IU; 
thia i e .  g; ri ofla i ,  g; pa tothe i  a id,  g; ia i ,  g; p rido i e, .  g; foli  a id, .  g; ita i  
B , .  μg; holi e, .  g; Fe fro  ferrous sulfate,  g; Cu from copper sulfate, 15 mg; I from calcium iodate, 2.025 
mg. b. Manganese from manganous oxide provided per kilogram: 10.125 mg (control, black bean), 32.01 mg (navy bean). c. Zinc 
from zinc oxide provided per kilogram: 213.068 mg (control), 150 mg (black bean), 198.02 mg (navy bean). d. Selenium from 






Calculations for Energy Requirements and Caloric Restriction  
Body condition scoring (BCS) was used to estimate ideal bodyweight (BW), and 
determined using a 9-point scale.191 A score of less than 4 was considered underweight, a score 
of either 4 or 5 was considered ideal BW, a score of 6 or 7 was overweight, and a score of 8 or 9 
was considered obese.258 For each point over 5, a dog was considered to be 10 % above his or 
her ideal body weight in kilograms.192 Using ideal weights determined by BCS, daily ME 
requirements for weight maintenance were calculated for each dog using the following formula: 
ME (kcal/day) = 110 x (ideal BW, kg)0.75.243; 257 Dogs were calorically restricted to 
approximately 60 % of their maintenance energy requirement. Apparent BW (kg) was measured 
at least every two weeks throughout each study.  
 
Proximate Analysis, Apparent Total Tract Digestibility (ATTD), and Bomb Calorimetry  
Proximate analysis was used to determine the crude nutrient profiles of the food and 
faecal samples as previously reported.257 Soluble and insoluble fibre fractions were determined 
as previously described.259 ATTD were evaluated at two weeks for the short-term study, and at 
twelve weeks for the long-term study and were calculated for total dry matter (TDM), crude 
protein (CP), crude fat (CF), and nitrogen free extract (NFE).  The following formula was used 
to determine NFE: NFE % = TDM % – CP % – CF % - crude fibre % – ash %. For each nutrient 
component, the ATTD was calculated on a dry matter (DM) basis using the following formula 
122: % ATTD = [(g of nutrient consumed – g of nutrient excreted) / (g of nutrient consumed)] × 
100. 
Total gross energy (GE) content was measured by bomb calorimetry for each diet, and in 
each faecal sample at two weeks for the short-term study and at twelve weeks for the long-term 






the long-term study and reported in kcal/kg using the following formula122: ME (kcal/kg of food) 
= {GE of food consumed – GE of faeces collected – [(g of protein consumed – g protein in 
faeces) × 1.25]}/ grams of food consumed × 1,000, where GE was in kcal/g, 1.25 kcal/g was the 
correction factor for energy lost in urine, and both diet and faecal values were on a DM basis.  
Dogs were excluded from the ATTD and ME analysis if owners reported dietary 
indiscretion during the faecal collection period, were unable to differentiate between samples 
from different dogs, or collected faecal samples for less than 3 days.  CON group exclusions: 
short-term, n=4 and long-term, n=1; BB group exclusions: short-term, n=1 and long-term, n=1; 
and NB group exclusions: short-term, n=3 and long-term, n=0.  
Statistical Analysis 
Non-parametric analyses were performed on all measures. For percent apparent weight 
loss, a two-way ANOVA (repeated measures) was performed within each study. For ATTD, ME, 
and food intake/kg BW, a two-way ANOVA (non-repeated measures) was performed. 
Bonferroni post-hoc tests were applied to correct for multiple comparisons. Statistical analyses 
for all measurements were performed using GraphPad Prism, Version 5.03 (San Diego, CA). 
Significance was reported at a p-value of p < 0.05. 
 
RESULTS AND DISCUSSION 
Nutrient Profiles of Bean-Based Dog Foods 
The primary objective of this study was to determine the digestibility of nutritionally 
complete, NB and BB based dog food when compared to a nutrient matched CON dog food in 
overweight or obese dogs undergoing calorically restricted weight loss. Proximate analysis and 






nutrient matched and isocaloric (Table 15). On an as-fed basis, for all diets, the estimated ME 
content of the diets was 3,314 kcal/kg, CP content was approximately 26 %, and CF was 8 %. 
Crude fibre was similar between the CON, BB, and NB diets (~4 %), while TDF was ~1 % 
higher in NB and BB diets when compared to CON. Compared to the CON diet, insoluble fibre 
was slightly increased in the BB diet (~1.5 %), while soluble fibre was slightly increased in the 
NB diet (~1 %).  
Companion Dog Characteristics, Dietary Intake, and Apparent Weight Loss  
Forty-five clinically healthy, adult, companion dogs, BCS classified as overweight or 
obese completed a short or long term calorically restricted weight loss trial and were assigned to 
either the NB, BB, or CON study groups. There was no difference in sex, median age, or BCS 
between dietary treatment groups or studies (Table 14). In both the short and long-term studies, 
percent apparent weight loss increased over time (p <0.0001) and was similar between dietary 
treatments in each study; in the short-term study the median weight loss was 4.05 % in CON, 
5.98 % in BB, and 6.14 % in NB; for the long-term study, the median weight loss was 17.90 % 
in CON, 14.0 % in BB, and 12.21 % in NB (Figure 9).  
Daily nutrient intake (g/kg ideal BW) was not different between groups (Table 16) except 
for soluble fibre, which was significantly higher in NB group (~0.4 g/kg ideal BW) compared to 
BB (~0.25 g/kg ideal BW), but not different from CON (~0.3 g/kg ideal BW). All dogs 
consumed approximately 2.5 g CP per kg ideal BW (medians ranged from 2.1 g – 7 /kg ideal 
BW), and dogs within the BB and NB group consumed, on average, 2 g cooked bean powder per 








Figure 9: Percent apparent weight loss in dogs consuming a bean-based or control diet over (a) 4-
weeks (short-term study, n =30) and (b) 12-weeks (long-term study, n = 15). In both (a) and (b) percent 
apparent weight loss increased over time (p <0.05), but not between dietary treatments at any time point. 






Table 16: Daily nutrient intake of forty-five overweight or obese adult, companion 
dogs undergoing calorically restricted weight loss on nutritionally complete bean-
based or nutrient-matched control diets.  
Daily Intake/kg 
ideal BW 
Control Diet Black Bean Diet Navy Bean Diet 
p-value Median (IQR) Median (IQR) Median (IQR) 
Total Dietary Intake, g  (As-fed basis) 
0.939  Short-Term  9.0 (8.5-9.7) 9.5 (8.8-10.2) 8.9 (8.6-10.3) 
 Long-Term    8.8 (8.2-10.1)     8.8 (8.5-9.0)    8.7 (8.6-9.1) 
ME (Estimated) Intake, Kcal (DM Basis) 
0.510  Short-Term  1.4 (1.4-1.7) 1.6 (1.5-2.0) 1.5 (1.5-1.8) 
 Long-Term  1.3 (1.3-1.6) 1.3 (1.2-1.5) 1.5 (1.3-1.6) 
Total DM Intake g/kg ideal BW 
0.900  Short-Term  8.7 (8.4-10.0) 9.5 (8.5-12.0) 8.5 (8.2-10.0) 
 Long-Term  8.0 (7.8-10.0)     7.4 (7.1-8.9)    8.3 (7.3-9.0) 
Crude Protein, g (DM Basis) 
0.808  Short-Term  2.4 (2.4-2.9) 2.7 (2.4-3.3) 2.4 (2.3-2.8) 
 Long-Term  2.2 (2.2-2.8)      2.1 (2-2.5) 2.3 (2.0-2.5) 
Crude Fat, g (DM Basis) 
0.729  Short-Term  0.8 (0.7-0.9) 0.8 (0.7-1.0) 0.7 (0.7-0.8) 
 Long-Term  0.7 (0.7-0.9) 0.6 (0.6-0.8) 0.7 (0.6-0.8) 
NFE, g (DM Basis) 
0.967  Short-Term  4.4 (4.2-5.2) 4.8 (4.3-5.9) 4.4 (4.2-5.2) 
 Long-Term  4.0 (3.9-5.1) 3.7 (3.6-4.5) 4.3 (3.8-4.7) 
Crude Fibre, g (DM Basis) 
0.087  Short-Term  0.4 (0.3-0.4)  0.4 (0.4-0.5)  0.3 (0.3-0.4)  
 Long-Term  0.3 (0.3-0.4) 0.3 (0.3-0.4) 0.3 (0.3-0.4) 
TDF, g (DM Basis) 
0.510  Short-Term  1.4 (1.4-1.7) 1.6 (1.5-2.0) 1.5 (1.5-1.8) 
 Long-Term  1.3 (1.3-1.6) 1.3 (1.2-1.5) 1.5 (1.3-1.6) 
Soluble Fibre, g (DM Basis) 
< 0.001  Short-Term  0.3 (0.3-0.4)ab 0.3 (0.3-0.4)a 0.4 (0.4-0.5)b 
 Long-Term  0.3 (0.3-0.4)ab 0.2 (0.2-0.3)a 0.4 (0.4-0.4)b 
Insoluble Fibre, g (DM Basis) 
0.133  Short-Term  1.1 (1.0-1.3) 1.3 (1.2-1.6) 1.1 (1.0-1.3) 
 Long-Term  1.0 (1.0-1.2) 1.0 (1.0-1.2) 1.1 (1.0-1.1) 
Cooked Bean Powder, g (DM Basis) 
< 0.001  Short-Term  0 (0-0)a 2.4 (2.1-2.9)b 2.1 (2.1-2.5)b 
 Long-Term  0 (0-0)a 1.8 (1.8-2.2)b 2.1 (1.8-2.3)b 
To determine differences in daily intake between diets and studies, each nutrient was 
evaluated with 2-way ANOVA. There were no differences between studies or interactions 
terms. A Bonferroni post-test was used to determine the groups with significant 
differences. Groups not sharing the same letter superscript are significantly different from 






Apparent Total Tract Digestibility and Metabolisable Energy of Black and NavyBean-Based Dog 
Diets during Weight Loss 
In the CON, BB, and NB diets, nutrient ATTD was consistent with expected ranges for 
standard ingredient and bean-based extruded dog diets.257 TDM, CP, CF, and NFE ATTD are 
presented as median and range (min-max, Table 17). There were no differences in ATTD 
between each study group of the short and long-term study. In the short-term study, median 
TDM ATTD was higher (p < 0.05) for BB (83.0 %) than CON (74.6 %), while NB was similar 
to both (80.2 %); in the long-term study, TDM ATTD was similar for all three diets: CON (73.7 
%), BB (79.6 %), and NB (77.5 %). For the NB diet, these results were consistent with previous 
studies demonstrating equal TDM ATTD compared to a nutrient matched CON diet.257  To our 
knowledge, this is the first report of a BB based canine diet ATTD. To verify that TDM ATTD 
was higher for the BB diet compared to CON, we performed a pooled analysis on the results 
from both trials. The differences in TDM ATTD between CON and BB remained significant 
(data not shown), further supporting that that the BB TDM was indeed more digestible than CON 
and may have not been significant in the short-term study due to the sample size.  
In the short-term study, CP ATTD was higher in BB (85.7 %) compared to CON (78.6 
%), and NB was similar to both (83.5 %); in the long-term study, CP ATTD was similar between 
the CON (80.9 %), BB (82.5 %), and NB (79.4 %). Again, the difference in CP ATTD between 
CON and BB remained significant when data from both the long and short-term studies were 
pooled (data not shown). The CP digestibility of these cooked bean powder diets supports the use 
of common beans as a major ingredient in weight loss dog food formulas, particularly because 
dietary protein intake is an important contributing factor towards lean mass retention.260 Results 
from this study support that BB may be particularly effective at contributing bioavailable 






needed to determine if BB based diets differentially preserve lean muscle mass during weight 
loss.  
CF was equally digestible between all diets in the short-term study: CON (89.8 %), BB 
(95.2 %), and NB (92.9 %); and the long-term study: CON (93.2 %), BB (94.1 %), and NB (89.4 
%).  
Carbohydrate ATTD, as measured by NFE, was higher in both the BB (89.3 %) and NB 
(87.6 %) diets compared to CON (83.2 %) in the short-term study, and similar between all diets 
in the long-term study: CON (82.1 %), BB (86.5 %), and NB (85.1 %). The NFE ATTD 
remained significantly higher in both bean groups when data from both the short and long-term 
studies were pooled (data not shown) supporting that the carbohydrates derived from the BB and 
NB were more digestible than those derived from corn and wheat based diets. Recent 
metabolomic studies support that metabolism of carbohydrates may be modulated in normal 
weight dogs consuming bean-based diets 94 even though carbohydrate digestibility was the same 
as the a control diet. 257 Therefore, the effects of bean intake on carbohydrate metabolism in dogs 
undergoing weight loss may be greater than for dogs maintaining weight. These data support the 
further investigation of carbohydrate metabolism in overweight and obese dogs consuming bean-
based diets during weight loss.  
ME was calculated for each group to determine the amount of utilisable energy provided 
by the CON, BB, and NB foods. Measured ME was similar between both the short and long-term 
studies and across all diets. Results are presented as a median (min-max, Table 17). Th  median 
ME for the CON diet was 3,446 kcal/kg for the short-term and 3,519 kcal/kg for the long-term 
study. In the BB diet, ME was 3,632 kcal/kg for the short-term and 3,507 kcal/kg for long-term 






term study. ME was highest in the BB short-term study (3,632 kcal/kg) and this was the only 
measured ME that was higher than the estimated ME of 3,314 kcal/kg (p = 0.004). These data 
support that the energy utilisation from bean based dog food was equivalent to standard 
ingredient dog food formulations in dogs undergoing calorically restricted weight loss. 
Table 17: Nutrient digestibility, metabolisable energy, and energy extraction efficiency of three nutritionally 
complete diets fed to overweight or obese adult companion dogs undergoing calorically restricted weight loss. 
Digestibility, % 
Control Diet Black Bean Diet Navy Bean Diet 
p-value Median (IQR) Median (IQR) Median (IQR) 
Total dry matter % 
0.015  Short-term  74.6 (67.0-80.7)a 83.0 (75.8-89.0)b 80.2 (66.8-83.5)ab 
 Long-term     73.7 (69.9-79.1) 79.6 (76.9-83.7)   77.5 (71.8-88.1) 
Crude protein 
0.040  Short-term    78.6 (73.1-84.6)a   85.7 (80.4-91.4)b    83.5 (78.7-87.4)ab 
 Long-term  80.9 (78.5-84.3) 82.5 (81.8-85.9) 79.4 (77.0-91.4) 
Crude fat 
0.120  Short-term  89.8 (88.7-92.9)  95.2 (88.5-97.7)  92.9 (77. 3-96.4)  
 Long-term  93.2 (90.7-93.5) 94.1 (90.5-96.1)    89.4 (87.1-95.9) 
Nitrogen free extract  
0.002  Short-term  83.2 (76.9-86.8)a 89.3 (82.3-91.9)b 87.6 (84.1-89.8)b 
 Long-term     82.1 (77.7-85.4) 86.5 (83.9-89.5) 85.1 (83.5-91.6) 
Metabolisable energy, kcal/kg 
0.617  Short-term  3,446 (3,188-3,674) 3,632 (3,348-3,804) 3,571 (3,235-3,689) 
 Long-term  3,519 (3,271-3,670) 3,507 (3,367-3.618) 3,434 (3,328-3,844) 
Digestibility was calculated on a DM basis. To determine differences in digestibilities between diets and studies, 
each nutrient was evaluated with 2-way ANOVA. There were no differences between studies or interactions terms 
(data not shown). A Bonferroni post-test was used to determine the groups with significant differences. Groups not 
sharing the same letter superscript are significantly different from each other. 
 
 Whole Blood Analyses and Serum Biochemistry Reveal Safety of Bean Diets During Companion 
Dog Weight Loss.  
To determine if dogs consuming the bean-based foods maintained indices of nutritional 
adequacy, comprehensive blood cell counts and serum biochemical analyses were performed for 
every dog at baseline and throughout the study as previously described.257; 258 No negative 
physiological effects were observed in any analyte measured (data not shown). To demonstrate 






AAFCO reference limits or hemoglobin, PCV, albumin, and ALP at the end of the study period. 
Results are presented as a median (min-max) along with the AAFCO limits for each analyte
(Table 18). The median albumin for the CON group was 3.9 g/dL and 3.9 g/dL; 3.9 g/dL and 4.0 
g/dL for the BB group: and 3.9 g/dL and 4.1 g/dL for the NB group, for the short and long-term 
studies respectively. The median ALP for the CON group was 40.5 IU/L and 41.0 IU/L; 51.0 
IU/L and 31.0 IU/L in the BB group; and 27.5 IU/L and 47.0 IU/L in the NB group for the short 
and long-term studies, respectively. The median PCV for the CON group was 51.0 % and 51.0 
%; 49.5 % and 56.0 % in the BB group; and 51.0 % and 51.0 % in the NB group for the short 
and long-term studies, respectively. The median hemoglobin for the CON group was 17.7 g/dL 
and 18.0 g/dL; for BB was 17.7 g/dL and 20.0 g/dL; and for NB was 17.8 g/dL and 17.9 g/dL for 
the short and long-term studies, respectively. Serum analytes values fell within AAFCO 
established reference limits, supporting that the experimental NB and BB dog foods provided 
adequate nutrition and were safe to consume during short and long-term weight loss.  This study 
applied AAFCO values for adult dog weight maintenance because there are no established va ues 
for dogs undergoing calorically restricted weight loss. Given that differences in canine serum 
analytes have been reported for overweight and obese dogs compared to normal weight dogs, 
and also that changes occur during weight loss 258; 261, future studies will need to determine if 










Table 18: Plasma and serum biochemical analysis of three diets fed to overweight or obese adult companion dogs 
undergoing calorically restricted weight loss. 
Analyte 
Control Group Black Bean Group Navy Bean Group Reference Values 
Median (Min-Max) Median (Min-Max) Median (Min-Max) Group (Individual) 
Hemoglobin, g/dL  
 Short-term  17.7 (16.2-18.4)  17.7 (16.7-19.4)  17.75 (16.0-19.2)   14.0 g/dL 
 Long-term  18.0 (16.7-19.0) 20.0 (17.1-20.4) 17.9 (15.1-19.2) (  12.0) 
Packed Cell Volume, %  
 Short-term  51.0 (46.0-54.0)  49.5 (48.0-55.0)  51.0 (47.0-55.0)   42% 
 Long-term  51.0 (47.0-51.0) 56.0 (50.0-59.0) 51.0 (42.0-53.0)  (36%) 
Albumin, g/dL  
 Short-term  3.9 (3.6-4.2)  3.9 (3.6-4.3)  3.9 (3.3-4.4)   2.8 g/dL 
 Long-term  3.9 (3.7-4.1) 4.0 (3.9-4.1) 4.1 (3.9-4.3) (  2.4) 
Alkaline Phosphatase, IU/L  
 Short-term  40.5 (27.0-320.0)  51.0 (26.0-152.0)  27.5 (16.0-76.0)   150 IU/L 
 Long-term  41.0 (23.0-  75.0) 31.0 (28.0-85.0) 47.0 (12.0-74.0) (  300) 
Values for blood and serum analytes were determined at four weeks (short-term), and twenty-six weeks (long-
term). Reference values were taken from AAFCO guidelines 122 for group means and individual dogs.  
Conducting weight loss and digestibility studies with companion dogs, as opposed to 
colony dogs, presents new challenges because owner compliance in feeding and sample 
collection must be accounted for, as well as lapses in dietary discretion when feeding and 
collecting samples in a multiple dog household. Although this study was succesful in achieving 
weight loss, many dogs did not achieve ideal weight during or following completion of the lng-
term study. This investigative team appreciates that lapses in study compliance may omplicate 
interpretation of the results. However, these challenges emphasise the need for effective 
communication and perhaps an accelerated translation of canine weight loss study findings to 
real-clinic settings for body weight management planning. 
CONCLUSIONS 
          In this study, we showed that nutritionally complete dog foods containing cooked bean 
powders were digestible by overweight or obese, adult, companion dogs undergoing short or 






provided utilisable energy, and the dogs maintained indices of nutritional adequacy when 
compared to a bean-free control dog food. Our findings of higher NFE ATTD in both the BB and 
NB diets compared to CON suggests that bean based dog foods may differentially impact canine 
carbohydrate metabolism.  This study concludes that cooked common beans are safe and 
digestible as a major food ingredient during canine weight loss, when fed in a nutritionally 
complete, extruded kibble, and provides rationale for the continued investigation of the potential 
for cooked beans to improve protein, lipid, and carbohydrate metabolism, which are important 
for overall canine health. 6 
 
  
                                                 
6 We would like to thank ADM Alliance Nutrition for providing the dog foods and Gordon Gregory at 
ADM Edible Bean Specialties for providing the cooked bean powder. We would also like to thank the 
Wellington Veterinary Hospital and the Flint Animal Cancer Center Clinical Trials Core for providing 
companion dogs for participation in this study and clinical oversight.  Additionally, we would like to 
thank Cadie Tillotson for technical assistance with study coordination.  This research received no specific 






CHAPTER 6: CONSUMPTION OF COOKED NAVY BEAN POWDERS MODULATES THE 
CANINE FECAL AND URINE METABOLOME7 
INTRODUCTION 
Dry common beans (Phaseolus vulgaris, L.) are a staple food ingredient that is rich in 
macro- and micro-nutrients, phytochemicals, and readily incorporated into commercial dog diet 
formulations. 262 To this end, we recently showed that cooked dry bean consumption at 25 % 
weight/weight (w/w) is safe and digestible in clinically healthy, normal weight dogs (Chapter 
4).193  
In addition to providing a unique source of nutrients that may improve nutritional status 
263, dry beans also contain a rich array of phytochemicals with health promoting properties, such 
as tocopherols, flavonoids, phytosterols, and enzyme inhibitors.264-266 Consumption of dry beans 
has been shown in humans and laboratory animal models to decrease risk factors for developing 
metabolic syndrome, cardiovascular disease, cancer, and diabetes.30; 265; 267 Dry bean intake has 
also been associated with improving longevity, promoting gastrointestinal health, facilitating 
healthy weight maintenance, and supporting hepatic function 44; 77; 234; 268; 269. One mechanism by 
which cooked bean intake may promote health is by altering fat metabolism: for example, serum 
lipid modulation is one of the most consistently reported effects of bean intake in humans and 
animals. Multiple studies demonstrate that increased bean consumption is associated with 
reduced serum cholesterol, low density lipoprotein cholesterol (LDL-C), and triglycerides with 
increased high-density lipoprotein cholesterol (HDL-C).267; 270-272 The combination of dry bean 
                                                 
7 This chapter was published in Current Metabolomics 2015:3(2):90-101. DOI: 
10.2174/2213235X03666150519234354. Authors are Genevieve M. Forster, Adam L. Heuberger, Corey 






macronutrients, micronutrients, and phytochemicals work together to promote health and reduce 
disease risk 262 and may have potential to improve the health of companion dogs as well.   
Metabolomics is becoming more frequently utilized in nutrition and veterinary sciences 
to evaluate phytochemical diversity in foods and to elucidate the functional responses of 
mammals to dietary interventions.273-275 Metabolomics can also provide candidate dietary 
biomarkers for specific food and diet patterns in serum, urine, or feces, as well as measure the 
effects of diet on disease risk factors.276; 277  
In this study, we evaluated the effect of adding 25 % w/w cooked navy bean (NB) 
powder on 1) the canine food metabolome and 2) the effects of this diet on serum biochemistry 
and the chemical composition of feces and urine in clinically healthy adult dogs, compared to  
control (CON) diet. The dogs consumed NB or CON diets for one month, and metabolites were 
characterized in the diet, urine, and feces using a combination of gas and liquid chromatography 
coupled with mass spectrometry (GC- and LC- MS). Serum analytes were determined using 
standard, clinical biochemistry panels.193 We hypothesized that the NB diet contains distinct 
phytochemicals compared to the CON diet and that NB consumption modulates the chemical 
composition of the canine fecal and urine metabolome. 
 
MATERIAL AND METHODS 
Ethics Statement 
 Clinical trial operations, animal care procedures, and biological sample 
collections were approved by the Colorado State University Institutional Animal Care and Use 








Twenty-one clinically healthy, normal weight, male and female dogs between the ages of 
2 and 7 years, and a variety of breeds were enrolled in a controlled, double-blinded, restrictively 
randomized, 4 week dietary intervention at the Flint Animal Cancer Center, Veterinary Teaching 
Hospital at Colorado State University as previously reported.193 A body condition score (BCS) 
was assigned to each dog by the study clinician using a 9-point scale.191 Dogs were evenly 
distributed and no differences were detected between diet groups with respect to BCS, age, 








Sample Collection and Processing 
Fecal, plasma, and urine samples were collected for clinical and analytical analysis at 
baseline, 2, and 4 week time points. Owners were instructed to collect fecal samples within 5
hours of being voided. Samples were either immediately frozen at -20 °C in provided containers 
and transferred to -80 °C, or brought to the study site and immediately stored at -80 °C until 
analysis. Serum samples for biochemical analysis were collected via venipuncture into a tube 
Table 19: Baseline characteristics of 21 canine study participants evaluated 
for metabolomic changes in response to consumption of bean-based diets.  
Characteristic Control (n=10) Navy Bean (n=11)  P-value1 
Age1, years 3.0 (2.0-4.0) 4.0 (2.8 - 5.3) 0.206 
Body Weight, kg 28.5 (19.0 – 33.0) 21.8 (19.9 - 25.88) 0.260 
Sex3 
0.670 Female 5 6 
Male 6 4 
BCS4 
1.00 BCS 4 & 5 9 8 
BCS 6 & 7 2 2 
1Age and weight are reported as median and interquartile range and differences 
between groups were evaluated with a Mann-Whitney t-test. Sex and Body 
Condition Score (BCS) are reported as number of dogs and differences were 
e aluated ith Fisher’s e a t test. 2Age is presented as reported by owner. 3All 
dogs were neutered with the exception of one male in the control group. 4 BCS 






without anticoagulant, allowed to coagulate for 15 min and centrifuged for 15 min at 1,500 rcf.  
Blood was collected at approximately the same time of day throughout the study to minimize 
postprandial variation. Urine was collected by owners or a study technician using a free-catch 
method, however in some cases where a urine sample was not obtained via free-catch, ultrasound 
guided cystocentesis was utilized at the clinician’s discretion. Serum cholesterol levels were 
obtained using standard clinical analytical methods as previously described.193   
Canine Diet Formulations and Nutrient Analysis 
A standard ingredient, CON diet was formulated to meet the Association of American 
Feed Control Officials (AAFCO) and National Research Council (NRC) adult dog maintenance 
requirements.122; 278 A second iso-nutrient and isocaloric diet containing 25 % w/w cooked NB 
powder was formulated to investigate the utility of common bean ingredients in dog food. A 
detailed ingredient and nutrient profile for each diet was previously published.193 Table 10 
provides a summary of the major ingredients in each diet. Energy requirements and daily food 
intake for weight maintenance were calculated for each individual dog as previously 
described.193 Briefly, the amount of food was determined by the energy density of each diet and 
the daily metabolizable energy (ME) requirement of each dog. Daily ME requirement was 
determined by the formula ME (kcal/day) =110 x (body weight, kg)0.75.278 
Targeted Analysis of Dietary Nutrient Profiles 
The macronutrient composition, on a dry matter basis, for the CON and NB diets 
respectively, was as follows: crude protein was 31.15 % and 29.91 %; crude fat was 14.00 % and 
13.58 %; organic matter was 91.37 % and 91.83 %; crude fiber was 2.95 % and 3.18 %; and 
gross energy was 4,967 kcal/kg and 4,957 kcal/kg. All macronutrients were equally digestible 






extracted and separated using thin layer chromatography (TLC) and analyzed via GC under 
previously reported conditions.219 Amino acid analysis was performed by Midwest Laboratories, 
Inc. (Omaha, NE) using standard methods (AOAC 994.12 (III)). Cystine, methionine, and 
tryptophan were analyzed using specialized protocols (AOAC 994.12 (Alt I) and 998.15). Total 
dietary fiber (TDF) and the soluble and insoluble fiber fractions were determined as previously 
described.259   
Canine Diet Preparation for Non-Targeted GC-MS Analysis 
The diets were ground to a powder using a mortar and pestle, and metabolites were 
extracted by adding 1 ml of ice-cold methanol:water (80:20, v:v) to 100 mg of diet and incubated 
for 1 hr at -80 °C. Samples were then centrifuged at 1,500 rcf for 5 min and the extract was 
transferred into 1.5 ml microcentrifuge tubes as previously described.279 Extracts were dried in a 
speedvac and methoximated by resuspending in pyridine (50 μL) with β5 mg/mL of 
methoxyamine hydrochloride and incubated at 60 °C for 45 min twice, with 10 min sonication in 
between. After methoximation, samples were incubated with 50 μL of N-methyl-N-
trimethylsilyltrifluoroacetamide with 1 % trimethylchlorosilane (MSTFA + 1 % TMCS, Thermo 
Scientific) at 60 °C for 30 min, followed by centrifugation at 3,000 rcf for 5 min. Samples were 
then cooled to room temperature (~22 °C), and the supernatant (80 μL) was transferred to a 150 
μL glass insert in a GC-MS autosampler vial.  
Canine Fecal and Urine Sample Preparation, Metabolite Separation and Detection by GC-MS and 
LC-MS 
Fecal metabolites were extracted using identical methods as the diets. Extracts were 
prepared with 100 mg of fecal material and methanol:water (80:20, v:v) as described above for 






supernatant was transferred to an autosampler vial and directly injected. Extracted metabolites 
from diet and fecal samples were analyzed by GC-MS and urine samples were analyzed by LC-
MS under similar conditions as previously described with minor differences280; 281. Specific run 
conditions are shown in Table 20.  
 
Mass Spectrometry Data Processing and Metabolite Annotation 
For each sample, a matrix of molecular features as defined by retention time and mass 
(m/z) was generated using XCMS.282 Each sample was injected twice and the relative abundance 
of each molecular feature was measured by determining the mean chromatographic peak area 
after normalization to total ion current. Mass spectra were generated using an algorithm that 
Table 20: LC and GC run conditions for metabolite separation and detection.  
Conditions LC GC 
System 
Acquity UPLC coupled to Q-TOF Micro 
(Waters) 
Trace GC Ultra coupled to a Thermo DSQ 
II (Thermo Scientific) 
Sample Injection  μl, i  dis rete ra do  lo ks =  μl, :  split ratio i  dis rete ra do  
blocks (n=2) 
Column 
Acquity UPLC T3 column (Waters, 1.8 
µM, 1.0 x 100 mm) 
30 m TG-5MS column (Thermo Scientific, 
.   i.d., .  μ  fil  thi k ess  
Condition A 100% water, 0.1% formic acid 80°C 
Condition B 
95% methanol, 5% water, 0.1% formic 
acid 
330 °C 
Hold Time (Condition A) 1 min 0.5 min 
Gradient Endpoint 100% B 330 °C 
Rate from A to B 6.25% B/min (16 min) 15 ºC/min (16.67 min) 
Hold Time (Condition B) 3 min 8 min 
Time to A 0.1 min - 
Reequilibration Time 5.9 min - 
Total Run Time 26 min 30 min 
Flow Rate 140 ul/min 1.2 mL/min (helium gas) 
Column Temp 40°C - 
Sample Temp 5°C - 
Ion mode Positive Electron impact 
Scan Range 50-1200 m/z 50-650 m/z 
Scan Rate 1 scan/sec 0.1 sec delay 5 scans/sec  
Calibration  5ppm (sodium formate) - 
Capillary Voltage 2200 V - 
Source Temp 130°C - 
Desolvation Temp 300°C - 
Flow Rate 400 L/hr (nitrogen gas) 1.2 mL/min (helium gas) 






clusters molecular features into spectra (‘clusters’ or ‘compounds’, C) based on co-variation and 
co-elution in the data set.195 The abundance of each cluster was determined as the weighted sum 
of the peak areas for all molecular features within a cluster. Mass spectral clusters were searched 
against in-house and external databases including NIST v12 (www.nist.gov), Massbank, Metli , 
and Golm (http://gmd.mpimp-golm.mpg.de) metabolite databases for annotation. The relative 
abundance of each fecal and urine metabolite was scaled to a median value of one. Each 
annotated metabolite is presented in Appendix 2 with its corresponding “cluster” number (C), 
identification confidence level 283, PubChem Compound Identifier (CID), and Simplified 
Molecular Input Line Entry Specification (SMILES).  
Statistical Analysis 
Continuous baseline characteristics of the dogs were evaluated by a Mann-Whitney t-test 
(age and weight) and categorical data were evaluated with a Fisher’s exact test (sex and BCS).  
 Diet, fecal and urine metabolites were evaluated with a principal components analysis 
(PCA, SIMCA P+ v12, Umetrics, Umea, Sweden) to determine global pattern changes or 
differences within each matrix. PCA was conducted with metabolite abundances that were mean-
centered and Pareto-scaled, and 95 % confidence intervals for the PCA model were utilized to 
identify outliers. Significance of each component was determined using analysis of variance of 
PC scores for each component with a threshold of p < 0.05. 
The relative abundance of each fecal and urine metabolite was scaled to a median value 
of one and is presented as the median and interquartile range (IQR).To determine differences in 
the relative abundance of each fecal and urine cluster/metabolite between diet groups and time, a 
mixed model linear regression analysis was applied using the lme4 package 284 in R.196 The 






repeated measures. A false discovery rate (FDR) correction was used to control for multiple 
comparisons. 197 An adjusted p-value < 0.1 was accepted as significant. When the time factor 
was significant, a post-hoc Wilcoxon matched-pairs signed rank test was used to determine the 
group in which a significant change occurred (GraphPad Prism version 5.03 for Windows, 
GraphPad Software, San Diego California USA, www.graphpad.com). When metabolites were 
significant by diet, a Mann Whitney t-test was used to determine the timepoint at which the 
differences were significant. Diet metabolite differences are shown as a fold difference betwe n 
the NB and CON diet (NB:CON). Metabolites that varied by more than 10 % relative abundance 
between diets were reported. For serum cholesterol levels, a repeated measures, 2-way ANOVA 




Targeted Nutrient Profiles were Similar between Navy Bean and Control Diets  
The major ingredients 
included in the CON and NB diets 
were wheat, corn, rice, and meat 
and bone meal, and poultry fat 
(Table 21). A detailed ingredient 
list has been previously reported 
in Table 10.193  
Total fat content (as-fed) was 13.0 % in the CON diet and 12.8 % NB diet. Sixteen 
individual fatty acids were detected in the diets, and in order of total fat composition in the NB 
Table 21: Major diet ingredients fed to 21 clinically healthy, adult 
dogs.  
Ingredient, % weight/weight Control Diet Navy Bean Diet 
cooked navy bean powder - 25.00 
Wheat 29.00 9.94 
Corn 25.49 20.60 
meat, bone, and poultry by-
product meal 
21.33 20.36 
Rice 12.50 12.50 
poultry fat 7.77 7.77 
supplements, fiber, and palatants 3.95 3.91 
Ingredients are reported on an-fed basis. A detailed ingredient list 






and CON diets, respectively were: oleic acid, 34.39 % and 33.5 %; linoleic acid, 24.49 % and 
25.71 %; palmitic acid, 22.44 % and 21.40 %; stearic acid, 6.25 % and 5.95 %; palmitoleic acid, 
5.6 % and 4.83 %, α-linolenic acid, 2.5 % and 2.44 %; vaccenic acid, 1.9 % and 2.38 %. Myristic 
acid, gondoic acid, arachidonic acid, Arachidic acid, margaric acid, dihomo--lin lenic acid, 
myristoleic acid, eicosadienoic acid and heptadecenoic acid each comprised less than 1 % of 
total fat (Figure 10A). Saturated fat content was 29.82 % and 28.48 % of the total fat content, 
and unsaturated fat was 70.18 % and 70.49 % of the total fat for the NB and CON diets, 
respectively. For the NB diet, n-3, n-6, and n-9 fatty acids comprised 2.50 %, 25.15 %, and 34.76 
% of total fat, respectively. For the CON diet, n-3, n-6, and n-9 fatty acids comprised 2.44 %, 
26.61 %, and 34.00 % of total fat, respectively. 
Crude protein levels were similar between the diets 193, and total amino acid profiles were 
likewise similar (Figure 10B). In order of percent of total diet in the NB  and CON diets, 
respectively, amino acid content was: glutamic acid, 3.88 % and 4.58 %; proline, 2.26 % and 
2.72 %; glycine, 2.10 % and 1.80 %; leucine, 1.87 % and 2.13 %; aspartic acid, 1.72 % and 7.70 
%; valine, 1.72 % and 1.16 %; alanine, 1.16 % and 1.79 %; lysine, 1.47 % and  1.45 %, tyrosine, 
1.23 % and 1.08 %; arginine 1.20 % and 1.50 %, serine, 1.15 % and 1.23 %; threonine, 0.96 % 
and 1.01 %; phenylalanine, 0.86 % and 0.95 %; isoleucine, 0.78 % and 0.78 %; histidine, 0.72 % 
and 0.90 %; methionine, 0.53 % and 0.53 %; cysteine, 0.47 % and 0.39 %; and tryptophan, 0.29 
% and 0.23 %. Other amino acids and amines not individually identified (e.g. choline and 
taurine) comprised 2.09 % and 2.17 % for the NB and CON diets, respectively. Lysine and 






Crude fiber was similar between diets.193 TDF was 15.09 % and 14.32 % for the NB and 
CON diets, respectively. Total soluble fiber was 4.69 % and 3.68 %, and total insoluble fiber was 
10.40 % and 10.64 % for the NB and CON diets, respectively (Figure 10C).  
 
Figure 10: Macronutrient diet components in 25 % navy bean powder and 
control diets. A) Detected saturated, n -3, 6, 9, 5, & 7 fatty acids in navy bean and 
control diets as a relative percent of total dietary fat. B) Dietary amino acid profiles, as 
a percentage of total diet. Amino acids supplemented in the diets are indicated with an 






Non-Targeted Metabolomics Revealed Phytochemical Profile Differencs between Control and 
Navy Bean Diets 
GC-MS analysis of the diets resulted in detection of 7,742 isolated features described by 
time and mass/charge ratio (m/z). These ions were collapsed into 833 clusters and showed 
significant variation between diets (Figure 11A). Of these 833 clusters, 18 metabolites were 
identified that had relative abundance differences of at least 10 % between diets. Metabolites that 
were greater in the NB diet compared to CON diet were 2-piperdinecarboxylic acid (41.49 fold 
increase); s-methyl cysteine (5.15 fold increase); 5-hydroxynorvaline (4.90 fold increase); 
sucrose (1.63 fold increase); citric acid (1.44 fold increase); -tocopherol (1.42 fold increase); -
sitosterol (1.36 fold increase); taurine (1.28 fold increase); α-tocopherol acetate (1.17 fold 
increase); fructose (1.15 fold increase); and Glycerol-3-Phosphate (G3P, 1.11 fold increase). 
Decreased metabolites included palmitelaidic acid (-1.12 fold decrease); L-threitol (-1.17 fold 
decrease); hydroquinone (-1.33 fold decrease); glucose (-1.46 fold decrease); D-pinitol (-1.57 
fold decrease), an unidentified monosaccharide (-1.75 decrease); and trehalose (-1.84 fold 







Figure 11: Metabolite profiles of a nutritionally complete, standard ingredient diet compared to an 
isocaloric, nutrient matched diet containing 25 % w/w cooked navy bean powder. A) Metabolite 
variance between 25 % navy bean powder and control diets. The Navy Bean diet is represented by squares 
and the control diet is represented by circles. B) Ratios of the relative abundance of identified metabolites in 






Lower Serum Cholesterol Levels in Dogs Consuming Navy Beans.  
After 4 weeks of dietary intervention, dogs in the NB diet group had lower cholesterol 
levels than dogs in the CON diet group (Figure 12). At baseline, for NB and CON diet groups, 
respectively, median serum cholesterol was 226 mg/dL (IQR: 177 to 243 mg/dL) and 244 mg/dL 
(IQR: 175 to 296 mg/dL), at two weeks serum cholesterol was 209 mg/dL (IQR: 202 to 233 
mg/dL) and 245 mg/dL (IQR: 220 to 313 mg/dL), and at 4 weeks 209 mg/dL (IQR: 195 to 225 
mg/dL) and 263 mg/dL (IQR: 233 to 289 mg/dL). Changes in serum cholesterol within group 
over time were not significant, and remained within normal ranges throughout the study. 
Figure 12: Serum cholesterol levels of 21 clinically healthy adult dogs during a 4 week dietary 
intervention trial establishing the safety and digestibility of 25 % w/w navy bean powder 
consumption compared to an isonutrient control diet. Dogs consuming the navy bean diet (n=10) had 
significantly lower serum cholesterol levels at 4 weeks compared to dogs consuming the control diet (n=11). 









Dietary Modulation of the Canine Fecal Metabolome 
12,121 peaks were detected by GC-MS in the canine fecal samples and were reduced to 
911 clusters. Principal components analysis revealed one dog in the NB group that was an outlier 
(95 % confidence across PC1 and PC2) which was subsequently excluded from statistical 
analysis. There were no significant differences in the principal component scores between or 
within groups at baseline or day 28 (data not shown), however, in dogs consuming the NB diet, 
we observed a consistent pattern shift in components 1 and 2 that was not observed in the CON 
group. To demonstrate this shift, fecal metabolite variance between groups and across time is 
shown as a principal components analysis (PCA, Figure 13A). Fecal metabolite change was 
highly variable over time within the CON diet group: 7/11 dogs showed a positive directional 
change in PC1 and 4/11 had a negative directional change. For PC2, 7/11 had a negative 
directional change and 4/11 had a positive directional change (Figure 13B). The sum effect of 
these directional changes resulted in approximately random distribution in the PC1 and PC2 
score plots. In the NB group within PC1, 4/9 dogs had a positive directional change and 5/9 dogs 
had a negative directional change and all dogs had a negative directional change in PC 2. In 
contrast with the CON group, the sum effect of these directional changes resulted in dogs 








Fifteen fecal metabolites were identified that showed significant changes over time 
within each group, or were different between groups at 4 weeks (Table 22). The relative 
abundance of these metabolites was not statistically significant between the NB and CON groups 
at baseline (data not shown).  Six metabolites were identified that changed in both the CON and 
NB diet groups after 4 weeks of consuming the micro- and macro-nutrient matched diets. Data 
are presented as relative abundance and median fold change from baseline, range of the data 
within group is given as IQR. The fecal metabolites that decreased in the CON and NB diet
groups, respectively, were α-tocopherol:  0.30 (0.20-0.41) and 0.37; lithocholic acid: 0.94 (0.38-
1.18) and 0.57 (0.48-1.08); myristic acid: 0.76 (0.71-0.92) and 0.81 (0.71-0.86); margaric acid: 
0.73 (0.48-0.88) and 0.69 (0.41-0.96); and a polycyclic hydrocarbon: 0.48 (0.25-2.02) and 0.44 
(0.11-2.37). One metabolite increased in the CON and NB diet groups, respectively: arachidic 
alcohol 2.38 (1.32-5.99) and 1.97 (1.08-4.29). Within the CON diet group, two metabolites 
Figure 13: Fecal metabolite variance between both diet groups, control and navy bean, at baseline and 
after 4 weeks of consuming either a 25 % w/w navy bean powder or control diet (A). Dogs consuming 
the Navy Bean diet (n=9) are represented by squares and dogs consuming the control diet (n=11) are 
represented by circles. Dog NB9 was determined to be an outlier at 4 weeks and was not included in the 
analysis. Variance between the dogs is represented by the distance between each symbol. Variance was not 
significant between diet groups. The direction of change in variance within the whole model in the control 






changed significantly over time (p < 0.10). Excretion of hydroquinone increased by 2.44 fold 
(1.84-3.13) and cycloartenol, a metabolic precursor of phytosterols, decreased by 0.65 fold (0.37-
0.79). While the change over time within the CON group was significant, differences between 
the CON and NB groups were not significant at either time point for these metabolites.  Within
the NB diet group, fecal excretion of glucose significantly increased by 1.64 fold (1.22-2.18), 
deoxycholic acid decreased by 0.52 (0.42-0.93), and α-tocopherol acetate decreased by 0.34 
(0.17-0.56). Excretion of three steroid like compounds increased in the NB group: steroid 
metabolite C30 increased by 9.04 fold (6.78-10.86); steroid metabolite 53 increased by 4.13 
(1.84-20.50); and steroid metabolite 179 increased by 11.43 fold (4.89-52.47).  These results are 
shown as the average scaled values at baseline and 4 weeks, and an average fold change within 







Table 22: Diet responsive canine fecal metabolites. 
 
 Control Diet Group Navy Bean Diet Group  
Metabolite  
(Library Cluster) 
Abundance Fold Change Abundance Fold Change P values 






















.  ↓ 
(0.20-0.94) 
0.751 0.010 0.850 












.  ↓ 
(0.48-1.08) 
0.842 0.076 0.972 












.  ↓ 
(0.71-0.86) 
0.950 0.043 0.972 












.  ↓ 
(0.41-0.96) 













.  ↓ 
(0.11-2.37) 
0.730 0.085 0.745 
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(6.78-10.86) 













.  ↑ 
(1.84-20.5) 













.  ↑ 
(4.89-52.47) 
0.916 0.056 0.102 
The normalized, scaled, relative abundance is reported as median (IQR). A mixed model linear regression with a false discovery rate correction was used to determine metabolites that changed over 
time or between diet groups (p < 0.10). Significant differences over time were confirmed by Wilcoxon matched-pairs sig ed ra k test a d are i di ated  arro s sho i g the dire tio  of ha ge ↓ 
or ↑ , p < . . A Ma  Whit e  t-test was used to determine if the metabolite was different at baseline. No significant differences between groups were detected at baseline for any of the reported 






Phytochemical Detection in Canine Urine by Non-targeted Metabolomics 
Urine samples were collected from the 21 dogs in at least one time point; however, 
sufficient urine samples at both time timepoints were not obtained in three dogs; two CON dogs 
and one NB dog. Repeated measures statistical analysis was therefore carried out in 9 NB dogs 
and 9 CON dogs. In the canine urine samples 5,585 ions were detected by LC-MS, these were 
collapsed into 1,110 clusters. The change in the global profile of urine metabolites was not 
different between groups, as was seen in the fecal metabolome (Figure 14). 
 
Figure 14: Urine metabolite variance between both diet groups, control and navy bean at baseline and 
after 4 weeks of consuming either a 25 % w/w navy bean powder or control diet (A). Dogs consuming 
the navy bean diet (n=9) are represented by squares and dogs consuming the control diet (n=9) are 
represented by circles. Variance between the dogs is represented by the distance between each symbol. 
Variance was not significant between diet groups. The direction of change in variance within the whole model 
in the control group (B) and navy bean group (C) is emphasized with arrows. 
Fifteen metabolites were identified that were significantly different by diet or time (Table 
23). Data are reported as median and IQR. In both groups, urinary excretion of estradiol, suberic 
acid, and two peptides increased, while excretion of a third peptide and kynurenine decreased. In 
the CON group, urinary excretion of a peptide (C63) increased by 514 fold (41.08-1,961.00), 
excretion of a saccharide (C625) increased by 17.92 fold (6.64-113.33), peptide C180 increased 






the NB group, a compound with an exact spectral match for trigonelline was detected, but un- 
retained within the chromatography, and was therefore putatively annotated as trigonelline. In 
the NB group, urinary trigonelline (putative) excretion increased by 9.73 fold (5.12-13.50), a 
dipeptide (C59) increased by 2.88 fold (1.69-3.84), peptide C909 increased by 2.23 fold (1.43-
2.56), and the flavonoid homoeridoictyol chalcone, an intermediate identified in common bean 






Table 23: Diet responsive canine urine metabolites.  
 
 Control Diet Group Navy Bean Diet Group  
Metabolite  
(Library Cluster) 
Abundance Fold Change Abundance Fold Change P values 





































































0.925 <0.001 0.750 


























































































































































0.087 0.262 0.006 













0.897 0.041 0.598 
The normalized, scaled, relative abundance is reported as median (IQR). A mixed model linear regression with a false discovery rate correction was used to determine 
metabolites that changed over time or between diet groups (p < 0.10). Significant differences over time were confirmed by Wilcoxon matched-pairs signed rank test and are 
i di ated  arro s sho i g the dire tio  of ha ge ↓ or ↑ , p < . . A Ma  Whit e  t-test was used to determine if the metabolite was different at baseline. No significant 
differences between groups were detected at baseline for any of the reported metabolites.  Metabolites are sorted by the diet  group in which a significant change occurred. NB: 







This study describes the food metabolome distinctions between an extruded canine diet 
formulated with 25 % w/w cooked NB powder compared to a nutrient matched CON diet. This 
study also demonstrates that dogs consuming the NB diet had fecal and urine metabolome 
changes that indicate modulation of lipid and carbohydrate metabolism.  
The targeted analysis of the nutrient profiles demonstrated that lipid, protein, and fiber 
were similar between the CON and NB diets, while the NB diet had slightly higher levels of 
soluble fiber (Figure 10). The non-targeted GC-MS metabolomics provided an advanced layer of 
food composition analysis, whereby significant differences in the bean-based food metabolome 
were detected. (Figure 11A). Increases in specific food metabolites such as 2-
piperdinecarboxylic acid and s-methyl cysteine (Figure 11B) have been reported in multiple 
common bean cultivars 285 and validated in human and mouse studies as a predictive biomarker 
of dry bean intake in plasma and fecal samples 286; 287. 2-Piperidinecarboxylic acid was detected 
in the fecal samples; however its relative abundance did not change over time in either the NB or 
CON group, and was not significantly different between groups (data not shown). -tocopherol 
and -tocopherol acetate were both higher in the NB diet compared to CON, while α-tocopherol 
content was similar across diets (Figure 11B). This finding is consistent with previous reports for 
legume seeds showing that the most abundant vitamin E isoform is -tocopherol.288 -sitosterol 
is the most abundant phytosterol in beans 289 and was elevated in the NB compared to CON diet. 
One of the mechanisms by which beans may modulate serum lipid profiles is via the activity of 







This food metabolome analysis also revealed differences in the carbohydrate profiles of 
the CON and NB diets. Sucrose, and surprisingly, fructose (given the reduced amount of corn) 
were higher in the NB diet compared to CON, while glucose and trehalose were lower. Although 
dietary glucose was lower in the NB diet, dogs consuming the NB diet had increased glucose 
excretion compared to CON, supporting that the NB diet also resulted in modulation of 
carbohydrate metabolism. Previous studies evaluating the carbohydrate profiles of whole, boiled 
beans have found that while relatively low, glucose is slightly higher than fructose, and that the 
most common carbohydrates present are the complex carbohydrates stachyose, kestose, and 
raffinose.290 These α-galactosides are highly fermentable and thought to be the primary inducers 
of bean-associated flatulence, but may also be responsible for multiple health benefits; including 
inhibiting growth of pathogenic bacteria, preventing colon cancer, increasing mineral absorption, 
improving lipid metabolism, and increasing SCFA acid production in the large intestine.291 
Oligosaccharide content of the diets was not determined in this study, however extrusion of bean 
powders has been shown to reduce oligosaccharide content.292 One explanation for the higher 
fructose content in the NB diet is that a fraction of the complex carbohydrates or 
oligosaccharides, all of which contain fructose, were reduced to simple carbohydrates first by the 
flour processing method and subsequent extrusion process to make the kibble. This hypothesis is 
supported by the observation that none of the dog owners reported a change in perceived 
flatulence in their dogs regardless of the diet consumed.193        
Dogs consuming a 25 % w/w NB bean diet for 4 weeks had significantly lower serum 
cholesterol levels compared to dogs consuming an iso-caloric and nutrient matched standard 
ingredient diet. While blood samples were all collected at approximately the same time of day 






However, variations within dog and triglyceride levels were not significantly different, 
supporting that the reported difference in cholesterol levels were reliable. One of the most 
frequently reported effects of bean intake, in human and laboratory animal studies, is beneficially 
altered serum lipid profiles.44; 267 This is also consistent with the reported changes in triglycerides 
and lipid carrier proteins (LDL and HDL) reported from overweight and obese dogs consuming a 
bean based diet during weight loss.293 The significant modulation of serum cholesterol by 
cooked, dry beans in dogs, without concurrent weight loss, is novel support for bean modulation 
of metabolism in a healthy weight host. The mechanism by which dry bean consumption reduced 
serum cholesterol in dogs is unknown, but may be attributed to dry bean components that inhibit 
cholesterol absorption in the small intestine264; 294; 295, prevent reuptake of bile acids via 
enterohepatic recirculation296; 297, or increase biliary bile acid and cholesterol or related sterol 
secretion.298-300 Contrary to expectations, given the increased cholesterol and bile acid content in 
bile associated with bean intake, fecal cholesterol excretion does not increase 297 and fecal bile 
acid excretion, especially secondary bile acids, actually decrease.296; 298; 301 Our results confirm 
these observations in dogs, as no changes in fecal cholesterol excretion were observed (data not 
shown), and fecal excretion of deoxycholic acid decreased in the NB group (Table 22). 
Coprostanol, a microbial byproduct of cholesterol degradation 302,  has been reported to increase 
with bean consumption.296 However, it is not present in canine feces possibly because the canine 
gut microbiome lacks the organisms responsible for this conversion.303 By utilizing a non-
targeted metabolomic approach, we found that dogs consuming the NB diet had a 4.13 to 11.43 
fold increase in fecal excretion of three steroid-like compounds (Table 22) not found in 
metabolite databases.  This finding provides rationale for an alternate mechanism by which beans 






detected in human stool samples with increased bean intake (unpublished data), and the 
identification of these metabolites will be useful to expand our knowledge regarding the bean-
facilitated excretion of additional lipid molecules.  
Urine metabolome analysis from dogs consuming beans showed that excretion of 
trigonelline (putative), a phytochemical found in beans, was significantly increased (Table 23).  
Interestingly, trigonelline, in humans, is more strongly associated with coffee intake146, but was 
recently described as a candidate biomarker of bean intake in human plasma.286 Trigonelline may 
be a candidate biomarker of NB intake in dogs, as urinary excretion in this study was not 
confounded by coffee consumption. This metabolite was not detected in the NB diet analysis as 
the food metabolome was analyzed using GC-MS, and trigonelline cannot be easily derivatized 
or volatilized using our GC-MS method. Additional metabolites found in urine of dogs 
consuming NBs included homoeriodictyol chalcone, a metabolite in a flavonoid biosynthesis 
identified in Phaseolus vulgaris (KEGG pathway pvu00941). Unlike the fecal metabolome, there 
was not a diet associated directional shift in the urinary metabolome. While there were 
metabolites that changed by both diet and time, the NB diet responsive metabolites were 
phytochemicals and peptides that may serve as candidate biomarkers for common bean intake.  
 
CONCLUSIONS 
In addition to providing a high quality source of nutrients, a 25 % w/w NB dog diet 
formulation was shown to have a distinct phytochemical composition compared to a standard, 
commercial diet formulation. The presence of bean phytochemicals in urine demonstrated the 
ability to detect candidate biomarkers of bean intake in dogs. Healthy weight companion dogs 






merit further investigation for improving the health and lifespan of companion dogs, as well as 
possible nutritional therapy for dogs with metabolic disorders. These data also support the utility 
of nutritional metabolomics in companion dogs.8 
 
  
                                                 
8 This work was supported in part by the Flint Animal Cancer Center at Colorado State University, Archer 
Daniels Midland Alliance Nutrition, and Edible Bean Specialties. The authors wish to thank Cadie 
Tilliotson and Dr. Kristen Weishaar for technical assistance with sample collection from canine 






CHAPTER 7: NUTRITIONAL WEIGHT LOSS THERAPY WITH COOKED BEAN 
POWDERS REGULATES SERUM LIPIDS AND BIOCHEMICAL ANALYTES IN 
OVERWEIGHT AND OBESE DOGS9 
INTRODUCTION 
 Over 35 % of American adults are obese304 with the consequence that obesity has now 
surpassed smoking as the leading cause of preventable disease in the U.S..305 Companion animal 
obesity is estimated at 30 – 40 % 227 and mirrors the obesity epidemic in humans. Similarities 
between dogs and humans with obesity associated co-morbidities also exist for osteoarthritis, 
diabetes, nephropathy, cancer, and dyslipidemia.306-309 Dogs represent an advanced translational 
model for cancer treatment 310; 311 and other disease management therapies312-314 and have been 
used extensively to evaluate surgical methods such as endoscopic pyloric suturing315, reversible 
gastric restriction implants316, and gastric bypass techniques.317 Additionally, dogs have been 
shown to be successful transitional models for evaluating protein intake, solving the nutritional 
mysteries behind pellagra and rickets318 as well as evaluating effects of diet on brain 
physiology.319 Pet dogs are especially relevant for evaluating nutritional weight loss therapies 
because they experience naturally occurring weight gain in the same home and living 
environment as humans. Companion dogs have similarities to human disease when compared to 
colony dogs possibly due to the role of environmental factors, including variable diets.320-322 
Furthermore, recent reports identified biomarkers of canine obesity with similarities to human 
biomarkers such as blood lipid values that change with weight loss.227; 323; 324  
                                                 
9 This chapter was originally published in Journal of Obesity and Weight Loss Therapy 2012:2(8):149. 
DOI: 10.4172/2165-7904.1000149. Authors are Genevieve M. Forster, Cadie A. Ollila, Jenna H. Burton, 






While many nutritional intervention strategies exist for weight loss, epidemiologica  
studies reveal that legume consumption promotes satiety and is more effective for weight loss 
than calorie restriction alone.325 Beans have also been shown to improve nutrient intake levels 
and regulate body weights and waist circumferences in humans providing additional weight 
management benefits.32  In addition to weight loss, beans have also shown to harbor chronic 
disease fighting properties for obesity related conditions such as heart disease326; 327, diabetes231, 
cancer212; 328; 329, and dyslipidemia.34; 39; 44 While studies investigating the role of beans for 
weight loss in dogs have not been previously performed, we have established the safety and 
digestibility of beans as a novel ingredient for inclusion in healthy adult dog diets.330   
Changes in dietary patterns, such as a calorie restricted diet lead to weight reduction; 
however the role of diet composition during the weight loss process merits research attention.325  
Given that cooked beans are a novel food ingredient for dogs, this study was conducted to 
evaluate whether eating beans as a major staple diet ingredient will alter metabolic parameters 
compared to dogs not consuming beans while undergoing similar weight loss.  We hypothesized 
that a 25 % weight/weight bean based diet improves the metabolic status of dogs compared to 
control diets during comparable weight loss.  
 
MATERIALS AND METHODS 
The Colorado State University Institutional Animal Care and Use Committee approved 
all clinical trial operations, animal care procedures, and collection of biological samp es for 









Thirty overweight or obese, clinically healthy, client owned adult dogs of different breeds 
were individually randomized based on their baseline BCS into 1 of 3 diet groups: control 
(CON), black bean (BB), or navy bean (NB). oth the owner and clinician were blinded to 
which diet the dog was consuming. Dogs were transitioned onto their assigned study diet over a 
4 day period; this was accomplished by mixing increasing proportions of the study diet with 
decreasing proportions for their normal diet over the 4 day period. Blood samples were collected 
at baseline and at 2 and 4 weeks post intervention. At the end of the 4 weeks dogs were 
transitioned over a 4 day period to their original diets.  
A signed consent form and medical history was required before enrolling in the study.  
The owner was required to bring the dog to the CSU VTH for weekly body weight (BW) checks 
and biweekly for physical exams, BCS monitoring, and blood collection.  Owners were required 
to feed the dog only the study diets in amounts that were calculated to achieve weight loss, and 
to record daily food intake and fecal scores. Exercise was recorded; however no changes in 
exercise activity were required for the study. A medical history form was completed by the 
owner at weeks 2 and 4 of the study to assess changes in the dogs’ health and behavior, such as 
vomiting or diarrhea, flatulence, energy level, as well as to assess palatability of the study diet.   
Inclusion/Exclusion criteria 
Dogs between the ages of 2 to 7 years with a BW of at least 10 kg and a BCS of at least 6 
on a 9 point scale 191 were eligible to participate in this clinical trial. Dogs were required to have 
normal biochemical and hematological values and normal thyroid function as determined by a 
screening total T4 test. If the total T4 was below the lower limit of normal, a full canine thyroid 






ensure adequate thyroid function. Dogs were excluded if they had hypothyroidism, dietary 
allergies, prior or current cancer history or other major medical illness, or had been administered 
antibiotics or analgesics within one month of starting the diet.  Concomitant medications were 
not allowed while on study, with the exception of heartworm preventative. 
Diet Compositions 
 All diets were formulated to meet the Association of American Feed Control Officials 
nutrient and energy requirements for adult dogs.215 Table 24 shows the nutrient profiles of the 
control and 25 % weight/weight black and navy bean diets. The complete formulations are 
presented in Table 15. Staple ingredients such as wheat, corn, and pork and bone meal were 
adjusted to account for the inclusion of bean powders (Vegefull; ADM Edible Bean Specialties, 
Decatur, IL), and to match nutrient and energy density. The control diet was manufactured and 
processed in the same location and 
under the same conditions as the 
bean diets (ADM Alliance 
Nutrition Feed Research Pilot 
Plant, Quincy, IL; Applied Food 
Biotechnology Plant in St. Charles, 
MO).  Navy and black beans were selected for investigation given their widespread consumption 
by humans and availability as cooked powders.  
Weight Loss Intervention  
Total daily energy intake requirements for each dog were determined by the dog’s BW 
and BCS at baseline. The BCS was determined by the clinician and study nurse using a 9-point 
Body Condition Scale.191 Using this scale, a score of less than 4 is underweight, a score of either 
Table 24: Nutrient profiles of canine weight loss diets.  
Nutrient Control Black Bean Navy Bean  
Moisture, % 4.98 4.41 5.04 
Protein, % 27.99 28.14 27.70 
Fat Acid Hydrolysis, % 8.84 8.47 8.42 
Crude Fiber, % 4.10 4.50 3.90 
Gross Energy, Kcal/g 4.74 4.57 4.61 
Values are presented on a dry matter basis, with the exception of 






4 or 5 is considered ideal BW, a score of 6 or 7 is overweight, and a score of 8 or 9 is considered 
obese. Ideal BW was determined using BCS. For a BCS of 6, a dog was considered 10 % over 
ideal BW, and for a BCS of 9, a dog is considered at least 40 % over ideal BW.331 The total 
required daily caloric intake to maintain ideal body weight was calculated using the following 
formula: daily metabolizable energy (ME) requirement (kcal) = 110 x (ideal BW (kg) ^0.75). To 
achieve a weight loss rate of 2 % BW/week, dogs consumed 60 % of the energy calculated to 
maintain ideal BW. Dog owners were instructed to only feed the prescribed diet for the duration 
of the study according to the dog’s normal feeding schedule. Daily food amounts were provided 
to the owners in pre-measured packets and determined by dividing the daily energy requirements 
of each dog for weight loss by the energy density of the diet. Water was provided ad libitum. 
Each dog owner maintained daily records of all food consumed, including any non-study 
consumed food. Any leftover or uneaten food was collected and weighed in the laboratory.  The 
total amount consumed was calculated by subtracting the weight of the leftover food from the 
original weight of the food prescribed for that day.   If dogs failed to achieve at least 0.5 % BW 
loss, caloric intake amounts were further decreased by 10 % at 2 weeks.  
Dietary Intake Records and Fecal Scores  
Owners recorded the total amount of food consumed each day and recorded a daily fecal 
score. A 5-point fecal scoring system was used: 1 = hard and dry, 2 = well formed, 3 = moist, 4 = 
no form, 5 = diarrhea. Space was also provided for any comments and owners were instructed to 
report any food intake outside of the prescribed diet.  Study compliance was determined by total 








Blood Sample Collection and Analysis 
Blood was collected after a 12 hour fast via jugular venipuncture at baseline, 2, and 4 
weeks post intervention. Two mL of whole blood was collected into an evacuated red top tube 
without anticoagulant for biochemistry panel analysis and 4-6 mL was collected into a plasm
separation tube with EDTA and used to determine lipid profiles.   
The CSU Clinical Pathology Laboratory performed all blood analyses as previously 
described.330 Briefly, the biochemistry panel was analyzed using a clinical chemistry analyzer 
(Hitachi 917; Roche Diagnostics, Indianapolis, IN), analytes evaluated include cholesterol, BUN, 
creatinine, total protein, albumin, globulin, ALP, ALT, AST, GGT, total bilirubin, glucose, 
calcium, chloride, magnesium, phosphorus, potassium, and sodium.  Total T4 and endogenous 
TSH, and TgAA was analyzed using an immunology analyzer (Siemens Immulite 1000, Los 
Angeles, CA), TgAA was analyzed by ELISA (Oxford Laboratories, MI) and Free T4 was 
analyzed by equilibrium dialysis at the Endocrine Section, Animal Health Diagnostic Laboratory 
(Michigan State University) using previously reported methods.332  The lipid analysis was 
performed by a Cobas c501 chemistry analyzer (Roche Healthcare Diagnostics, Indianapolis, IN) 
which measured total triglycerides (TG) and high-density lipoprotein (HDL). Low-density 
lipoprotein (LDL) levels were calculated to equal: total cholesterol – HDL – (TG / 5).333 
Cholesterol values were obtained from the biochemistry panel, performed at the time of 
collection.   
Statistical Analysis 
Statistical analysis was performed using SAS 9.2 (SAS Institute Inc. Cary, NC).  A model 
was fit separately for each response variable (weight, lipids, etc) using proc mixed.  The model 






dogs were captured using a random dog effect (where dog is nested within diet).  Comparisons of 
interest were estimated and tested using contrasts of the model.  TG, alkaline phosphatase (ALP), 
alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were log transformed to 
satisfy the assumption of normality. Data are reported as means ± SEM for all response 
variables.  One dog in the black bean group had elevated levels of TG at 4 weeks, was deemed a 
statistical outlier and as the dog may have gotten into food before the blood draw this data point 
was removed from the 4 week TG analysis. Differences between groups in baseline, age, and 
weight were assessed using a one-way ANOVA (Graphpad V.5.2, La Jolla, CA). Differences 
between groups in sex and baseline BCS were analyzed using Fisher’s exact test (R Project 
software, Vienna, Austria). Results were considered significant when P ≤ 0.05. 
 
RESULTS 
Of the 40 dogs screened, 7 failed to meet inclusion criteria and three were dropped from 
the study between 1 and β weeks for food refusal, physical injury, and an owner’s schedule not 
permitting follow up visits. Thirty dogs completed the study and no differences were observed in 
age, weight, sex, or BCS at baseline between 30 dogs in the control, black bean and navy bean 
diet groups (Table 25).  The average age (years) in the control group was 5.8 ± 0.42, 4.3 ± 0.54 
in the black bean group, and 4.6 ± 0.58 in the navy bean group (P > 0.12). In the control group, 
7/10 dogs were female, 3/10 were male; In the black bean group 6/10 dogs were female and 4/10 
were male; and in the navy bean group 4/10 dogs were female and 6/10 were male. All male 
dogs were castrated and all female dogs except one in the control group were spayed. Dogs with 
BCS of either 6 or 7 were considered overweight and dogs with BCS of either 8 or 9 were 






black bean group, 4/10 dogs were overweight and 6/10 were obese; and in the navy bean group 
7/10 dogs were overweight and 3/10 were obese. No gastrointestinal discomfort or changes in 
flatulence were reported by owners. All owners reported adherence to the study diet, with a few 
exceptions (such as eating food scraps dropped by children, receiving cookies from the groomer, 
etc.) that were evenly distributed across groups. Some owners expressed uncertainty of the total 
amount of extra food their dog consumed. All owners were reasonably sure that their dog was 













 Effect of Caloric Restricted diets on Canine Weight Loss. 
Daily caloric intake was calculated to achieve a loss of 0.5-2 % BW per week. Across all 
groups, 26/30 dogs achieved loss within this range. Figure 15 shows the average percent weight 
lost at 2 and 4 weeks post intervention. In all groups, weight loss was significant between 
baseline and 4 weeks. In the control group, average weight lost at 2 weeks was 3.2 % ± 0.59 and 
4.2 % ± 0.88 at 4 weeks (P < 0.001). In the black bean group, average weight lost at 2 weeks was 
Table 25: Characteristics of thirty overweight dogs fed bean-based or 
control during weight loss. 
 Control  Black Bean  Navy Bean 
P Value Parameter Mean SEM  Mean SEM  Mean SEM 
Age, years1 5.8 0.42  4.3 0.54  4.6 0.58 0.12 
Weight, kg1 33.0 4.50  26.7 3.19  28.8 3.61 0.50 
 ____________Number of Dogs_____________  
Sex2      0.53 
   Female 7  6  4  
   Male 3  4  6  
BCS3      0.45 
   6-7 7  4  7  
   8-9 3  6  3  
1Significant differences between groups were evaluated using a one-way 
ANOVA. 
2All but one female participant in the control group was spayed and all males 
ere astrated. Sig ifi a e as e aluated usi g Fisher’s e a t test.  
3Body Condition Score (BCS): Nine-point scale where BCS 4 and 5 are ideal, 6 
and 7 are overweight, and 8 and 9 are obese (35). Significance was evaluated 







3.3 % ± 0.75 and 5.2 % ± 0.92 at 4 weeks (P < 0.001).  In the navy bean group, average weight 
lost at 2 weeks was 3.5 % ± 0.72 and 6.5 % ± 0.95 at 4 weeks (P <0.001).  No difference in 
percent weight loss was seen between groups (P > 0.05). The greatest percent lost was seen in 
the navy bean group > black bean group > control group.    
Figure Anchor 
Navy and black beans differentially modulate blood lipids in dogs during weight loss. 
Total serum cholesterol was significantly decreased in overweight dogs after 2 and 4 
weeks of calorie restriction in the control and bean diet groups while TG, HDL, and LDL were 
also significantly reduced in at least one of the bean diet groups (Table 26). In the control group, 
total serum cholesterol was reduced by an average of 15 mg/dl after 2 weeks (P < 0.05), and 
showed a total average decrease of 17 mg/dl (P < 0.02) after 4 weeks. In the black bean group, 
total serum cholesterol was reduced by an average of 38 mg/dl after 2 weeks (P < 0.001), for a 
total average decrease of 40 mg/dl (P < 0.001) after 4 weeks. In the navy bean group, total serum 
Figure 15: Percent weight loss of 30 adult dogs in a 4 week calorie restricted dietary 
intervention study. Dogs in all diet groups had significant weight reduction at 2 and 4 weeks, no 
significant differences were observed between groups, significant change is shown within each group 






cholesterol was reduced by an average of 46 mg/dl after 2 weeks (P < 0.001), and 54 mg/dl after 
4 weeks (P < 0.001). No significant differences in serum total cholesterol were observed between 
groups at 2 or 4 weeks. Total cholesterol was significantly higher in dogs consuming the black 
bean diet compared to control at baseline (P = 0.05). 
Total serum TG were significantly decreased in all groups at 2 weeks, however only navy 
bean fed dogs continued to show a significant decrease at 4 weeks (Table 26). TG levels wer  
not normally distributed and statistics were performed on log transformed variables and are 
reported as means ± (SEM). In the control group, total serum TG decreased from 123 mg/dl ± 
21.16 at baseline to 89 mg/dl ± 28.62 at 2 weeks (P < 0.03) and 105 mg/dl ±24.65 at 4 weeks, for 
a total decrease of 18 mg/dl (P = 0.09). In the black bean group, total serum TG decreased from 
127 mg/dl ± 21.84 at baseline to 94 mg/dl ± 12.24 at 2 weeks (P = 0.05) and 132 mg/dl ± 28.63 
at 4 weeks for total increase of 5 mg/dl (P = 0.22). In the navy bean group, total serum TG 
decreased from 140 mg/dl ± 31.43 to 96 mg/dl ± 22.37 at 2 weeks (P < 0.01) and 77 mg/dl ± 
11.04 at 4 weeks for a total decrease of 63 mg/dl (P < 0.001).  
HDL and LDL were significantly reduced from baseline in both the black and navy bean 
diet at 2 and 4 weeks (Table 26). HDL of the dogs fed the control diet decreased by 5 mg/dl (P = 
0.45) after 4 weeks. In black bean fed dogs HDL decreased an average of 23 mg/dl (P < 0.001), 
and in navy bean fed dogs HDL decreased an average of 27 mg/dl (P < 0.001) after 4 weeks. In 
control fed dogs LDL decreased an average of 9 mg/dl after 4 weeks (P = 0.08), in black bean 
fed dogs LDL decreased an average of 17 mg/dl after 4 weeks (P < 0.001), and in the navy bean 








Dietary Navy or Black Bean effects on Blood Chemistry and Electrolytes  
Selected non-lipid serum analytes from the clinical biochemistry panel that have been 
associated with obesity and modulated by weight loss in both dogs and humans were assessed t 
baseline, 2, and 4 weeks post intervention in control, navy bean and black bean fed overweight 
and obese dogs (Table 27 and Table 28).  
After 4 weeks, total protein was decreased an average of 0.21 g/dl (P = 0.03), AST was 
decreased an average of 9 IU/L (P < 0.01), and total bilirubin was decreased an average of 0.04 
mg/dl (P = 0.05) in the dogs fed with the control diet. In the black bean fed dogs, after 4 weeks 
creatinine was increased by 0.06 mg/dl (P = 0.05) and ALP was decreased by 49 IU/L (P = 
0.01), yet all values remained within clinically normal ranges. In the navy bean fed dogs, after 4 
weeks blood urea nitrogen (BUN) was decreased by 5 mg/dl (P <0.001) and creatinine was 
increased 0.11 mg/dl (P < 0.001). At 4 weeks no changes were seen in albumin, ALT, gamma 
glutamyl transferase (GGT), globulin, or glucose within any group (Table 27).  
Of the serum electrolytes measured, none were changed in the control group. In the black 
bean group, magnesium was increased 0.07 mg/dl (P = 0.05) and phosphorus was increased 0.39 
mg/dl (P = 0.04). In the navy bean group, chloride was increased by 1.00 meq/L (P =0.03). No 
































Baseline vs 4 
Week 





























































































1Data are presented as mean (± SEM). 2Normal ranges are from published reports.3Statistical analysis was performed on log transformed values to meet assumptions of 







Table 27: Selected blood chemistry analytes of thirty overweight dogs fed bean-based or control diets during weight loss. 
Analyte1 
(Normal Range)2 
Control  Black Bean Navy Bean 
   Baseline vs 4 Week    Baseline vs 4 Week    Baseline vs 4 Week 






























































































































































































































































1Data are presented as mean (± SEM). 2Normal ranges are in-house references.3Statistical analysis was performed on log transformed values to meet assumptions of normality, 
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Laboratory, clinical, and epidemiological studies show that dry bean intake is associated 
with increased weight loss and lower body weights32; 39; 334 Weight loss was intentionally 
achieved in the control diet fed dogs as well as for the experimental bean diets in this study due 
to caloric restriction. The navy and black bean diets showed a trend towards enhanced effects on 
weight loss after one month compared to the control. While this finding was not statistically 
significant, we postulate that a larger sample size and longer weight loss time may reveal more 
robust differences as previously reported with bean intake in humans.39  Three of the four dogs 
(1/10 black bean, 1/10 navy bean, 1/10 control) who failed to achieve weight loss may have been 
due to dietary non-compliance as the owners expressed uncertainty of the dog’s intake in spite of 
attempts to adhere to study diet. This highlights the challenges faced by owners and clinicians 
when undertaking a weight loss program for a companion animal and underscores the 
importance of developing weight management therapies that account for these challenges.  The 
fourth dog (black bean diet) failed to lose weight in the 4 week period most likely due to resting 
energy requirements outside of the calculated required energy estimates as the owner was 
reasonably sure the dog was only consuming prescribed food. Other weight loss related 
measurements modulated by dry bean intake include decreased waist circumference and 
inflammatory biomarker expression.32; 39; 326; 335 The macro and micronutrient composition of dry 
beans are thought to promote weight loss by providing low glycemic index sources of fiber, 
protein, minerals, and phytochemicals.228; 334 Increased protein intake has been shown to improve 
weight loss 336 with plant proteins having higher satiety ratings than animal proteins337.  Dry bean 
fiber  may promote weight loss by improving satiety with altered transit time in the intestines, 






that compete with protein and glucose for uptake and utilization334, and enhanced release of 
cholecystokinin40 which may have short term effects on energy intake and gastric emptying.338 
Bean phytochemicals such as phenolic compounds may interfere with glucose transport in the 
small intestine, phytic acid may delay glucose absorption leading to improved satity and 
modulated energy uptake334, and many phytosterols and saponins have been implicated in 
cholesterol reduction.232; 339  
 Lipid metabolism is an important component to weight loss as dyslipidemia underlies 
many of the comorbidities associated with obesity.340 Weight loss has repeatedly been shown to 
reduce serum cholesterol levels in both humans and dogs 341; 342 and increased plant fiber intake 
has been shown to lower cholesterol levels after only 1 week with the same efficacy as first 
generation statins.343 Our study shows serum cholesterol reduction occurred after 2 weeks of 
weight loss and was sustained throughout the study (Table 26). While not statistically ignificant, 
dogs consuming beans showed the largest change at 2 weeks whereas the decrease in the control
group was similar between 2 and 4 weeks. This finding demonstrated that serum cholesterol 
reduction may be an early biomarker for a metabolic response to bean intake and weight loss 
wherein previous reports in dogs showed decreased serum cholesterol after 60 days344, 90 
days341, and after the full amount of time required to reach ideal weight.345; 346 Furthermore, TG, 
HDL and LDL were reduced in at least one of the bean diet groups, a finding consistent in 
human studies 44, with the exception of HDL which has been shown to increase in humans after 
bean consumption.347 It should be noted, that LDL levels were determined indirectly using 
Friedewald’s equation333 and are therefore only indicative of trends between groups,  and may 
not be reflective of actual values due to variance with HDL and LDL metabolism in dogs 






 Modulation of lipid metabolism by dry bean consumption has several proposed 
mechanisms which may work in conjunction with weight loss. Epidemiological studie have 
revealed inverse relationships between dietary protein sources and cholesterol levels.348 Di tary 
fiber is thought to correct dyslipidemia by decreasing fat intake and increasing bile acid and 
cholesterol losses in the small intestines.349 A meta-analysis of non-legume soluble fiber also 
revealed a slight improvement in lipid profiles.350 In contrast, dry bean fiber has been shown to 
alter blood lipids by preventing micelle formation and preventing absorption of cholesterol and 
fatty acids making these compounds available for fermentation in the large intestine, and 
increasing the rate of removal of LDL.351 In vitro studies have suggested that dry beans have a 
higher capacity for binding to bile acids than do soy proteins or wheat gluten222; 352 and rat 
studies have shown higher bile acid synthesis and excretion with whole bean diets.353; 354 Human 
studies have further demonstrated the interruption of the enterohepatic circulation of bile acids 
and increased excretion of acidic fecal sterols after prolonged bean consumption.36 
Characterization of bean fractions associated with lipid modulation in rats revealed that the 
starch and fiber component had the greatest lipid lowering effects 354, as well as upregulation of 
hepatic LDL receptor and cholesterol 7 alpha-hydroxylase expression.355 These findings, taken 
together with the observed lipid metabolism changes in the bean groups suggest that there may 
be multiple compounds working in concert. Beans contain numerous bioactive components356 
and dietary intervention studies continue to show beneficial changes in blood lipids, regardless of 
underlying health conditions.34; 325 
Non-lipid serum analytes previously reported to be associated with weight loss in both 
dogs and humans were also evaluated. BUN is decreased in overweight dogs compared to lean 






namely no changes344; 345, or increased levels of BUN.341; 357 In this study, all dogs had BUN 
values within normal ranges, and only dogs on the navy bean diet showed an average decrease of 
5 mg/dl (P < 0.001) during weight loss (Table 27). Creatinine levels have also been shown to be 
elevated in overweight dogs compared to lean dogs 341, however changes in serum creatinine 
levels have also been variably reported with increases and decreases after 60 and 90 days of 
weight loss.341; 344; 345  Creatinine levels remained constant during the 4-week study in our control 
group and increased in both bean diet groups but remained within normal reference range. The 
precursor for creatinine, creatine, is generated from the urea cycle and has been touted as a 
supplement for stimulating muscle growth in athletes.358 This candidate biomarker may have 
important implications in understanding the role of beans for maintaining muscle mass during 
weight loss. Total protein has been shown to be increased in overweight dogs compared to lean 
341 and to decrease after 60 and 90 days of weight loss.341; 344 In this study, total protein decreased 
in the control group (P = 0.03), however remained unchanged in the bean groups. Albumin has 
been demonstrated to be increased in overweight dogs 341 and reduced in dogs undergoing weight 
loss.341; 344; 345 Serum albumin levels were not changed herein and may be reflective of the 4 
week study time period of weight loss examined as previous studies have reported changes after 
60-90 days. Enzymes ALP, ALT, AST, and GGT have all been positively associated with 
increased body fat in obese humans, with ALP dependent on gender.359 ALP is elevated in 
overweight dogs and reduced in dogs undergoing weight loss.341; 345 ALP was significantly 
reduced in dogs consuming black beans (P = 0.01) and had a decreasing trend in the navy bean 
group (P = 0.08). AST levels have not previously been shown to change with weight loss in dogs 
346, however it was significantly decreased in the control group (P < 0.01).  Bilirubin, while not  






diets 344 as was observed in the control group. Glucose levels were not altered in any of the 3 diet 
groups and have not previously been shown to change with weight loss in dogs 341; 344; 346; 360, 
although increased glucose levels in overweight dogs have been reported.341 No analyte was 
changed outside of normal ranges.  
Beans are an effective staple food ingredient and a quality protein source during weight 
loss and these results suggest that consuming a diet with high dry bean intake improves lipid 
profiles along with other metabolic biomarkers when compared to a non-bean caloric restricted 
diet alone.  Furthermore, dry bean consumption has been associated with increased longevity 234, 
reduced tumor growth in colon 361; 362, mammary tissue 41, upper digestive tract and stomach 329,
and prostate 363, decreased risk for cardiovascular disease 347, and diabetes.364; 365 
This study has demonstrated the ability of dietary bean intake to modulate blood lipids 
beyond what is expected from weight loss alone. Furthermore, the changes in blood biochemical 
analytes suggest a role for beans in liver and kidney function in dogs undergoing weight loss. 
This overweight dog trial was a practical and relevant approach to advance our understanding of 
the effects of dry bean consumption for lipid modulation during weight loss, because it accounts 
for variations in non-controlled living environments. Moreover, the companion animal dogs in 
this study represent a realistic reflection of serum lipid and biochemical profile variations nd 
population based responses. Taken together, these results provide rationale for further 
explorations of the effects of dry bean consumption for chronic disease prevention, and 
regulation of lipid metabolism with weight loss.10  
                                                 
10 We would like the Dry Bean Health Research Program, the Shipley Foundation, and the Animal Cancer 
Center for support of this study. We would also like to acknowledge Susan Lana and Kim Arnett in the 






CHAPTER 8: EFFECTS OF BEAN-BASED WEIGHT LOSS THERAPIES ON THE 
METABOLOME, INFLAMMATION, AND GUT HORMONES IN OVERWEIGHT AND 
OBESE DOGS 
INTRODUCTION 
Consumption of common beans (Phaseolus vulgaris, L.) has been correlated with 
increased longevity31, reduced risk for cardiovascular disease30, lower glycemic response to 
meals366, and decreased risk for advanced adenoma recurrence.367 Cooked common beans 
support weight loss in humans368 and frequent consumption is associated with lower body 
weight.32 Individuals consuming beans during weight loss have also experienced improvements 
in glucose homeostasis, decreased serum cholesterol, triglycerides, LDL, and increases in HDL 
that are not observed in caloric restricted groups without bean intake.66; 369 Rebello, et al. 
recently reviewed the effects of bean consumption on human obesity and found that bean intake 
improves weight loss over caloric restriction alone, increases metabolic rates, improves satiety, 
reduces dyslipidemia, and improves metabolic syndrome parameters.76 Cooked common beans 
comprise a unique combination of macro-, micro-, and phytonutrients that are associated with 
metabolic improvements in glucose, lipid, and carbohydrate metabolism as well as decreased 
inflammation, and increased satiety through the modulation of orexic gut hormones (reviewed in 
Chapter 1).   
Obesity is the primary nutritional disorder in dogs in developed countries with over 40 % 
of dogs classified as overweight or obese in the U.S.3, UK4, Australia5, and China.6 Overweight 
dogs have reduced lifespans,8 and are at higher risk for developing multiple chronic diseases and 






metabolic and endocrine disorder with white adipose tissue producing multiple inflammatory 
mediators, hormones, and growth factors.370 Similar to humans, dogs with excess adipose tissue 
may have increased inflammation as indicated by higher levels of circulating CRP175, TNF-
alpha, and IL-6.371 Overweight dogs also have alterations in gut hormone expression such that 
leptin is increased and adiponectin and ghrelin are decreased. We have demonstrated that 
overweight and obese dogs may have different serum biochemistry than normal weight dogs, and 
other canine studies have shown changes in serum lipid profiles, and liver enzymes (Chapter 
3).198 We have also demonstrated significant differences in the metabolome of normal weight 
versus overweight and obese dogs (Figure 8), and others have demonstrated that weight gain in 
dogs induces changes in carbohydrate, energy, and protein metabolome profiles.372 Th  
culmination of these aberrancies are detected as an increase in insulin resistance, hyperlipidemia, 
and endocrine dysfunction making overweight and obese dogs at higher risk for developing 
chronic diseases.373  
Many of the metabolic aberrancies associated with canine obesity can be reversed with 
weight loss. Diet, lifestyle, and behavior based interventions to reduce adiposity have been 
successful in correcting dyslipidemia, reducing renal stress, normalizing endocrine function, and 
reducing inflammation.344; 374-380 Therefore, inclusion of cooked common beans into nutritionally 
completed dog foods may potentiate the benefits of weight loss in dogs. Given that cooked 
common bean powder, when incorporated into an extruded, dry, kibble, is safe and digestible by 
dogs during weight loss120 (Chapter 4), consumption of bean-based diets modulates serum lipids 
and analytes in overweight and obese dogs, independent of weight loss95 (Chapter 7), and we 
found that in normal weight dogs consuming a bean-based diet for weight maintenance, 






intake on the metabolome, inflammation, and gut hormone expression during weight loss were 
evaluated.  
The objectives of this research were 1) to evaluate the effects of weight loss on the 
metabolome, inflammasome, and gut hormones of clinically healthy, adult, companion dogs 
undergoing calorically restricted weight loss on nutrient matched BB and NB based and control 
(CON) diets and 2) determine the effects of cooked black (BB) and navy (NB) bean powders on 
the macro- and phyto-nutrient profiles of nutritionally complete, low fat dog foods. We 
hypothesize that dogs consuming the bean-based diets will have decreased inflammation, a shift 
in gut hormone expression to increases insulin sensitivity, as well experience changes in the 
metabolome consistent with improved carbohydrate and lipid metabolism. We also expect that 
the addition of bean powders to nutritionally complete, bean-based dog food formulations for 
weight loss, will increase the phytochemical diversity of the diets, and improve the 
macronutrient profiles for weight loss as was seen in diet formulations for weigh maintenance 
(Figure 11).  
 
METHODS AND MATERIALS 
Study Design/Dogs 
Thirty clinically healthy, overweight  or obese, adult, male and female, companion dogs 
were recruited to participate in a randomized, placebo controlled, double blinded, bean-based 
dietary weight loss study as previously reported (Chapter 7).258 Dogs were calorically restricted 
to achieve a weight loss rate of 0.5 % to 2 % body weight per week and randomized based on 
body condition score (BCS) to one of two bean-based foods, or an iso-caloric, nutrient matched 






(Table 14).95 Clinical assessments and routine diagnostics were performed at baseline and 
throughout the study. Biological samples were collected at baseline, 2 weeks, and 4 weeks. 
Whole blood was collected via venipuncture after a 12 hour fast into glass tubes containing 
EDTA, urine was collected primarily by free catch, and owners were instructed to collect fecal 
samples within 5 hours of being voided. Samples were processed and stored at -80 °C as 
previously described.94; 95; 120 There were no differences between the groups in percent body 
weight lost at 2 or 4 weeks.  
The Colorado State University Institutional Animal Care and Use Committee approved 
all clinical trial operations, animal care procedures, and collection of biological samp es for 
analysis before beginning the study (IACUC 13-4316A) and all owners provided informed 
written consent.  
Diet formulations and analysis 
A complete description of nutrient profiles, ingredients, and caloric content were 
previously reported (Table 15). The crude protein content, as-fed, was approximately 26 %; 
carbohydrate content (as calculated by nitrogen free extract) was about 48 %; crude fiber was 
about 4 %; and measured metabolizable energy was approximately 3,500 kcal/kg. All nutrients 
were equally digestible across diets with the exception of carbohydrates which were more 
digestible in both the NB and BB diets compared to CON, and protein and total dry matter which 
had higher digestibility in the BB diet compared to CON  (Table 17). 
Amino acid analysis was performed by Midwest Laboratories, Inc. (Omaha, NE) using 
standard methods (AOAC 994.12 (III)). Cystine, methionine, and tryptophan were analyzed 






Fatty acids were extracted from 100 mg of ground diet with 3 ml of a 2:1 methanol-
chloroform solution, and 25 µl of 10 µ l/ml C17:0 (as an internal standard), vortexed and 
sonicated for 10 minutes. One ml of chloroform was added to each diet sample, vortexed and 
sonicated for an additional minute. Samples were then centrifuged for 7 min at 216 x g and the 
pellet re-extracted with 1 ml of chloroform. Supernatants from both extractions were pooled, 
vortexted and centrifuged for 5 minutes at 300 x g to separate the chloroform fraction. The 
chloroform fraction was filtered through sodium sulfate cartridge and rinsed with an additional 1 
ml of chloroform. The filtered extract and rinsate were pooled and dried under nitrogen. Extracts 
were then derivatized and methylated in 1 ml hexane and 3 ml boron trifluoride in 14 % 
methanol at 100 °C for 30 minutes. Dervatized samples were cooled to room temperature and 1 
ml of water was added. Samples were again vortexed and centrifuged to separate the hexane 
layer which was transferred to a gas chromatography (GC) sampler vial. 2 µl of sample was 
injected into a DB-Wax column (30 m, 0.25 i.d., 25 µm film thickness, Agilent Technologies: 
Santa Clara, CA). The initial starting temperature was 90 °C which was held for 2 min, ramped 
to 208 °C at 70 °C/min and then increased to 230 °C at 3 °C/min, then to 240 °C at 2 °C/min for 
a total run time of 16.5 minutes. Samples were injected into the injection port at 240 °C in 
splitless mode and scanned between 40-500 m/z.  
Non-Targeted Metabolomic Profiles 
Fecal, plasma, urine, and diet samples were prepared, extracted and derivatized as 
previously described.94 Samples were analyzed by GC and liquid chromatography (LC) coupled 
to mass spectrometry (MS) under previously described conditions281; 381. Individual features, 
described by mass, charge and retention time were generated in XCMS. The average abundance 






metabolites.195 The relative abundance of each cluster was calculated based on the weighted sum 
of all features within the cluster and scaled to a median of one. Spectra were screened against in-
house and external libraries including NIST v12 (www.nist.gov), Massbank, Metlin, and Golm 
(http://gmd.mpimp-golm.mpg.de) metabolite databases for annotation. 
Gut Hormone Analysis 
Canine gut hormones glucose-dependent insulinotropic peptide (GIP), peptide YY 
(PYY), pancreatic polypeptide (PP), leptin, insulin, and glucagon were detected using the 
Milliplex magnetic bead multiplex assay (Catalog #CGTMAG-98K: Billerica, MA) and 
analyzed on a Luminex 200 (Austin, TX) as described by the assay protocol. All samples were 
assayed in duplicate and quality controls run on every plate. Adiponectin was detected using an 
ELISA assay (Cat #EZCADP63K: Millipore, Billerica, MA) and performed as directed by the 
assay protocol. 
Cytokine Detection 
Canine plasma was analyzed for cytokines using a magnetic bead based multiplex assay 
(Cat#CCYTMG-90K, Millipore, Billerica, MA). Analytes examined were GM-CSF, IL-2, IL-6, 
IL -7, IL-8, IL-15, IL-18, IP-10, KC-like, and MCP-1. CRP was analyzed using a well validated, 
single ELISA (PHASE canine CRP Assay:TP-803, Tridelta, Kildare, Ireland). All assays were 
performed according to specific protocol instructions. Levels of IL-6, MCP-1, TNF-α, I N- , 
and GM-CSF are being analyzed and verified using canine specific single ELISAs (Cat#s: 









To determine the magnitude of differences in compounds across the CON, NB, and BB 
diets, the absolute difference of the relative abundance of a compound between a specific bean 
diet and CON was normalized to the relative abundance of CON with the following formula: 
(|BB or NB – CON|/CON) x 100 = % difference from CON. To determine differences between 
NB and BB, BB was arbitrarily selected as the reference value. Compounds that were more than 
10 % different were reported. A principal components analysis (PCA) was used to determine the 
overall variance between diets and the clusters (metabolites) contributing to that variance. A one 
way ANOVA was used to determine clusters that varied in relative abundance between diets, 
however because this variance is only based on technical replicates, only clusters with an 
ANOVA p-value < 0.05 and at least 10 % difference in abundance, or were significant 
contributors to the variance in a PC, are reported individually.  
All metabolomic profiles were evaluated with a PCA to determine global pattern changes 
or differences within each matrix. PCA was conducted with metabolite abundances that were 
mean-centered and Pareto-scaled, and 95 % confidence intervals for the PCA model were 
utilized to identify outliers. Significance of each component was determined using analysis of 
variance of PC scores for each component with a threshold of p < 0.05. 
The relative abundance of each fecal, plasma and urine metabolite was scaled to a median 
value of one and is presented as the median and interquartile range (IQR).To determine 
differences in the relative abundance of each fecal and urine cluster/metabolite between diet 
groups and time, a mixed model linear regression analysis was applied using the lme4 package
284 in R.196 The model included fixed effects for diet x time and the random effect for animal ID 






multiple comparisons.197 An adjusted p-value < 0.1 was accepted as significant. Metabolites that 
were significant by both time and diet are reported and post-hoc ANOVAs were performed to 
determine which diet group a significant change over time occurred (GraphPad Prism verson 
5.03 for Windows, GraphPad Software, San Diego California USA, www.graphpad.com).  
 
RESULTS 
Fasted Canine Plasma Gut Hormones and Inflammatory Biomarkers after Four Weeks of Weight 
Loss on Bean-Based or Control Diets 
Six canine gut hormones were evaluated in the plasma of all dogs at baseline and after 2 
and 4 weeks of weight loss and dietary intervention with a multiplex assay. Hormones assayed 
included GIP, glucagon, insulin, leptin, PP, and PYY (Figure 16). All hormone levels were 
similar across groups at baseline with the exception of GIP which was elevated in the NB group. 
At baseline, the median fasted plasma level of GIP was 7.0 pg/ml, 5.4 pg/ml, and 32.0 pg/ml for 
dogs in the CON, BB, and NB diet groups, respectively. The median values did not change over 
time in any group except for NB, in which the median level decreased by 32.0 pg/ml to 4.7 pg/ml 
and at 4 weeks was not different from CON or BB. Median glucagon plasma levels at baseline 
were 24.2 pg/ml, 26.8 pg/ml, and 34.2 pg/ml; median insulin plasma levels were 360.2 pg/ml, 
594.2 pg/ml, and 394.8 pg/ml; median leptin plasma levels were 4,955.4 pg/ml, 5,445.3 pg/ml, 
and 5,258.3 pg/ml; median PP plasma levels were 36.7 pg/ml, 35.5 pg/ml, and 63.0 pg/ml; 
median adiponectin plasma levels were 2.4 ng/ml, 3.2 ng/ml, and 2.5 ng/ml for CON, BB, and 
NB, respectively and did not change over time in any group. Median PYY serum levels were 






in the CON group, decreased to 93.9 pg/ml at 2 weeks, and then increased back to 108.3 pg/ml at 
4 weeks and was not different from baseline. PYY did not change in either the BB or NB group.  
Figure 16: Fasted canine gut hormone levels in plasma at baseline and after 2 and 4 week of weight 
loss while consuming a control diet (clear bars), black bean diet (gray bars) or navy bean diet (dark gray 
bars). GIP (A), glucagon (B), insulin (C), leptin (D), PP (E), and PYY (F) were all evaluated together using a 













































































































































































































A panel of 11 inflammatory mediators was used to evaluate systemic inflammation in all 
30 dogs at baseline and 4 weeks and 5 dogs from each group were also evaluated at 2 weeks. 
Inflammatory biomarkers included GM-CSF, IL-2, IL-6, IL-7, IL-8, IL-15, IL-18, IP-10, KC-
like protein, and MCP-1. The number of dogs assayed at each timepoint and within diet group, 
and the number of samples with detectable amounts of each cytokine are shown in Table 29.  
Table 29: Canine plasma samples with inflammatory biomarker levels above the limits of quantitation 
(detected/total assayed). 
Diet Control Black Bean Navy Bean 
Cytokine Baseline 2wk 4wk Baseline 2wk 4wk Baseline 2wk 4wk 
CRP 7/7 N/A 7/7 7/7  7/7 8/8  8/8 
GM-CSF 4/10 3/5 4/10 5/10 3/5 6/10 4/10 3/6 5/10 
IL-2 3/10 3/10 3/10 5/10 3/5 6/10 4/10 2/6 2/10 
Il-6 3/10 2/5 3/10 4/10 3/5 5/10 4/10 2/6 2/10 
Il-7 5/10 3/5 3/10 6/10 2/5 6/10 7/10 1/6 3/10 
Il-8 10/10 5/5 10/10 9/10 4/5 10/10 10/10 6/6 9/10 
Il-15 5/10 4/5 6/10 8/10 3/5 7/10 6/10 4/6 6/6 
IL-18 8/10 4/5 8/10 10/10 5/5 8/10 9/10 5/6 9/10 
IP-10 2/10 2/5 2/10 0/10 0/5 0/10 2/10 2/6 3/10 
KC-Like 9/10 5/5 8/10 9/10 3/5 9/10 9/10 4/5 9/10 
MCP-1 9/10 5/5 8/10 8/10 3/5 8/10 8/10 5/6 7/10 
 
Multiple analytes were below limits of detection in over 50 % of the dogs. Of the 
detected analytes, the predominant inflammatory cytokine detected was IL-8 (detected in 96 % 
of the dogs), followed by IL-18 (87 %), and KC-like protein (86 %). No differences over time or 
between diet groups were observed. C reactive protein (CRP) has been evaluated in the majority 
of the 30 overweight dogs who completed the 4 week study, before and after weight loss. Within 
this subset, no significant differences in plasma levels of CRP were observed, before or after 
weight loss (Table 30). A non-parametric, one-way ANOVA was used to determine if there were 
significant differences between diet groups at each timepoint and Dunn’s Multiple Comparison 






elevated in dogs in the BB diet group compared to dogs in the CON and NB diet groups, 
although there were no significant differences between baseline and 4 weeks in any of the dogs. 
IP-10 was the only other analyte significantly different between groups and at baseline was 
significantly higher in the CON group compared to the navy bean group (not detected in the 
black bean group) and at 2 weeks was higher in the navy bean group compared to the CON 
group; levels were not significantly different at 4 weeks between any diet group.   
Detection of TNF-α and IFN-  and verification of IL-6, MCP-1, and GM-CSF are 








Table 30: Detectable levels of plasma inflammatory biomarkers in 30 overweight or obese dogs at baseline and after 2 and 4 weeks of calorically 
restricted weight loss. 
 Control Black Bean Navy Bean 



































































































































253.1 ±  
90.67 
323.0 ±  
127.6 
155 ±  
81.68 
0.05 
2,157 ±  
5,213 







349.3 ±  
468.3 
































0.87 ND ND ND  
47.61 ±  
15.59 




























189.5 ±  
111.2 
144.5 ±  
64.22 
180.5 ±  
167.9 
0.78 
291.3 ±  
317.5 
241.2 ±  
24.62 
329.3 ±  
350.3 
0.88 
155.9 ±  
64.92 
130.5 ±  
42.72 
130.6 ±  
59.61 
0.76 
Data are presented as mean ± SD. The number of samples assayed and detected are given in Table 29.  
aA one-way ANOVA with no repeated measures was used to analyze these data. Because all dogs were not detected at all timepoints a repeated measures 
test is not possible, each measurement is therefore treated like an independent variable. GM-CSF, IL-2, IL-6, IL-7, IL-8, IL-15, IL-18, IL-15, IL-18, IP-10, KC-Like, 






Non-targeted Metabolomic Analysis of the Metabolome of Overweight and Obese Dogs after Four 
Weeks of Calorically Restricted Weight Loss 
Fecal, plasma, and urine samples were analyzed by GC- and LC-MS for changes in the 
metabolome in response to 4 weeks of weight loss (Figure 17). To define changes in the 
metabolome associated with time during weight loss, PCA components from each matrix 
significant by the time term were analyzed to determent the compounds or clusters that 
contributed to the weight loss/time effect. For fecal LC-MS data, PC1 (10.7 % variance), PC3 
(8.0 % variance), PC6 (5.1 % variance), and PC7 (4.3 % variance) were all significant (p < 0.05). 
Figure 17A shows the total variance in LC detected fecal between baseline, 2 weeks, and 4 
weeks between PC1 and PC3. Within PC1, 14 metabolites significantly explained the total 
variance associated with time, and 16 explained the variance in PC3, 7 of which were similar 
with PC1. In total, 37 clusters explained the variance associated with time. For fecal GC-MS 
data, PC7 (4.1 % variance) and PC12 (1.6 %) were significant with respect to time (p < 0.05), 
but only described a very small amount of the total variance (Figure 17B).  PC7 contained 14 
compounds, PC12 contained 27, 22 of which were unique to PC12. 
Plasma LC components that were significant with respect to time were PC2 (12.2 % 
variance), PC6 (2.7 % variance), PC8 (2.0 % variance), PC10 (1.7 %) and PC17 (0.7 % 
variance). PC2 and PC6 are plotted in Figure 17C. PC2 contained 7 significant compounds, 4 of 
which were unique; PC6 contained 3 significant compounds, 1 of which was unique; PC 8 
contained 3 significant compounds, 2 of which were unique; PC17 contained 7 unique 
compounds, 5 of which were unique. Plasma GC components that were significant with respect 
to time were PC6 (3.9 % variance), PC9 (2.9 % variance), and PC15 (0.09 % variance). PC6 and 
PC9 are plotted in Figure 17D. PC6 contained 13 significant compounds, 6 of which were unique 






PC15, 10 compounds contributed to the variance, 5 of which were unique. In total, 29 
compounds significantly presented to the variation over time.  
In urine samples analyzed by LC variance over time with weight loss was explained in 
PC4 (5.9 % variance), PC7 (4.0 % variance), and PC15 (1.4 % variance). Figure 17E shows the 
variance over time in PC4 versus PC7. PC4 contained 8 compounds that contributed significantly 
to the variation, 1 of which was unique; PC7 contained 13 significant compounds, 4 of which 
were unique; PC15 contained 24 unique compounds, 17 of which were unique. In urine 
compounds detected by GC, components PC7 (2.4 % variance) and PC20 (0.6 %) were 







Figure 17: Orthogonal variation in the metabolome of 30 adult dogs undergoing calorically restricted 
weight loss for 4 weeks. Variation in the fecal metabolome with weight loss by LC-MS (A) and GC-MS (B). 
Variation in the canine plasma metabolome by LC-MS (C) and GC-MS (D). Variation in the canine urine 
metabolome with weight loss by LC-MS (E) and GC-MS (F). Different time points are indicated by color 
(baseline = gray, 2 weeks = blue and 4 weeks = green) and diet groups are indicated by shape (circle = 
control, square = black bean, and triangle = navy bean). 




























































































































































































































The number of compounds or clusters detected by LC- or GC-MS in canine feces, 
plasma, and urine that significantly contributed to variation by diet (CON, BB, or NB) and 
weight loss (time) are summarized in Figure 18.  Also included are data from Chapter 3, which 
describe the variation in the canine metabolome by weight class (normal weight, overweight or 
obese). There were 152 metabolites that varied by weight loss, 139 that varied by diet, and 78 
that varied only by weight class. Ten metabolites varied by diet, weight loss, and weight class; 
43 metabolites describe variation by both weight loss and diet; and 20 by adiposity and weight 
loss.
Figure 18: Number of compounds that contribute to the orthogonal variation in 
the canine fecal, plasma, and urine metabolome by diet, weight classification, 
and time with weight loss. Numbers in parenthesis indicate the total number of 
compounds that contribute to PC significantly associated with weight class (normal 
weight, overweight, or obese); time with weight loss (0, 2, or 4 week time points); and 
diet, CON, BB, or NB. The small circle indicates a special statistical case where the diet 
and time with weight loss interactions were significant: 23 of the 47 metabolites were 






Effects of Bean-Consumption on the Canine Metabolome during Calorically Restricted Weight 
Loss 
To determine which metabolites were differentially altered in the bean consuming dogs 
compared to dogs consuming the CON diet, the relative abundance of each individual metabolite 
was analyzed for variation using mixed model regression. The total number of detected and 
significant clusters are presented in Table 31. GC-MS platforms detected the highest number of 
compounds across all three matrices, however LC-MS compounds had the highest proportion of 
significantly different compounds; 35 clusters were associated with time, 411 clusters wer  
associated with time and 48 clusters were significant by diet x time interactions.  
 
To define the metabolites that were differentially modulated in the bean diet groups, the 
48 compounds or clusters were further evaluated to determine the time and group the differences 
occurred in. The plasma compounds were primarily different between the NB and CON groups 
at baseline (data not shown). Compounds that were similar between all three groups at baseline 
and only changed in bean-consuming dogs are summarized in Figure 19. Three compounds 
Table 31: Total number and number of significant metabolite clusters detected by GC- and LC-MS in canine 
fecal, plasma, and urine.  
 Number of Clusters by Matrix Number by Factor and Interaction 
Matrix GC LC Diet Time Diet x Time 
Fecal  1,112 795    
Diet 0 21 21   
Time 2 173  175  
Diet x Time 0 25   25 
Plasma 554 348    
Diet 0 2 2   
Time 17 39  56  
Diet x Time 3 11   14 
Urine 1,139 1,318    
Diet 0 12 12   
Time 1 179  180  
Diet x Time 0 9   9 
Total  23 471 35 411 48 
Total number of detected and significant clusters are indicated by bolding. Significance was determined with mixed 






increased in both the BB and NB fecal samples (Figure 19A), 3 increased in urine samples 
(Figure 19C), while 4 compounds decreased in fecal samples (Figure 19B). Identification of 
these compounds is underway, but one fecal compound (C58, Figure 19A, middle panel) has 





































































































































































































































































































































Figure 19: Differentially modulated metabolites by time in the overweight canine metabolome during 
weight loss. A) Fecal (F) metabolites detected by UPLC-MS that increased in both bean BB and NB diet 
groups and were significantly different from CON (p < 0.05); B) fecal metabolites that decreased in both the 
BB and NB group compared to CON; C) Urine metabolites that increased in the BB and NB groups compared 
to CON. The CON group is indicated by clear boxes, the BB group by light gray boxes, and the NB group by 
dark gray boxes. Samples were collected at baseline, and 2 and 4 weeks after beginning a 4 week, calorically 
restricted weight loss intervention. Each compound is labeled with its cluster number (C), matrix (F=fecal, 







Targeted Macronutrient and Non-Targeted Metabolomic Analysis of Diets Reveals Diversity in 
Amino Acids, Lipids, and Small Molecule Profiles of Bean-Based Dog Foods 
We previously reported that the CON, NB, and BB diets were nutrient matched and 
isocaloric (Table 15) and that the bean-based diets were digestible compared to CON (Table 17). 
The total crude protein content in all three diets was approximately 26 % as-fed. Total amino 
acid content as a percent of total diet is shown in Figure 20 in order of descending abundance 
relative to CON. Glutamic acid was the most abundant amino acid (3.72 %) followed by proline 
(2.13 %), glycine (1.89 %), leucine (1.71 %), arginine (1.55 %), aspartic acid (1.54 %), alanine 
(1.50 %), valine (1.48 %), lysine (1.3 %), isoleucine (0.97 %), threonine (0.96 %), tyrosine (0.96 
%), phenylalanine (0.85 %), serine (0.82 %), histidine (0.69 %), methionine (0.49 %), cysteine 
(0.36 %), tryptophan (0.32 %, and other amino acids such as taurine (2.96 %). The BB diet had 6 
amino acids that were at least 10 % different from and higher than CON, in order of difference: 
serine (52 %), tryptophan (31 %), aspartic acid (27 %), lysine (18 %), threonine (14 %), and 
valine (14 %); unidentified amino acids were 37 % lower than CON. The NB had 10 amino acids 
that were at least 10 % different from CON. In order of difference, amino acids that were higher 
in NB were cysteine (50 %), tryptophan (38 %), lysine (22 %), phenylalanine (15 %), tyrosine 
(15 %), valine (14 %), and leucine (11 %). Amino acids that were lower in the NB compared to 
CON were proline (25 %), glycine (-16 %), histidine (15 %), and other amino acids (25 %). Nine 
amino acids were at least 10 % different between BB and NB: the BB diet had higher levels of 
serine (33 %), proline (23 %), glycine (17 %), histidine (16 %), and aspartic acid (13 %). Amino 
acids that were higher in NB compared to BB were cysteine (59 %), phenylalanine (21 %), 
leucine (17 %), isoleucine (13 %), and other amino acids (20 %).  The summed magnitude of 
difference in amino acids different by greater than 10 % between CON and BB was 193 %, 245 















































































































































Figure 20: Total amino acid profiles of low-fat CON (gray bars), BB (dark gray bars) and NB (black 
bars) dog foods as a percent of total diet. Other  amino acids include non-protein amino acids, such as s-
methyl cysteine, conditionally essential amino acids such as taurine. Amino acids that were at least 10 % 
different from CON are indicated by asterisks (*) and amino acids that have at least a 10 % difference 
between BB and NB are indicated with bars and asterisks (|-*-|). 
Total crude fat content of the diets was between 8 % - 8.4 % (Table 15). Fatty acid 
content is presented as the relative abundance of total fat (Figure 21): the most abundant 
unsaturated fatty acids in CON were oleic acid (29.42 %), linoleic acid (β6.0β %), α-linolenic 
acid (3.28 %), arachidonic acid (0.76 %), gondic acid (075 %), eicosapentaenoic acid (0.26 %), 
and eicosadienoic acid (0.09 %). In order of abundance, saturated fatty acids were palmitic acid 
(26.03 %), stearic acid (7.13 %), palmitoleic acid (4.73 %), myristic acid (0.85 %), margaric acid 
(0.21 %), arachidic acid (0.16 %), myristoleic acid (0.14 %), and pentadecylic acid (0.16 %). In 
the BB and NB diets, α-linoenic acid was increased 66 % and 100 %; eicosapentaenoic acid was 
increased by 38 % and 31 %; arachidic acid was increased by 31 % and 38 %; palmitoleic acid 
was decreased by 28 % and 14 %; myristic acid was decreased by 27 % and 28 %; and gondic 
acid was decreased by 31 % and 16 % difference, respectively. Compared to CON, the BB diet 
was higher in linoleic acid (23 % difference); myristoleic acid, arachidonic acid, and 






arachidonic acid (26 % difference), and lower in stearic acid (12 %), pentadecylic acid (14 %), 
and myristoleic acid (25 %).  The NB diet also contained the unique fatty acids behenic acid 
(0.19 % relative abundance) and eicosatrienoic acid (0.20 %).   Between the BB and NB diets, 
the BB diet contained higher amounts of pentadecylic acid (14 % increase), margaric acid (13 % 
increase), and linoleic acid (12 % increase); compared to BB, the NB diet contained higher 
amounts of gondic acid (β1 % increase), α-linolenic acid (20 % increase), and palmitoleic acid 




























































































































































































































































Figure 21: Fatty acid profiles of low-fat CON (gray bars), BB (dark gray bars) and NB (black bars) dog 
foods as a relative percent of total dietary fat. Fatty acids that were at least 10 % different from CON are 
indicated by asterisks (*) and amino acids that have at least a 10 % difference between BB and NB are 
indicated with bars and asterisks (|-*-|). 
Non-targeted metabolomics was used to detect small molecules and phytochemicals in 
the CON, BB, and NB dog foods. One thousand, two hundred two clusters were detected by LC-
MS and a PCA reveals a significant variation of 54 % (p < 0.001) between the CON and bean-
based diets (PC1), and a variation 16 % (p < 0.001) between BB and NB diets ( Figure 22A). 






CON foods and 15 LC clusters significantly describe the variation in PC2 between the two 
different bean diets. One thousand, eight hundred twenty-one clusters were detected by GC-MS 
and a PCA reveals a significant variation of 75 % (p < 0.001) between the CON and bean-based 
diets (PC1), and a non-significant variation of 13.7 % (p = 0.052) between BB and NB diets 
(PC2,  Figure 22B). Thirty GC clusters significantly (p < 0.05) describe the variation in PC1 
between the CON and bean-based diets. One of the primary metabolites currently identified in 
PC1 was 2-piperidinecarboxylic acid. This compound contributed to the variation between the 
CON and bean diets, but was not a contributor in PC2 (differences between the bean diets).  
Metabolites that were at least 10 % higher in both bean groups, compared to CON are 
expected to included carbohydrates, amino acids, peptides, lipids, and phytochemicals such as 
trigonelline and s-methylcysteine.  

























































Control Black Bean Navy Bean
A. B.
Figure 22: Principal components analysis (PCA) of dog food metabolites detected by non-targeted LC-MS 
(A) and GC-MS (B). Control diet replicates are indicated by gray circles, black bean diets are indicated by 
red squares, and navy bean diets are indicated by blue triangles. P values indicate the level of significance 







Bean Intake Was Not Strongly Associated with Changes in Canine Gut Hormone Expression and 
Inflammatory Biomarkers Were Below Limits of Detection  
A panel of gut hormones and inflammatory cytokines was assayed in the plasma of 
overweight and obese dogs undergoing calorically restricted weight loss. Gut hormones were 
detected in all samples, but did not appear to be modulated overtime, regardless of diet. The 
exception to this was GIP, which was higher in the NB group at baseline compared to both CON 
and BB groups, but was significantly reduced by 4 weeks so that there were no differences 
between groups. GIP, previously gastric inhibitory peptide, has been renamed as glucose-
dependent insulinotropic peptide to reflect its role in increasing insulin secretion. GIP expression 
has been shown to be important in coupling excess nutrient intake to obesity382 and decreasing 
GIP expression in mice has been shown to prevent obesity in the context of a high fat diet.383 Th  
elevation GIP in the NB group may indicate a concentration of dogs with higher risk for 
metabolic syndrome than in the CON and BB group. This hypothesis is somewhat supported by 
the observation that the majority of plasma metabolites that were significant by time and diet 
interactions, were different between the NB and CON groups at baseline. The observation that 
modulation of GIP only occurred in dogs with elevated levels is consistent with multiple other 
studies showing that bean-derived phytonutrients have discriminatory activity, such that 
physiological effects are only observed when abnormal perturbations are already present, such as 
in the case of cancer.384-391 Because this effect was only seen in the NB group where GIP levels 
were different at baseline, it is difficult to determine whether this effect occurred as an effect of 
weight loss, bean intake, or a combination of both, but does provide additional rationale for the 






with canine obesity. PYY was slightly increased in the CON group after 2 weeks of weight loss 
and then went back to baseline levels at 4 weeks. PYY is an anorexic hormone, and increases 
postprandially, in humans, for up to 6 hours.392 Given the state of caloric deficit of these dogs, 
anorexic hormones would be expected to decreases, this finding may reflect a true physiological 
effect; however it seems more likely some of the CON dogs may have inadvertently had shorter 
fasting times before the blood draw at the two week time point. The rationale for measuring 
serum levels of these gut hormones was to determine if a bean-based diet was able to increase 
satiety and insulin sensitivity in dogs undergoing weight loss. These data support that in dogs 
with abnormal PYY expression, a bean diet may play a role in regulation. Further studies are 
warranted to determine the effects of bean intake on canine gut hormone expression 
postprandially. While gut hormone levels are a relatively simple way to approximate satie y, the 
majority of endocrine molecules have very short half-lives and are most dynamic immediately 
after food consumption, such as GIP, which has a half-life of minutes. Other molecules may be 
enzymatically degraded, as is the case with amylin, ghrelin, and GLP-1. To appropriately detect 
these analytes in plasma, enzyme inhibitors must be present in the blood collection tube at the 
time of collection. As enzyme inhibitors were not used at the time these samples were collected, 
we were unable to accurately detect other, important gut hormones. In addition to measuring 
changes in gut hormones postprandially, future studies should also employ the use of direct 
measurable outcomes of satiety, such as amount of food consumed as a second meal, as satiety 
can be influenced by multiple factors outside of hormone expression. Insulin sensitivity could 
also be assessed directly via euglycemic clamp or glucose tolerance methods after a period of






utilize a testing structure that allows companion dogs to be fed and sampled in a controlled 
environment.  
For the majority of the samples, inflammatory cytokine concentrations were below the 
limits of quantification for the multiplex assay. While this platform has been well validated for 
other species, only performance parameters with recombinant protein in an artificial plasma 
matrix have been validated for canine specific analytes. One of the advantages to using the 
multiplex assay is that a minimum amount of sample is needed to detect multiple analyt s, 
however detection can be affected by the plasma matrix making it difficult to determine if 
circulating cytokines were truly low, or if the plasma matrix interfered with detection. Given the 
small number of samples in which inflammatory cytokines were detected, a valid statistical 
measurement of changes over time was not possible. CRP was analyzed in a subset of the dogs 
and was detected in all samples; however levels did not change after 4 weeks.  
Previous studies have shown significant reductions in circulating canine cytokines after 3 
and 6 months of weight loss using this same panel374 and other studies have reported decreases in 
CRP and MCP-1 after completion of a weight loss program.393 Interestingly, in intact female 
research dogs, inflammation indices did not change with weight loss.394 While multiple examples 
of discrepancies are present in published research regarding the relationship of canine obesity 
and gut hormones, adipocytes, and inflammatory biomarkers, and the ability of weight loss to 
modify these parameters, current published studies typically have small sample sizes and utilize 
diverse populations.395 Changes in gut hormones and inflammatory biomarkers have not been 
reported with only 4 weeks of weight loss in dogs. Aside from the low detection frequency in 
inflammatory biomarkers, the lack of change in this study could be a function of the short 






sampling time in relation to the last meal. In human studies, a single bean-based mel has been 
shown to alter glucose metabolism, reduce inflammatory biomarkers, and modulate gut 
hormones70 and in this cohort of dogs, lipids were modulated after only 2 weeks of bean 
consumption with weight loss396, indicating metabolic pathways were altered. These 
observations support that changes in adipokine expression may be occurring in these dogs and 
provides the rationale for the further investigating inflammatory biomarker concentrations with 
assays less sensitive to the plasma matrix and sampling collections after meal consumption for 
gut hormone analysis.  
Non-targeted Metabolomics Reveals Changes in the Metabolome of Overweight and Obese Dogs 
after Four Weeks of Calorically Restricted Weight Loss 
Changes in the canine metabolome over time revealed a large number of compounds that 
changed over the 4 week period regardless of diet. Compounds detected in fecal, plasma, and 
urine samples contributed to the variation between baseline, 2 and 4 week samples (Figure 19) 
and 411 compounds were significant by time in at least one of the diet groups (Table 31).While 
these compounds have yet to be individually identified, metabolomic studies in humans 
undergoing weight loss have revealed changes in serum lipids, such that saturated and 
monounsaturated fatty acids are decreased.397 Other studies have found that individuals with a 
greater weight loss response can be differentiated by decreased levels of citric acid, succinic
acid, dodecanol, threonic acid, and coumaric acid and increased levels of arachidonic acid.398 It 
is therefore reasonable to expect the metabolite changes in this cohort of dogs will be associated 
with serum lipids and energy metabolism. These data indicate that the canine metabolome is 






Additional analyses and future studies in dogs may be able to define metabolites associated with 
greater weight loss to determine the efficacy of weight loss interventions for individual dogs. 286  
 
Consumption of Bean-based Diets during Weight Loss Modulates Individual Metabolites within 
the Canine Metabolome 
Ten metabolites changed in both bean diets over time and were different from CON. 
Three compounds increased in fecal samples, one of which has been identified as uvaol, a 
compound usually described in olive oil, ubiquitous in plants399, but not yet described in 
common beans. Uvaol may have cardiovascular protective, chemopreventive, antioxidative, and 
anti-inflammatory properties400 and may represent a novel mechanism by which beans improve 
health outcomes. Further studies are needed to confirm the contribution of uvaol by the bean 
powders; however, as the only ingredient difference between the CON and bean-based dog foods 
were the cooked bean powders, it is reasonable to attribute the presence of uvaol in the feces of 
dogs consuming the bean-based diets to the bean powders themselves. As the metabolite profiles 
of the diets are now available, they can be interrogated for the presence of uvaol, however 
metabolomic analysis of the navy bean powder used in the NB diet did not reveal the presence of 
this compound (data not shown).  
Four fecal compounds decreased in the bean groups over time and compared to CON. 
Previous metabolites that decreased in bean fed dogs were vitamin E isoforms and bile acids, 
both of which were detected by GC-MS.  
Three compounds increased in the urine of dogs consuming a bean-based diet. Based on 
results from previous studies in dogs consuming a navy bean diet for weight maintenance, we 
hypothesize that these compounds will represent bean phytochemicals that are biomarkers of 






In addition to these compounds that changed over time in both bean groups and compared 
to CON, additional compounds may have changed in only one bean group. Additional 
interrogation of this data set could reveal changes that are specific to one bean diet group. One 
factor complicating the interpretation of these data is that for the fecal, plasma, and urine 
metabolome analysis, baseline data from an additional 15 overweight and obese dogs are 
currently included. Because the individual ID was accounted for in the time course analysis, this 
should have minimal effects, but could dilute or exaggerate any true baseline variation between 
the diet groups. Eliminating these dogs from future analysis could reveal more metabolites that 
vary by the time x diet interaction.  
Cooked Bean Powder Dog Foods Have Amino Acid Profiles Associated with Increased Satiety and 
Weight Reduction  
Total protein content is associated with increased satiety, however amino acid profiles 
have been shown to play an important role as well.59; 401 Overall, compared to CON, bean-based 
diets were higher in tryptophan, lysine, and valine; BB diets were lower in unidentified amino 
acids, but higher in serine, aspartic acid, and threonine; NB diets were higher in cysteine, 
phenylalanine, tyrosine, and leucine, but lower in histidine, glycine, proline, and other amino 
acids (Figure 20). Furthermore, the two bean-based diets were different from each other with 
respect to serine, proline, glycine, histidine, aspartic acid, cysteine, phenylalanine, leucine
isoleucine, and other, unidentified amino acids.  
Tryptophan had a relative increase of 31 % and 38 % in the BB and NB diets, 
respectively. Tryptophan supplementation has been associated with increased satiety402 as it can 
be metabolized into serotonin.403 However, in obese humans undergoing weight loss, circulating 






kynurenine pathway is over expressed404 and tryptophan is metabolized into kynurenine, 
kynurenic acid, xanturenic acid, and quinolinic acid.403 Tryptophan metabolism has been shown 
to change in dogs undergoing rapid weight gain372 and serotonin levels are lower in obese dogs 
than normal weight dogs.405 While multiple factors determine metabolism, higher content of 
dietary tryptophan could lead to higher levels of serotonin synthesis.  
Common beans are rich in branched chain amino acids, and leucine and valine were 
higher in the NB, and NB and CON diets, respectively. When administered centrally, leucine has 
been shown to induce anorexia, enhance expression of leptin, and reduce body weight.406 While 
studies with oral supplementation of leucine have shown mixed anorexic effects, convincing 
evidence supports that increased dietary leucine may decrease adiposity by increasing metbolic 
rates and improve glycemic control.406 Overall, higher levels of dietary branched chain amino 
acid intake is associated with reduced rates of obesity407 and may represent a beneficial bean-
related amino acid profile for regulating a healthy body weight.  
Interestingly, total arginine and glutamate (as glutamic acid) were not different between 
any of the diets (average relative abundance 1.57 %, and 3.67 %, respectively) although beans 
have been shown to be relatively high in these amino acids. Glutamine is the primary amino acid 
across multiple dietary proteins and is highly associated with satiety408 thus, the relative potential 
contribution of glutamine to satiety was equivalent between diets. While beans are limited in 
sulfur containing amino acids, methionine only had minimal differences between the CON and 
bean-based diets, but lysine was 18 % and 22 % higher in the BB and NB diets, respectively. 
While restricting dietary methionine has been shown to exert beneficial metabolic effects in 
obese adults409, these data indicate that replacement of 25 % weight/weight of the diet 






results in an amino acid profile that, independent of other nutrients, provide additional benefits to 
weight management.  
Lipid Profiles of Bean-Based Diets Support Reduced Inflammation, Dyslipidemia and Insulin 
Resistance 
While the total fat profiles of the CON, BB, and NB diets were similar, individual fatty 
acids varied both with the inclusion of bean powders and by the type of bean powder (Figure 21). 
Bean-based diets were higher in the omega-γ f tty acids α-linolenic acid and eicosapentaenoic 
acid while only the NB diet contained eicosatrienoic acid. Omega-3 fatty acids are strongly 
associated with decreasing body weight, modulating gut hormones, and reducing inflammation 
and insulin resistance.410; 411 In humans and lab animals, α-linoleic acid is inversely associated 
with adiposity412, eicosapentoaenoic acid is associated with improving insulin sensitivity and 
reducing inflammation.413 While excessive supplementation of omega-3 fatty acids can have 
undesired consequences in dogs414, dietary levels are associated with improvements in 
osteoarthritis415 and inflammation416. While common beans do contain relatively high levels of 
the omega-γ fatty acid α-linoleic acid, because the overall fat content is so low, they are 
generally regarded as having a minor role in overall dietary contribution.417 The primary source 
of the remaining fatty acids was most likely the fish meal, which was composed 1 % 
weight/weight of each of the dog food formulations (Table 15). In general, the bean based diets 
were lower in saturated fatty acids than CON (with the exception of arachidic acid and margaric 
acid): both bean diets were lower in palmitoleic acid, myristic acid, and myristoleic acid (which 
not detected in the BB diet; the NB diet was lower in stearic acid, and pentadecylic acid, but 
contained behenic acid, which was not detected in either the CON or BB diet. Lower levels of 






improve cardiovascular health418, and while of lower concern in dogs, obese dogs are at higher 
risk for cardio-respiratory disease than normal weight dogs.419 Overall, the lipid profiles of the 
bean based diets are consistent with profiles associated with reducing inflammation, improving 
serum lipid profiles, and beneficially modulating glucose homeostasis.  
 
CONCLUSIONS 
This study evaluated the effects of including a cooked bean powder at 25 % 
weight/weight on the nutrient profiles of macro and micronutrient matched CON, BB, and NB 
extruded dog foods and the metabolic effects of these diets on dogs undergoing weight loss.  
Targeted analysis of the amino acid and lipid contents of the diets demonstrated profiles 
consistent with beneficial effects on metabolism and inflammation. The non-targeted 
metabolomic analysis of the diets revealed a subset of compounds that together described up to 
75 % variance between the CON and BB and NB diets, while variance between the BB and NB 
was also significant with 16 % of the variance explained. 2-piperdinecarboxylic acid was one of 
the identified diet metabolites that has previously been described as biomarker of bean intake in 
humans and mice.  The metabolomes of dogs changed significantly with weight loss, regardless 
of diet and compounds were identified that differentiated dogs consuming a bean-based diet from 
dogs consuming a CON diet. While weight loss and bean consumption were not associated with 
changes in detectable inflammatory biomarkers or gut hormones in this study, the metabolome of 
these dogs offers the opportunity to discover metabolites associated with improvements in lipid 
and carbohydrate metabolism and other potential, small molecule mediators of inflammation. 
Further studies are needed to determine the ideal sample collection period to detect changs in 






This study has demonstrated the beneficial effects of including cooked bean powders in dog 
foods formulated for weight loss and the magnitude of canine metabolites that are responsive to 






 CHAPTER 9: CONCLUSIONS AND FUTURE DIRECTIONS 
Summary of Major Findings 
 Companion dogs are exposed to potential endocrine and metabolic disruptors 
through environmental pollutants and obesity.  
 Bean-based diets are safe, digestible, and well tolerated in companion dogs. 
 Metabolic aberrancies in overweight dogs can be modulated with weight loss. 
 Modulation of lipid and carbohydrate metabolism is enhanced in companion dogs 
consuming beans.   
Our hypotheses that companion dogs are exposed to low dose mixtures of pesticides, and 
that overweight and obese dogs have altered clinical serum biochemical analytes and 
hemograms, altered gut microflora, and metabolic aberrancies compared to normal weight dogs 
were partially supported:  
 Low levels of atrazine were detected in the urine of all 21, normal weight dogs.  
 Dogs were exposed to a novel mixture of 15 parent pesticide compounds from the 
environment with the potential to disrupt metabolic and endocrine function.  
 Diet was not a driving factor for pesticide exposure in this cohort of dogs. 
 The proportions of overweight and obese dogs with hemolysis, CK, and AST levels 
outside reference ranges were higher than normal weight dogs.  
 The fecal microbiomes of all dogs were highly diverse and not different between 
normal weight, overweight, or obese dogs.  
 The metabolomes of overweight and obese dogs were significantly different from 
normal dogs. The greatest variation was in plasma metabolites detected by the LC 
platform.  
Our hypotheses that nutritionally complete bean-based dog foods are digestible, safe, and 
nutritionally adequate for adult dog weight maintenance and support calorically restricted weight 






 For weight maintenance, the navy bean-based dog food was equally as digestible 
as the matched control diet.  
 For weight loss, low fat, black and navy bean-based dog foods were as digestible 
as the nutrient matched control diet.  
 Protein digestibility was higher in the black bean dog food and carbohydrate 
digestibility was higher in both the black and navy bean-based dog foods, 
compared to control.   
 Total percentage of body weight loss was equivalent between all calorically 
restricted weight loss groups.  
 All dogs maintained indices of nutritional adequacy as defined by AAFCO.  
 None of the owners reported noticeable changes in their dog’s flatulence, 
regardless of diet.   
Our hypotheses that dogs consuming a bean based diet will have alterations in their lipid 
and carbohydrate metabolism and that inclusion of 25 % weight/weight cooked bean powder 
nutritionally complete dog foods increases phytonutrient diversity were supported: 
 After consuming a navy bean based dog food for 4 weeks, normal weight dogs 
had lower cholesterol than dogs consuming the nutrient matched control diet.  
 Only dogs consuming a navy or black bean based diets had reductions in 
triglycerides, HDL and LDL levels at 4 weeks.  
 Fecal glucose and steroid-like excretion increased in bean consuming normal 
weight dogs.  
 Urine metabolites included validated biomarkers of bean intake. 
 Fasted gut hormone levels and detected inflammatory biomarkers did not change 
with weight loss or bean intake.  
 The urine and fecal metabolome of overweight and obese dogs shifted 
significantly in response to weight loss, independent of diet. However, 10 fecal 
and urine metabolites differentiated metabolic changes in both bean groups over 
time compared to the control group.  
 Bean-based diets had distinct lipid and amino acids profiles compared to control 
diets and bean type. The navy bean diet comprised a distinct carbohydrate and 






 Small molecule variation between bean based diets was significant by both LC- 
and GC-MS, but only LC metabolites described significant variation between the 
black and navy bean diets.    
Limitations 
 One of the limitations of these studies was the significant baseline variation 
between dogs. The diversity of the canine participants was intentional to represent 
the physiological variations in companion dogs; however, it limited our ability to 
detect subtle changes. For example, serum cholesterol was different in the short-
term weigh loss study in the black bean diet group compared to both navy bean 
and control, but dogs were randomized based on BCS, not cholesterol. This may 
have masked subtle differences in cholesterol metabolism differences between 
bean and control groups. Future studies may need to increase the randomization 
criteria and sample size or use cross-over study designs and run-in periods to 
minimize variation and increase power for detecting subtle effects on metabolic 
parameters.  
 A second limitation to these studies was owner compliance and is inherent to 
studies in companion animals. Several owners reported that their dogs may not 
have been appropriately fasted, and when metabolic analyses supported this (such 
elevated triglyceride levels or metabolome outliers) data would require exclusion. 
In other cases, owners were unable to complete fecal and urine sample collections 
at home or mixed samples. To control for food intake prior to sample collection, 
future studies could implement study designs that required overnight housing to 
insure compliance and increase the integrity of sample collection.  
 Especially in the long-term weight loss study, several owners requested to move 
into a weight maintenance phase before ideal weight was reached and one 
participant was withdrawn from the study because the owner was unwilling to 
stop feeding treats. The primary source of follow up for the weight loss studies 
were weight checks every 2 weeks. Given the known challenges associated with 
successful weight loss in companion dogs, compliance to weight loss protocols 
could be potentially enhanced by more frequent interactions with owners to track 
compliance.   
 This study was not able to accurately evaluate ghrelin, amylin, or glucagon-like 
peptide-1 as they have short half-lives, are enzymatically degraded, and can only 
be reliably detected when enzymatic inhibitors are added to plasma at the time of 
the draw.  
 In this cohort of 66 dogs, overweight dogs were more likely to have hemolytic 









 Clinical biochemical and hemogram analysis may lack sensitivity in detecting 
metabolic aberrancies in dogs that may increase disease risk and support 
expanded use of metabolomic platforms to assess metabolic dysfunction in dogs. 
 Overweight dogs have altered metabolomes compared to normal weight dogs and 
future interrogation of this data may reveal similarities between cancer and obese 
metabolic profiles.  
 Serum chloride levels were different between normal weight, overweight, and 
obese dogs but normalized in the navy bean group with 4 weeks of weight loss. 
These data indicate that more pronounced effects of bean intake may be observed 
in the presence of dysregulated metabolism. 
 The bean-based diet associated modifications of the canine metabolome are most 
likely the result of small molecule or phytochemical content of beans as the macro 
and micronutrients were controlled.   
 Dog foods containing 25 % w/w cooked bean powder contain adequate amounts 
of phytochemicals to detect bean-associated biomarkers of intake in dogs.   
 The plasma metabolomes described the greatest variation between normal weight 
and overweight dogs while the fecal and urine metabolomes contained the 
greatest number of metabolites that were responsive to diet and weight loss 
interventions. These data may indicate that excreted, versus circulating molecules 
are most useful for detecting responses to interventions while circulating 
molecules may be more useful for detecting established metabolic dysfunction.  
 Our hypothesis that bean intake improves gut hormone profiles was not supported 
by the results from this study. While it is possible that the amount of weight lost 
after 4 weeks was not sufficient to induce detectable changes, it is also possible 
that hormone expression changed postprandially and was therefore not detected in 
fasted samples. In addition to postprandial effects of bean intake on satiety and 
insulin sensitivity related hormones, future studies should also directly assess the 
effects of bean intake on glucose homeostasis and insulin responsiveness.  
 
FUTURE DIRECTIONS 
Further Interrogation of Metabolomic Data 
The next step for evaluating the obesity-associated differences, and diet and weight-loss 






were different between normal weight, overweight and obese dogs and determine metabolic 
pathways that are disturbed in overweight dogs and modulated with weight loss. To begin, 
specific metabolite biomarkers associated with obesity will be assessed. For example, in obese 
humans, higher levels of circulating amino acids have been detected and may be linked to 
increasing insulin resistance by mTOR activation420  and associated with increases in obesity 
associated gut-permeability.421 We will be able to determine if overweight/obese dogs have 
higher levels of circulating amino acids and detect previously described biomarkers of mTOR 
activation such as phosphatidylcholine and lysophosphatidic acids metabolites.422 Elevated levels 
of mannitol or xylitol in plasma samples would provide evidence for increased gut 
permeability423, but, in this particular cohort of dogs, could be confounded by dietary intake.  
Human metabolomic studies have also reported a strong relationship between obesity and 
circulating levels of energy and glycolysis related compounds, such that glucose, lactat
pyruvate, and glycerol are elevated along with small molecule indices of inflammation, such as 
glycoprotein acetyles.420 To globally determine specific pathways with potential disruption in 
overweight and obese dogs, annotated compounds will be uploaded to Metaboanalyst424 
(http://www.metaboanalyst.ca/), a metabolomic pathway analysis tool that links individual 
metabolites with their respective metabolic pathways. This will allow us to determine the full 
range of metabolic pathways differentially affected in overweight and obese dogs and to cross 
reference them with pathway disruptions associated with cancer. In addition to providing a 
greater understanding of the metabolic perturbances associated with canine obesity, these data 
will also provide novel insight into the mechanisms underlying obesity associated co-morbidities 






The amino acid and lipid profiles of the bean-based diets have been associated with 
decreased inflammation and increased insulin sensitivity and may have affected metabolic 
pathways upstream from gut hormone expression, such as mTOR activation. We will annotate 
the small molecules in the bean diets and determine their potential bioactivity. Future st dies are 
needed to quantify the presence of bioactive molecules in bean-based diets and to correlate 
intake with modulation of metabolic parameters.  Once annotations have been completed in the 
canine metabolome, we will also determine metabolic pathways altered during weight loss, with 
and without bean intake. Of particular interest will be modification of aberrant pathways shared 
between obesity and cancer. We expect to see increases in fecal lipid excretion, decreases in 
circulating amino acids and lipids, and increase expression of bean-associated intake biom rkers 
in urine indicating pathway level changes in glucose homeostasis, inflammation, and lipid 
metabolism.  
Future Studies 
Study 1: This dissertation has provided evidence that companion dogs are exposed to 
environmental pollutants, however the extent and route of this exposure remains unknown. To 
further investigate the extent of environmental exposures in dogs, future studies need to address 
the following questions:  
1. What are the relevant chemicals and their metabolites to study to in dogs? 
2. What environmental chemicals are dogs exposed to? 
3. What are the routes of exposure in companion dogs to environmental pollutants?  
The first step will be to develop a panel of environmentally and biologically relevant 
pesticides to detect. This dissertation has provided information on 15 parent pesticides that can 






residues to look for. To expand this list, compounds currently monitored in human populations 
should also be evaluated in dogs, and targeted methods to both detect and quantify exposures 
will be useful in determining if environmental exposures have a causative role in canine obesty 
and disease. Once this detection panel has been created and validated in canine samples, a cross 
sectional study across companion dogs of different breeds, ages, gender, and living environments 
(rural vs. suburban, etc.) can be performed. In addition to detecting excreted chemicals, the study 
design should also incorporate diet and water sample analysis, as well as full pesticide u e data, 
and detailed medical records with detailed anthelmintic usage information. These studies could 
be designed to determine baseline exposures in healthy dogs, normal weight verses overweight 
dogs, or could sample across different diseases, e.g. cancer type to determine relationships 
between exposures and disease outcomes.   
Study 2: Beans have been shown to have potent anti-tumorigenic activities in humans 
and rodents, but not yet in dogs. This dissertation has demonstrated the potential of bean-based 
diets to modulate aberrant canine metabolism and the ability to confirm bean intake with bean-
associated biomarker detection. Studies to determine if a bean-based diet can modulate cancer 
associated metabolic disruptions in dogs are warranted. To more directly assess the potential of 
bean-based diets to reduce cancer risk in dogs, both mechanistic in vi ro and longitudinal studies 
are needed to answer the following questions:  
1. Do bean-derived phytonutrients have direct tumoricidal activity against canine 
cancer cells in vitro? 
2. Is the ex vivo tumoricidal activity of canine white blood cells and plasma 
improved after bean consumption? 






Study 3: Conflicting evidence exists in the literature regarding the causative role of 
obesity in cancer in dogs. This dissertation has demonstrated the utility of metabolomic 
platforms to detect changes in metabolomic profiles. Literature and data-based comparisons can 
be used to determine similarities in metabolic disturbances associated with cancer and obesity, 
however direct comparisons are needed to determine a physiological relationship between canine 
obesity and cancer and answer the following questions: 
1. What metabolic aberrancies are shared between obese dogs and dogs with cancer 
that are not shared with normal weight dogs? 
2. Are obese dogs with identified metabolic pathway dysfunctions associated with 
obesity and cancer at higher risk for developing cancer than obese that do not 
have the same metabolic aberrancies? 
3. If yes, does modulation of the dysfunction result in reduced risk of developing 
cancer?   
Study 4: One finding of potential clinical importance in this dissertation is that the 
proportion of overweight dogs with hemolytic values was higher than normal weight dogs. While 
previous studies have reported serum analytes in lean and obese dogs, none of these studies 
reported either the degree of hemolysis in samples or the proportion of hemolytic samples from 
lean and obese dogs. Excess free hemoglobin has the potential to alter accurate detection of 
multiple analytes and further investigation of the relationship between hemolytic venipuncture 
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Appendix 1: Baseline characteristics of 66 companion dogs that participated in one of three 
randomized, controlled dietary intervention clinical trials investigating the safety and digestibility 
of bean-based diets for weight maintenance and loss. 








C11 4 Normal Weight 16.4 2 F/S Mixed - Unknown 
NB10 4 Normal Weight 19.7 5 F/S Mixed - Unknown 
NB2 4 Normal Weight 22.5 5 M/N Wirehaired Pointer 
NB9 4 Normal Weight 18.7 3 F/S Rottweiler 
C1 5 Normal Weight 30.9 2 M/N Mixed - Unknown 
C10 5 Normal Weight 25.8 2 M/N Mixed - Unknown 
C2 5 Normal Weight 19 3 F/S Pit Bull 
C3 5 Normal Weight 10.6 3 M/N Mixed - Unknown 
C5 5 Normal Weight 30.7 5 F/S Golden Retriever 
C6 5 Normal Weight 28.5 4 M/N Pit Bull 
C9 5 Normal Weight 33 3 M/I Labrador Retriever 
NB1 5 Normal Weight 32.1 3 M/N Golden Retriever 
NB3 5 Normal Weight 24.1 7 F/S Dalmatian 
NB4 5 Normal Weight 20 4 F/S Mixed - Unknown 
NB8 5 Normal Weight 20.5 3 F/S Standard Poodle 
C4 6 Overweight 39.2 2 M/N Mixed - Unknown 
C7 6 Overweight 50.4 4 F/S Saint Bernard 
NB5 6 Overweight 21.1 2 M/N Australian Cattle Dog 
NB6 6 Overweight 24.2 2 F/S Australian Cattle Dog 
O_BB2 6 Overweight 17.2 3 F/S Basset Hound 
O_C1 6 Overweight 27.4 6 F/S Dalmatian 
O_C6 6 Overweight 22.4 5 F/S Australian Shepherd 
O_NB7 6 Overweight 25.9 5 M/N Australian Shepherd 
C8 7 Overweight 25.6 5 F/S Mixed - Unknown 
NB7 7 Overweight 30.9 6 M/N Mixed - Unknown 
O_BB13 7 Overweight 28.5 3 F/S Pit Bull 
O_BB14 7 Overweight 46.8 3 F/S Labrador Retriever 
O_BB5 7 Overweight 14.2 2 F/S Boston Terrier Mix 
O_BB7 7 Overweight 31.8 5 F/S Pit Bull 
O_BB8 7 Overweight 30.6 5 M/N Australian Cattle Dog 
O_C11 7 Overweight 33.1 10 M/N Cocker Spaniel 
O_C14 7 Overweight 25.2 2 F/S Labrador Retriever Mix 
O_C2 7 Overweight 37.3 6 M/N Labrador/Border Collie Mix 
O_C3 7 Overweight 62.4 4 F/I Saint Bernard 
O_C4 7 Overweight 42.7 7 F/S Labrador Retriever 
O_C5 7 Overweight 14.7 7 M/N Corgie 
O_C7 7 Overweight 15.4 3 M/N Mixed - Unknown 
O_NB1 7 Overweight 32.6 6 M/N Airdale Mix 
O_NB12 7 Overweight 63.7 3 M/N Border Collie/Corgi Mix 
O_NB2 7 Overweight 36 2 M/N Border Collie Mix 
O_NB3 7 Overweight 17.8 4 F/S Boston Terrier 














Appendix 1: Continued from previous page 
O_NB8 7 Overweight 21.2 6 F/S Australian Shepherd 
O_NB9 7 Overweight 34.3 2 F/S Boxer 
O_BB1 8 Obese 23.8 5 F/S Keeshond 
O_BB10 8 Obese 38.1 2 M/N Australian Shepherd Mix 
O_BB11 8 Obese 24.9 3 F/I Labrador/Pitbull Mix 
O_BB12 8 Obese 44.5 3 M/N Labrador/Pitbull Mix 
O_BB15 8 Obese 37.7 6 F/S Labrador Retriever Mix 
O_BB3 8 Obese 40.8 7 M/N Australian Cattle Dog 
O_BB9 8 Obese 32.8 6 F/S Australian Cattle Dog 
O_C10 8 Obese 31.6 7 F/S Border Collie 
O_C12 8 Obese 36.5 3 F/S American Spaniel 
O_C13 8 Obese 42.2 2 M/N German Shepherd/Labrador Mix 
O_C8 8 Obese 37.7 7 F/S Labrador Reteriever Mix 
O_NB10 8 Obese 44.4 5 M/N Karelian Bear Dog Mix 
O_NB13 8 Obese 39.5 6 M/N Golden Retriever 
O_NB14 8 Obese 38.3 6 F/S Border Collie/NewFoundland Mix 
O_NB5 8 Obese 10 4 M/N Daschund 
O_BB4 9 Obese 27 5 F/S Border Collie/Australian Shepherd Mix 
O_BB6 9 Obese 10.7 3 M/N Shiz Shu 
O_C15 9 Obese 38.5 7 F/S Labrador Retriever  
O_C9 9 Obese 38.6 6 F/S Golden Retriever 
O_NB11 9 Obese 16.2 7 M/N Labrador Retriever 
O_NB15 9 Obese 48.5 7 F/S Labrador Retreiver  
O_NB6 9 Obese 21.2 4 M/N Daschund 
1As reported by owner. BCS: Body Condition Score, 9 point scale 191. Dog ID indicates diet group: C = Control, BB 
= Black Bean, NB = Navy Bean; O_ indicates dogs that participated in a weight loss study. The sex of each dog is 








Appendix 2: Metabolite detected in navy bean and control dog foods and normal weight dog feces and urine with GC or LC-MS. 













C4 2-Piperidinecarboxylic acid 2 849 C1CCNC(C1)C(=O)O 
C56 s-methyl cysteine 2 24417 CSCC(C(=O)O)N 
C186 5-hydroxynorvaline 2 95562 C(CC(C(=O)O)N)CO 
C1 Sucrose 2 5988 C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O)O 
C7 Citric acid 2 311 C(C(=O)O)C(CC(=O)O)(C(=O)O)O 
C490 -tocopherol 2 92729 CC1=C(C=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)O 
C84 β-sitosterol 2 222284 CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C 
C18 Taurine 2 1123 C(CS(=O)(=O)O)N 
C825 α-tocopherol acetate 2 86472 CC1=C2C(=C(C(=C1C)OC(=O)C)C)CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C 
C91 Fructose 2 5984 C(C(C(C(C(=O)CO)O)O)O)O 
C30 Glycerol-3-Phosphate 2 754 C(C(COP(=O)(O)O)O)O 
C385 α-tocopherol 2 14985 CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O 
C2 Deoxycholic acid 2 222528 CC(CCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C 
C5 Lithocholic acid 2 9903 CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C 
C35 Palmitoleic acid 2 5282745 CCCCCCC=CCCCCCCCC(=O)O 
C269 L-Threitol 2 445969 C(C(C(CO)O)O)O 
C526 Hydroquinone 2 785 C1=CC(=CC=C1O)O 
C9 Glucose 2 79025 C(C1C(C(C(C(O1)O)O)O)O)O 
C10 D-Pinitol 2 164619 COC1C(C(C(C(C1O)O)O)O)O 
C19 Monosaccharide 3   
C3 Trehalose 2 7427 C(C1C(C(C(C(O1)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O 
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C40 α-Tocopherol 2 14985 CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O 
C59 Lithocholic acid  2 9903 CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C 
C246 Myristic Acid  2 11005 CCCCCCCCCCCCCC(=O)O 
C688 Margaric acid  2 10465 CCCCCCCCCCCCCCCCC(=O)O 
C190 Polycyclic Hydrocarbon  3   
C691 Arachidic Alcohol  2 12404 CCCCCCCCCCCCCCCCCCCCO 
C428 Hydroquinone  2 785 C1=CC(=CC=C1O)O 
C292 Cycloartenol  2 382580 CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)O)C)C 
C4 Deoxycholic acid  2 222528 CC(CCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C 
C232 α-Tocopherol acetate  2 86472 CC1=C2C(=C(C(=C1C)OC(=O)C)C)CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C 
C1 Glucose  2 79025 C(C1C(C(C(C(O1)O)O)O)O)O 
C30 Steroid  3   
C53 Steroid  3   
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C6 Estradiol  2 5757 CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O 
C24 Peptide  3   
C36 Peptide  3   
C69 Peptide  3   
C18 Suberic acid  2 10457 C(CCCC(=O)O)CCC(=O)O 
C5 Kynurenine  2 846 C1=CC=C(C(=C1)C(=O)CC(C(=O)O)N)N 
C63 Peptide  3   
C180 Peptide  3   
C625 Saccharide  3   
C17 Peptide  3   
C196 Trigonelline 2 5570 C[N+]1=CC=CC(=C1)C(=O)[O-] 
C909 Peptide  3   
C156 homoeriodictyol chalcone 2 21117850 COC1=C(C=CC(=C1)C=CC(=O)C2=C(C=C(C=C2O)O)O)O 
C59 Dipeptide 3   
C32 Kynurenic acid 2 3845 C1=CC=C2C(=C1)C(=O)C=C(N2)C(=O)O 
Each annotated metabolite is reported with its corresponding “cluster” number (C), identification confidence level, PubChem 
Compound Identifier (CID), and Simplified Molecular Input Line Entry Specification (SMILES). Confidence levels were assigned 
based on criteria defined by Sumner et. al. (Proposed minimum reporting standards for chemical analysis Chemical Analysis 
Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 2007, 3 (3), 211-221.): 1 = metabolite annotation 
confirmed with authentic standards; 2 = annotation based on spectral similarities with in–house and public libraries; 3 = compound 
classification based on spectral similarities with in-house and public libraries; and 4 = unknown compounds. aAnalyzed with GC-
MS; banalyzed with LC-MS.  
 
